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1. Rheumatoid Arthritis 
 
Rheumatoid arthritis (RA) can be defined as a chronic inflammatory disease with 
systemic autoimmune component, and is mainly characterized by aggressive synovial 
hyperplasia, synovitis, progressive destruction of cartilage, and bone erosion with painful 
swelling of small joints, fatigue, prolonged stiffness, and fever caused by immune responses and 
specific innate inflammatory processes (Zvaifler 1965, Creemers 2004, Brooks 2006).  
Global prevalence of RA has been estimated to be around 0.5-1.0% of adults in 
developed countries with a large variation across regions and approximately three-times more 
common in the female gender. The disease may begin at any age, but around 80% of all patients 
initiate the disease between the ages of 35 and 50 years (Rudan, Sidhu et al. 2015).  
RA patients exhibit an inflammatory chronic condition, which usually affects 
symmetrically diarthrodial and small joints of hands and feet. RA is characterized by the 
inflammation of synovial joint tissues leading hyperplasia of the synovial lining cell layer and the 
formation of rheumatoid pannus, which is capable of destroying adjacent cartilage and bone 
and causing subsequent joint deformity (Verpoort, van Dongen et al. 2004). Additional 
characteristic features of RA synovitis include neo-angiogenesis and infiltration of immune cells 
such as macrophages and lymphocytes which can form aggregates. Autoimmunity, identified by 
the production of auto-antibodies such as rheumatoid factor (RF) or anti-citrullinated protein 
antibodies (ACPA) precedes the clinically detectable onset of inflammatory arthritis and can last 
for years (Chapuy-Regaud, Nogueira et al. 2005, Wegner, Lundberg et al. 2010). The clinic 
outcome is extremely variable and may extend from a soft autolimitant AR to a multisystemic 
inflammation with a rapid outcome (Finckh 2009). In this sense, about 40% of patients, AR 
disease may involve an extraarticular component, affecting various organs and systems 
including skin, lungs, eyes, heart and blood vessels. The progressive articular or extra-articular 
deterioration, leads deformity, pain, functional disability and a decrease in life expectancy of 
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these patients.  These characteristics justify its multidisciplinary approach, which includes 
medical treatment, physiotherapy and nutritional therapy. The different treatments are aimed 
primarily to suppress the inflammatory process alleviating the symptoms and signs of the 
disease. 
 The etiology of RA is unknown. A genetic predisposition suggested by a link with HLA-
DR4 and related allotypes of MHC class II, the T-cell-associated protein PTPN22, STAT4 and 
TRAFI1/C5, among others gene polymorphisms, has been related to a worse outcoming and a 
higher degree of articular destruction and extra-articular manifestations (Messemaker, Huizinga 
et al. 2015). However, the concordance rate of RA in monozygotic twins is low but higher than 
that in dizygotic twins suggesting that in addition to genetic factors, environmental factors as 
well as their interaction can be decisive in the development and disease progression. Among 
environmental factors, smoking has been recognized as a major risk factor RA. In fact, smoking 
has been associated with an increased risk of developing seropositive RA (RF and/or ACPA) 
(Chang, Yang et al. 2014). Nevertheless, other environmental factors including socio-economic, 
hormonal, silica exposure, stimuli like viruses, bacteria and stress, and dietetic factors may 
contribute to the disease progression (Cutolo 2007, Gomez-Puerta, Gedmintas et al. 2013). 
The pathogenesis of RA is incompletely understood but hyperplasia of the synovial 
membrane is a hallmark of RA pathology, which is characterized by both hyperproliferation of 
synovial fibroblasts and massive infiltration of inflammatory immune cells, including CD4+ T-
cells and innate immune cells (Komatsu and Takayanagi 2012). Once the process starts, a 
progressive recruitment of inflammatory T cells and macrophages into the joints occurs through 
a complex series of adhesion and migratory events. In this sense, initially there is an extensive 
increase in the number of innate effector cells in the synovial lining layer, which becomes several 
layers thick. Sublining layer becomes infiltrated with inflammatory mononuclear cells, including 
lymphocytes and macrophages and mast cells.  In fact, macrophages are central effectors of 
synovitis and act though release of cytokines, reactive oxygen and nitrogen intermediates, 
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production of prostanoids and matrix-degrading enzymes, phagocytosis and antigen 
presentation. In addition, neutrophils transmigrate rapidly from the intravascular compartment 
to synovial fluid in the joint cavity contributing to the joint swelling and synthesizing 
prostaglandins, proteases and reactive oxygen intermediates (Cascao, Rosario et al. 2010). All of 
these cells, including resident fibroblasts, produce cytokines, which together with locally 
produced autoantibodies and immune complexes and complement, maintain the chronic 
inflammation leading the membrane expansion, which forms pannus. The cell layer of fibroblast- 
and macrophage-like cells which compose the pannus, can produce proteinases, receptor 
activator of nuclear factor kappa B ligand (RANKL) and other factors causing cartilage 
destruction. The persistent synthesis of proinflammatory cytokines plays a remarkable role in 
the development of RA disease from early autoimmunity step through continuous chronic 
inflammation into destruction of joint tissue. In addition, the prolonged immune activation is 
the main responsible to erosive and systemic bone loss and an increased propensity to fall in RA 
patients.   
The development of the inflammatory process in RA involves many different type of cells 
and a complex cytokine network. Upon activation and expansion, CD4+ T cells develop into 
different T helper cell subsets with different cytokine profile and distinct effector functions. 
Activated T cells that secret IFNϒ, IL2, IL12, IL18, TNF are produced in the synovial fluid and 
expressed in the synovial membrane. Particularly, TNF and IL-1β are considered as the main 
proinflammatory cytokines in the pathogenesis of RA. TNF plays a fundamental role through 
activation of cytokine and chemokine expression, expression of endothelial-cell adhesion 
molecules, protection of synovial fibroblasts, promotion of angiogenesis, suppression of 
regulatory T cells and induction of pain (McInnes and Schett 2011). In fact, treatment with TNF-
α inhibitors results in decreased inflammation and bone protection in RA patients (Scott and 
Kingsley 2006). IL-1 family cytokines are also abundantly expressed in RA and promote the 
activation of leucocytes, endothelial cells, chondrocytes and osteoclasts (Brennan and McInnes 
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2008). Th17 cells, via their production of IL-17, contribute crucially to joint inflammation and 
bone erosion in RA (Kotake, Udagawa et al. 1999, Lubberts 2010, Jung, Kim et al. 2014). IL-6 and 
TGF-β induce Th17 development and IL-23 promotes Th17 cell expansion. In addition, these 
cytokines activate macrophages to secret other proinflammatory cytokines such as TNF and IL-
1β, IL-6, IL-12, RANKL expression on T cells, promote the differentiation of B cells and stimulate 
the release of matrix metalloproteases (MMP) provoking the degradation of the cartilage and 
the activation of osteoclasts leading to the bone resorption (Schett and Teitelbaum 2009, 
Chimenti, Triggianese et al. 2015).  
Figure 1. Adaptive and Innate Immune Processes within the Joint in Rheumatoid Arthritis (McInnes and 
Schett 2011) 
Understanding the intracellular targets that regulate cytokines in RA can potentially lead 
to new therapeutic interventions. In this sense, the inhibition of key signal transduction 
pathways in inflammation such as mitogen-activated protein kinase (MAPK) pathway, 
phosphatidylinositol-3 protein kinase (PI3) pathway, janus kinase-signal transducer and 
activator of transcription (Jak-STAT) and nuclear factor kappa B (NFKB) would be expected to 
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abolish the cell activation by cytokines and production of these proinflammatory cytokines in 
RA (Morel and Berenbaum 2004). For example, NF-κB is activated in the synovium of patients 
with RA and regulates genes that contribute to inflammation including TNF, IL-6, IL8, iNOS and 
COX-2 (Aupperle, Bennett et al. 2001). Similarly, MAPK have attracted considerable attention as 
potent therapeutic targets in RA. MAPK are also key regulators of cytokines and MMP 
production and could also targeted in RA. All three kinases families, c-Jun N-terminal kinase 
(JNK), p38 and extracellular signal-regulated kinase (ERK), are expressed in rheumatoid synovial 
tissue (Schett, Tohidast-Akrad et al. 2000).  
1.1. Pharmacological treatment of RA 
The current pharmacological therapies for the treatment of RA are designed to fast 
control the disease activity and prevent the progression of damage in tissues. These include 
early and strict control of the activity, the use of drugs for the treatment of moderate disease, 
and induction of remission with use of biological drugs. 
First line therapy including medications that suppress inflammation such as nonsteroidal 
anti-inflammatory drugs (NSAIDs) and glucocorticoids; they act rapidly to improve pain and 
swelling due to RA. Disease-modifying antirheumatic drugs (DMARDs) are slower-acting 
compounds, not only improve symptoms but also diminish clinical and radiographic progression. 
In 1999, first biological-response modifier was marketed. These agents were designed to target 
the inflammatory mediators of tissue damage in RA (TNF-α, IL-1). The newest pharmacological 
target are anti-IL-6-receptor monoclonal antibodies. 
NSAIDs 
NSAIDs relieve the bone and joint inflammatory symptoms of RA; can be useful in the 
first weeks after the onset of RA symptoms while a diagnostic workup is undertaken, before a 
diagnosis is certain, and as bridge therapy while waiting for a slow-acting DMARD to become 
effective. The mechanism of action of NSAIDs is the inhibition of COX. COX is critical in the 
metabolism of arachidonic acid to the pro-inflammatory prostaglandins. Two isoforms of COX 
 Introducción 
 
8 
 
have been extensively studied in humans: COX-1 and COX-2. COX-1 is expressed constitutively 
in the stomach, intestines, kidneys, and platelets and is involved in functions such as gastric 
protection from hydrochloric acid. COX-2, a predominantly inducible isoenzyme, is involved in 
the production of prostaglandins E2 and I2, which are upregulated in the inflammatory response 
(Vane and Botting 1998). NSAIDs are usually well tolerated for short periods of time; however, 
with chronic use they sometimes lead to gastrointestinal complications, such us ulcer formation, 
perforations, and bleeding (Chiba, Sato et al. 2005). Another potential adverse effect of NSAIDs 
is their renal toxicity. 
Glucocorticoids. 
Glucocorticoids have been widely used in the treatment of RA. Although high doses of 
glucocorticoids clearly cause unacceptable toxicity, daily doses of prednisone (or its equivalent) 
of ≤15 mg may diminish pain and swelling in many patients. This dosage of glucocorticoids may 
also have a limited disease-modifying effect in patients with RA (van Everdingen, Jacobs et al. 
2002). First, they promote the expression of lipocortin-1, which inhibits the enzyme 
phospholipase A2 and the generation of arachidonic acid. Second, their transcription products 
inhibit the action of NF-κΒ and AP-1 protein, which act to upregulate proinflammatory 
molecules, like TNF and IL-1. Third, they exert an effect through membrane-associated receptors 
and second messengers-a nongenomic effect (De Bosscher, Schmitz et al. 1997). Glucocorticoids 
present a large number of adverse effects such us, diabetes, hypertension, peptic ulcer, among 
others. Given the slow onset of action of traditional DMARDs, low doses of glucocorticoids are 
often used as a bridge therapy to control symptoms until the DMARDs or biological agents 
become effective. Monotherapy with glucocorticoids is not recommended. 
DMARDs 
Methotrexate 
Methotrexate low dose is used as an immunosuppressant in autoimmune and rheumatic 
diseases. Methotrexate treatment has demonstrated effectiveness, reliability, sustained long-
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term action and high tolerability. Up to four mechanisms of action have been proposed for the 
drug. First, it works as an antifolate agent (Quemeneur, Gerland et al. 2003). Second, 
methotrexate may diminish the accumulation of toxic compounds, especially polyamines, which 
contribute to tissue injury in RA (Cronstein 2005). Third, methotrexate may reduce intracellular 
levels of glutathione (Phillips, 2003). Finally, it increases extracellular adenosine levels, an anti-
inflammatory action (Montesinos, Desai et al. 2003). All of these mechanisms induce inhibition 
of the immune cellular proliferation and strong anti-inflammatory activity. Potential adverse 
effects of methotrexate include hepatitis and cirrhosis, oral ulcers, cytopenias, and interstitial 
pneumonitis. According these side effects, it is important monitoring patients receiving 
methotrexate treatment (Kremer, Alarcon et al. 1994).   
Hydroxychloroquine  
Hydroxychloroquine is an antimalarial that has been introduced as therapy for RA. The 
efficacy of hydroxychloroquine depends on the interference with antigen presentation; 
lysosomal membrane stabilization, and inhibition the metabolism of deoxyribonucleotides (Fox 
and Kang 1993, Weber and Levitz 2000). Hydroxychloroquine is rarely used as monotherapy for 
RA; its main clinical utility is in combination with other DMARDs.  
Sulfasalazine 
Sulfasalazine is cleaved in the intestine by bacterial organisms into 5-aminosalicylic acid 
and sulfapyridine. Sulfapyridine seems to exert the therapeutic action after intestinal 
absorption. The mechanism of action of sulfasalazine is based on neutrophil function inhibition, 
immunoglobulin levels reduction, and interference with T-cell function via suppression of NF-κB 
activation (Carlin, Djursater et al. 1992, Gadangi, Longaker et al. 1996). The most common 
toxicities are gastro intestinal-related (nausea, vomiting, diarrhea, abdominal pain) and 
hematologic in nature (neutropenia, thrombocytopenia), but the drug is generally considered 
safe and well-tolerated (Symmons, Salmon et al. 1988).  
Leflunomide 
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Leflunomide is an immunomodulatory drug, is a competitive inhibitor of dihydroorotate 
dehydrogenase, enzyme required for the de novo synthesis of pyrimidines, necessaries for the 
activation of lymphocytes. Therefore, blockade of the pyrimidine-synthesis pathway has 
antiproliferative effects. Leflunomide is generally well tolerated; hepatotoxicity and 
gastrointestinal intolerance are its most important adverse reaction (Olsen and Stein 2004). It is 
most commonly used as an alternative for methotrexate-intolerant patients. 
Other antirheumatic drugs 
Gold salts, their mechanism of action include the reduction of circulating B cells, immune 
complexes, rheumatoid factor, and immunoglobulin levels (Hirohata, Nakanishi et al. 1999). 
Long treatment with gold salts could present toxic reactions, including mucocutaneous 
reactions, proteinuria, and cytopenias. 
Minocycline, from tetracycline family, in addition to their antimicrobial action, it has anti-
inflammatory and immunomodulatory properties (O'Dell, Paulsen et al. 1999). Among its side 
effects, include autoimmune syndromes (serum sickness, polyarthritis, druginduced lupus, and 
vasculitis), headaches, GI intolerance, and a greying skin pigmentation. 
Cyclosporine, a calcineurin inhibitor demonstrated efficacy in the treatment of RA (Sawitzke AD 
2005). However, given the availability of safer DMARDs and biological agents, its role is now 
limited to a third-line agent after failure of first- and second-line drugs. 
Biological agents 
TNF- α antagonist 
TNF-α, an inflammatory cytokine, that is important in the pathogenesis of RA, binds to 
two receptors, the type 1 TNF receptor (p55) and the type 2 TNF receptor (p75), that are 
expressed on many types of cells. The biologic activity of TNF-α can be attenuated by soluble 
TNF receptors. Patients with RA have high concentrations of TNF-α in the synovial fluid. TNF-α 
is localized to the junction of the inflammatory pannus and healthy cartilage, and high synovial 
fluid TNF-α concentrations are associated with the erosion of bone (Olsen and Stein 2004).  
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Infliximab  
Infliximab is a chimeric molecule that joins the Fc region of human immunoglobulin G1 
(IgG1) with the variable region of a mouse antibody against TNF-α (Elliot, Maini et al. 2008). It 
binds to soluble and membrane-bound TNF-α with high affinity, impairing the binding of TNF-α 
to its receptor; inducing a complement and antibody-dependent response against cells that 
express TNF-α. Infliximab can be used as monotherapy, but administration infliximab plus 
methotrexate is more effective (Lipsky, van der Heijde et al. 2000).  
Etanercept  
Etanercept is a soluble molecule composed of two recombinant p75 TNF-receptor proteins fused 
together to form a dimer (Nestorov 2005). Each of these molecules is linked to the Fc portion of 
human IgG1 to provide them a longer half-life. Etanercept is indicated in the treatment of 
refractory RA to others DMARDs included methotrexate. 
Adalimumab 
Adalimumab is a recombinant human IgG1 monoclonal antibody that binds to human 
TNF-α with high affinity, both impairing cytokine binding to its receptors and lysing cells that 
express TNF-a on their surface. It has a long circulating half-life (approximately 10–20 hours) and 
can be self-administered. Adalimumab is indicated in the treatment of refractory RA to others 
DMARDs included methotrexate. 
IL-1 antagonist 
Anakinra 
IL-1 is a pro-inflammatory cytokine produced by monocytes, macrophages, and some 
specialized cells in the synovial lining, has inflammatory effects that include the induction of IL-
6 and COX-2. In patients with rheumatoid arthritis, levels of IL-1-receptor antagonist in the 
damaged joint are diminished. Anakinra is a recombinant form of human interleukin- 1–receptor 
antagonist that targets the type I interleukin-1 receptor that is expressed in many tissues. 
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Anakinra in combination with methotrexate are indicated in patients who have not responded 
to methotrexate monotherapy (Cohen, Hurd et al. 2002).  
Anti-CD20 
Rituximab 
Rituximab is a monoclonal antibody directed against an antigen, CD20, on the surface of 
all B cells other than stem cells and pre-B lymphocytes. It does not affect plasma cells since they 
do not possess CD20 on their cell surface. It exerts its effect by binding to CD20 on B cells and 
causing cell lysis by both complement-dependent and antibody-dependent cell mediated 
cytotoxicity. It has efficacy in RA patients who have failed conventional DMARDs and in RA 
patients who have failed anti- TNF agents (Edwards, Szczepanski et al. 2004, Cohen, Emery et al. 
2006).  
Anti-CD80/86 
Abatacept 
Abatacept is a fusion protein linking the extracellular domain of human cytotoxic T-
lymphocyte associated antigen 4 (CTLA-4) to the Fc portion of human IgG1. It works by 
competing for the binding between CD28 on the T cell and CD80/86 on the antigen-presenting 
cell. This is an important co-stimulatory signal that is essential for T cell activation (Fan and Leong 
2007). It is effective in patients who have an inadequate response to either methotrexate or one 
or more TNF-inhibitors (Genovese, Becker et al. 2005).  
IL-6 antagonist 
Tocilizumab 
Tocilizumab is a humanized anti-human IL-6 receptor antibody that specifically inhibits 
the biological activity of IL-6 by competitively inhibiting the binding of IL-6 to the IL-6 receptor 
(Paul-Pletzer 2006). Tocilizumab monotherapy has been shown to be effective in the treatment 
of RA and may be an option for patients that have side effects with combination biologics and 
DMARDs (Mima and Nishimoto 2008).  
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2. Nutritional therapy in RA  
Clinical characteristics of RA justify its multidisciplinary approach, within which nutritional 
intervention is included. In the last years, it has been highlighted that consumption of some 
foods as well as a nutritive function, have a profound influence on health outcomes. Certain 
nutritional components influence the cellular metabolism and interfere in the pathological 
inflammatory process, so that they may act as coadjutant in the treatment of many 
inflammatory diseases, among which RA is included (Sales, Oliviero et al. 2009, Gonzalez 
Cernadas, Rodriguez-Romero et al. 2014).  
Importantly, recent research has suggested that dietary patterns such as the traditional 
Mediterranean diet of countries that surround the Mediterranean Sea may confer protection 
from certain chronic diseases related to oxidative stress, inflammation and the immune system. 
Essentially, the traditional diet emphasizes foods from plant sources such as vegetables, fruits, 
nuts, and grains, fish , limited meat consumption, small amounts of wine and olive oil as the 
main fat source. The beneficial effects of the Mediterranean diet has been proven not only to 
cardiovascular diseases but also for diabetes, obesity, arthritis and cancer (Cardeno, Sanchez-
Hidalgo et al. 2013). Evidence points out that Mediterranean diet decreases both pain and 
disease activity leading to better outcomes, and decreasing the doses of anti-inflammatory 
drugs, which exhibit important secondary effects (Smedslund, Byfuglien et al. 2010).  
Evidence on polyunsaturated fatty acids suggests that they produce clinical improvement 
and inhibitory effects over the RA inflammatory response. Fatty acids can influence 
inflammation through a variety of mechanisms, including acting via cell surface and intracellular 
receptors/sensors that control inflammatory cell signaling and gene expression patterns. Some 
effects of fatty acids on inflammatory cells appear to be mediated by, or at least are associated 
with, changes in fatty acid composition of cell membranes. Changes in these compositions can 
modify membrane fluidity, lipid raft formation, cell signaling leading to altered gene expression, 
and the pattern of lipid and peptide mediator production. During inflammatory diseases, 
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eicosanoids are produced from polyunsaturated fatty acids present in cellular membranes. 
Inflammatory activity of these molecules depends on the nature of their precursors (Calder 
2011).  
Cells involved in the inflammatory response are typically rich in the n-6 fatty acid arachidonic 
acid, so when arachidonic acid (n-6) is present, pro-inflammatory molecules are released. 
Whereas eicosapentaenoic acid (EPA) (n-3)-derived eicosanoids are weakly inflammatory but 
the contents of arachidonic acid and of the n-3 fatty acids eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) can be altered through oral administration of EPA and DHA. 
In this way, fish oils, rich in n-3 polyunsaturated fatty acids, increase the content of 
eicosapentaenoic-eicosanoids and decrease arachidonic acid in immune and endothelial cells 
leading to a lower inflammatory activity. EPA and DHA give rise to resolvins, which are anti-
inflammatory, and inflammation resolving. Mechanisms underlying the anti-inflammatory 
actions of marine n-3 fatty acids  also include disruption of lipid rafts, inhibition of activation of 
the pro-inflammatory transcription factor nuclear factor kappa B so reducing expression of 
inflammatory genes, activation of the anti-inflammatory transcription factor peroxisome 
proliferator activated receptor γ and binding to the G protein coupled receptor GPR120 (Calder 
2015). Thus, fatty acid exposure and the fatty acid composition of human inflammatory cells 
influences their function. As a result of their anti-inflammatory actions marine n-3 fatty acids 
have therapeutic efficacy in rheumatoid arthritis, although benefits in other inflammatory 
diseases and conditions have not been unequivocally demonstrated (Calder 2012).  
Fish oil has been shown to slow the development of arthritis in animal models and to reduce 
disease severity. A number of randomized controlled trials of marine n-3 PUFAs have been 
performed in patients with RA. Evidence is seen for a fairly consistent, but modest, benefit of 
marine n-3 PUFAs on joint swelling and pain, duration of morning stiffness, global assessments 
of pain and disease activity, and use of non-steroidal anti-inflammatory drugs The therapeutic 
dose of n-3 fatty acids is not clear (Miles and Calder 2012).  
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Recently a randomized controlled trial (RCT) of high-dose v. low-dose fish oil in recent-onset 
RA demonstrated that the group allocated to high-dose fish oil had increased remission and 
decreased failure of DMARD therapy. In addition, fish oil was associated with benefits additional 
to those achieved by combination 'treat-to-target' DMARDs with similar methotrexate use. 
These included reduced triple DMARD failure and a higher rate of the American College of 
Rheumatology remission (Smedslund, Byfuglien et al. 2010). 
As regards with olive oil , and specifically the beneficial effect of extra virgin olive oil  
(EVOO) consumption has been ascribed to non-polar lipids  or its high monounsaturated fatty 
acid (MUFA) content present in the major fraction of EVOO (98–99%) (Berbert, Kondo et al. 
2005, Bermudez, Lopez et al. 2011). However, EVOO also contains multiple minor components 
with important biological properties. Nowadays, it is clear that many of the beneficial effects of 
ingesting EVOO are due to its minor polyphenol compounds such as flavonoids, lignans 
(acetoxypinoresinol), secoiridoids (oleuropein-aglycone and ligstroside aglycone) and their 
hydrolysis products hydroxytyrosol (HT) and tyrosol (Ty), respectively, among others.  
Recently we have evaluated the effects of dietary EVOO on type II collagen-induced 
arthritis (CIA) in mice.  EVOO diet significantly reduced joint edema and cartilage destruction, 
preventing the arthritis development (Rosillo, Sanchez-Hidalgo et al. 2015). Besides, we also 
have studied the effects of the oral administration of the polyphenol extract (PE) from EVOO in 
the arthritis model of CIA in mice. We demonstrated that PE decreased joint edema, cell 
migration, cartilage degradation and bone erosion by reducing the levels of proinflammatory 
cytokines and prostaglandin E2 in the joint as well as the expression of cyclooxygenase-2 and 
microsomal prostaglandin E synthase-1 (Rosillo, Alcaraz et al. 2014). We could suggest that the 
responsibility for such beneficial properties could to be assigned to both an adequate fatty acid 
profile of EVOO and the high proportion of phenolic compounds in according with our recent 
data (Sanchez-Fidalgo, Cardeno et al. 2013, Rosillo, Alcaraz et al. 2014, Aparicio-Soto, Sanchez-
Hidalgo et al. 2015).  Also the presence of other valuable minor components   present in the 
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unsaponifiable fraction of the oil such as aliphatic and triterpenic alcohols, sterols, 
hydrocarbons, phytosterols with important antiinflammatory properties (Cardeno, Magnusson 
et al. 2014, Sanchez-Fidalgo, Villegas et al. 2015) could play a pivotal role.  Moreover, these 
improved effects observed could be due to a possible synergistic effect among EVOO 
constituents, since it is not clear whether all the possible beneficial mechanisms act 
independently of each other or whether they have a synergistic or competitive action.  
Antioxidant supplements and diets have long been advocated for the treatment of RA, 
osteoarthritis (OA) and other inflammatory arthritis. In RA, reactive oxygen species and other 
free radicals are associated with the inflammation process via numerous pathways (Mahajan 
2004). These include the role of nitrous oxide in regulating vascular tone, superoxide in 
fibroblast proliferation and hydrogen peroxide in the transcription of cytokines IL-2 and TNF-α. 
During inflammation, oxidation modifies low-density lipoproteins, inactivates α-1-protease 
inhibitor, damages DNA and causes lipid peroxidation. Reactive oxygen species also damage 
cartilage and the extracellular matrix and inhibit collagen and proteoglycan synthesis. Evidence 
that increased oxidative stress or deficient antioxidant status are important in the pathogenesis 
of RA comes from several studies .Epidemiological studies have shown that low intake of dietary 
antioxidants is associated with the incidence of RA. Furthermore, animal studies have 
demonstrated an anti-inflammatory role for some antioxidants including superoxide dismutase 
(SOD) and vitamin E in experimentally induced arthritis (Canter, Wider et al. 2007). Clinical trials 
testing the efficacy of vitamin E in the treatment inflammatory arthritis have been 
methodologically weak and have produced contradictory findings.   
In addition, in a randomized clinical trial in which 64 women with RA who fulfilled the 
eligibility criteria were randomly allocated to an intervention or a control group. Vitamin K1 or 
placebo was administered to the participants for 8 weeks. Vitamin K1 supplementation did not 
alter joint destruction and immune status in the patients with RA compared with the controls 
(Shishavan, Gargari et al. 2015). Thus, there is presently no convincing evidence that selenium, 
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vitamin A, vitamin C, Vitamin K1 or the combination product selenium ACE is effective in the 
treatment of any type of arthritis. 
Furthermore, to its well-documented involvement in mineral homeostasis, vitamin D 
seems to have broad effects on human health that go beyond the skeletal system. Prominent 
among these so-called non-classical effects of vitamin D are its immunomodulatory properties. 
The association of vitamin D deficiency with RA severity supports the hypothesis of a role for 
vitamin D in the initiation or progression of the disease, or possibly both. However, whether 
25(OH)D status is a cause or consequence of RA is still incompletely understood and requires 
further analysis in prospective vitamin D supplementation trials (Jeffery, Raza et al. 2015).  
Suboptimal vitamin D status was recently acknowledged as an independent predictor of 
cardiovascular diseases and all-cause mortality in several clinical settings, and its serum levels 
are commonly reduced in Rheumatoid Arthritis (RA). Patients affected by RA present 
accelerated atherosclerosis and increased cardiovascular morbidity and mortality with respect 
to the general population. In a recent study, RA patients with moderate disease activity 
presented with low vitamin D levels, low CD34+ cell count, increased PWV and cIMT; we found 
that vitamin D deficiency is associated to CD34+ cell reduction in peripheral blood, and with 
fibrinogen levels. This suggests that vitamin D might contribute to endothelial homeostasis in 
patients with RA (Lo Gullo, Mandraffino et al. 2015).  
3. Dietary polyphenols in the control of RA 
Polyphenols are the biggest group of phytochemicals, and many of them have been found 
in plant-based foods. Dietary polyphenols have receive much attention among nutritionist, food 
scientist and consumer due their roles in human health (Tsao 2010). More than 8000 phenolic 
structures are currently known, and among them over 4,000 flavonoids have been identified 
(Pandey and Rizvi 2009).  
It has been reported that dietary polyphenols have pronounced anti-inflammatory, anti-
cancerous and immunomodulatory effects to reduce the onset of disease progression (Liu 2003).  
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Their beneficial effects on rheumatoid arthritis derive from their ability to the regulation of 
B and T cell responses, the inhibition of relevant signalling pathways such as JAK-STAT, MAPKs 
and NF-κB thus controlling the production of inflammatory mediators such as cytokines, 
chemokines, proinflammatory enzymes (Fouda and Berika 2009, Hou, Wu et al. 2009).  
Most of the phytochemicals are represented by polyphenols, which are divided into several 
classes according to their chemical structures (Bruneton 2001).  
• Phenolic acids that are present in artichoke, green coffee, tea, rosemary and other 
fruits. They can be further divided into two main types, benzoic acid (C6-C1) and cinnamic 
acid (C6-C3). 
• Lignans that are present in sesame and line seeds. It has been described their 
antimicrobial, antifungal and antitussive proprieties. 
• Diarylheptanoids and arylalkanones are derived from phenylpropane acid, including 
curcuminoids and gingerols. 
• Stilbenes present in the human diet in low quantities. Resveratrol is the main studied 
compound of this group. 
• Flavonoids including six groups: Flavones, Flavonols, Flavanones, Flavanols, 
Anthocyanins and Isoflavones. 
A wide range of evidences have demonstrated the anti-inflammatory and antiarthritic 
effects of several dietary polyphenols in vitro (Table 1) and in vivo (Table 2). 
3.1. Phenolic acids. 
Phenolic acids can be further divided into two main types, benzoic acid (C6-C1) and 
cinnamic acid (C6-C3). While fruits and vegetables contain many free phenolic acids, in grains and 
seeds (particularly in the bran or hull) phenolic acids are often in the bound form. There are 
some evidences in vitro and in vivo studies where demonstrates that some of these phenolic 
acids could show antiarthritic effects. 
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3.1.1. Benzoic acid derived 
Yoon et al. have shown anti-inflammatory effects of gallic acid using fibroblast-like 
synoviocytes (RA-FLS) cells isolated from the synovial tissues of patients with RA. They 
demonstrated that gallic acid could induce apoptosis in RA-FSL through regulation of apoptosis 
related protein expressions such as caspase-3, Bcl-2, Bax, p53 and pAkt. As well, gallic acid was 
able to reduce pro-inflammatory cytokines (IL-1β, IL-6), chemokines (CCL-2/MCP-1, CCL-7/MCP-
3), COX-2, and MMP-9 gene expression (Yoon, Chung et al. 2013). On the other hand, treatment 
with protocatechuic acid significantly reduced the paw swelling in adjuvant-induced arthritis 
(AIA) in rats. Additionally, these treatment could decease lipid peroxides (LPO) expression and 
reactive free radicals nitric oxide (NO) levels and increase antioxidant enzyme expression, such 
as, superoxide dismutase (SOD), catalase and glutathione (GSH) in liver. The antiarthritic activity 
of protocatechuic acid was found to be equivalent to that of diclofenac sodium (Lende, 
Kshirsagar et al. 2011).  
3.1.2. Cinnamic acid derived 
It is well know that T cells are involved in initialling disease process and, even more, 
emerging evidence suggests that these cells also perpetuate RA pathogenesis at the late stage 
by secreting various mediators, such as receptor activator of NK-kB ligand (RANKL), IL-17 and 
osteopontin, which influence osteoclasts and FLS (Cho, Yoon et al. 2004, Xu, Nie et al. 2005). 
Rosmarinic acid has shown has apoptotic activity toward T cells from RA patients and further 
verified target T cell subsets. CD3+CD25+ activated T-cell subsets from most of the RA patients 
displayed significantly higher apoptosis rates than did the PBMCs and total CD3+ T cells. 
Furthermore, activated and effector CD4+ T cells, including CD4+CD25+ and CD4+CD45RO+ T 
cells, had a tendency of being more susceptible to rosmarinic acid-induced apoptosis than that 
of resting and naïve T-cell subsets. Rosmarinic acid was able to induce the release of cytochrome 
c from mitochondria and the blockage of mitochondrial depolarization inhibited apoptosis (Hur, 
Suh et al. 2007). On the other hand, Hsu et al., have reported that Rosmarinic acid decreased 
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the number of multinucleated osteoclasts in a dose-dependent manner using osteoclast-
precursor cell line RAW264.7 stained with tartrate-resistant acid phosphatase (TRAP). The 
effects of this phenolic acid on osteclatogenesis were further confirmed by using primary murine 
bone marrow-derived macrophages (BMM) stimulated with RANKL. Rosmarinic acid was able to 
significantly reduced the c-fos, nuclear factor of activated T cells c1(NFATc1), TRAP, OSCAR, DC-
STAMP, and ß3 integrin mRNA expression through inhibition of phosphorylation of p38 and ERK 
MAPKs and blocking the IkB degradation and supressing the subsequent nuclear translocation 
of NF-kB p65 (Hsu, Cheng et al. 2011). Similar activity showed chlorogenic acid who inhibited 
RANKL- mediated osteoclast differentiation by down-regulation of phosphorylation of p38, JNK 
and ERK MAPKs and IkB degradation. Chlorogenic acid, also supressed the mRNA expression of 
NFATc1, TRAP and OSCAR in RANKL-treated BMMs (Kwak, Lee et al. 2013). According to the in 
vivo studies, rosmarinic acid has been verified that ameliorated CIA, as manifested by reduction 
of synovitis and depletion of COX-2 positive cells in affected joints (Youn, Lee et al. 2003). The 
immunomodulatory effect of chlorogenic acid, was described by Chauhan et al. in AIA in rats. In 
this model, chlorogenic acid was able to control the total (CD3) and differentiated (CD4 and CD8) 
T cells count and supressed CD80/86 co-stimulatory molecule. Also this phenolic acid had the 
ability of diminish Th1 cytokines (IL-2, IFN-γ and IL-12) and elevate Th2 cytokines (IL-4 and IL-10) 
in CD4+ cells (Chauhan, Satti et al. 2012). p-cumaric acid also showed immunomodulatory and 
anti-inflammatory in AIA in rats. The cinnamic acid derived improved the arthritic disease 
through reduced the macrophage phagocytic index, circulating immune complex in sera and 
synovial TNF-α expression (Pragasam, Venkatesan et al. 2013).  
3.2. Flavonoids 
3.2.1. Flavones 
Apigenin and luteolin are flavones abundantly present in common fruits and vegetables 
such as chamomile tea and celery among others food. It has been demonstrated that apigenin 
has potential as antiarthritic agent using in vitro model (Shin, Kim et al. 2009). This dietary- plant 
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flavonoid was able to inhibit the proliferation of RA-FSLs by inducing apoptosis through 
activation of the effectors caspase-3 and caspase-7. Apigenin treatment resulted in activation of 
ERK MAPK, and when the cells were treated with the ERK inhibitor, apigenin-induced apoptosis 
was reduced.  
On the other hand, the authors demonstrated that the induction of the apoptosis and 
the activation of ERK by apigenin, it was due to the apigenin-induced generation of ROS (Shin, 
Kim et al. 2009). Similar results showed Sun et al., apigenin treatment was able to induce 
apoptosis of RA-FSLs, which was coupled with increased caspase-3 expression and activity and 
decreased Bcl-2/Bax ratio. These results were likely associated with downregulation of PI3-K/Akt 
activity (Sun, Jiang et al. 2012). Hou et al., reported that luteolin inhibited the proliferation of 
collagen-induced arthritis (CIA) rat synovial fibroblasts, which was accompanied by a decrease 
in MMP-1 and MMP-3 secretion.  Besides, cytokine production (IL-6, IL-8, IL-15 and TGF-β) were 
found to be lower in CIA rat synovial fibroblasts treated with luteolin. The authors also 
demonstrated that luteolin treatment caused a delay of cells in the G2/M phase and this 
polyphenol inhibited the MAPK/ERKs and PI3K-Akt pathways (Hou, Wu et al. 2009). Other in 
vitro study on SW982 cell line, demonstrated that luteolin treatment resulted in inhibition of IL-
1β-induced MMP-1, MMP-3, TNF-α and IL-6 production. Moreover, IL-1b-induced activator 
protein-1 (AP-1) and NF-κB activation were inhibited by luteolin (Choi and Lee 2010). Nobiletin 
is a citrus flavone present especially in tangerines. Nobiletin shown anti-inflammatory effects 
since it was able to downregulate the production of MMP-1, MMP-3 and MMP-9 and PGE2 in IL-
1 stimulated rabbit synovial fibroblast, moreover this citrus polyphenol, inhibited the 
proliferation of these cells (Ishiwa, Sato et al. 2000). This citrus flavone ameliorated CIA in mice. 
The reduced arthritis index and severity were accompanied by   a suppression of 
osteoclastogenesis and TRAP activity in RAKNL-stimulated RAW264.7 cells. Moreover, nobiletin 
treatment resulted in inhibition of activation of MAPKs as well as AP-1/NF-kB pathways 
(Murakami, Song et al. 2007). On the other hand, in another CIA study, nobiletin was able to 
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improve the severity of damage and the authors, also demonstrated that this flavone reduced 
aggrecanase-1/a disintegrin and MMP with thrombospondin-like motifs (ADAMTS)-4 and 
ADAMTS-5 mRNA expression in CIA mice (Imada, Lin et al. 2008).  
3.2.2. Flavonols 
Quercetin, kaempferol and myricetin are found in several foods, including onions, 
berries, grapes and red wine and exhibit a wide range of antiarhritic effects. Sato et al. 
demonstrated in 1997 that quercetin supresses IL-8 and MPC-1 mRNA in human synovial 
fibroblats stimulate with TNF-α. H2O2 mediated induction of IL-8 and MCP-1 genes was also 
inhibited by quercetin in synovial fibroblats. Besides quercetin inhibited the induction of NF-kB 
by TNF-α (Sato, Miyazaki et al. 1997). Other study in RA-FLS treated with quercetin reported that 
quercetin inhibited the IL-1β-induced proliferation. In addition, quercetin downregulated the 
expression of MMP-1, MMP-3, COX-2 and production of PGE2 in RA-SFs via inhibition of IL-1β-
induced activation of NF-kB and phosphorylation of p38, JNK and ERK MAPKs pathway (Sung, 
Lee et al. 2012). The apoptotic pathway of quercetin in RA-SFs was described by Xiao et al., DNA 
fragmentation assay showed that quercetin elevated the apoptosis of RA-SFs, accompanying 
with enhanced caspase-3 and caspase-9 cleavages. Moreover, quercetin caused loss of 
mitochondrial membrane potential and cytochrome C release to cytosol and also decreased Bcl-
2/Bax ratio. Additionally, quercetin elevated phosphorylation at ser15. Indicating that quercetin-
induced apoptosis of RA-SFs was through mitochondrial pathway, in which p53 played an 
important role (Xiao, Hao et al. 2013). In vitro antioxidants studies have revealed the scavenging 
activity of ABTS and DPPH radicals, inhibition of nitric oxide and the superoxide radical 
scavenging capacity of quercetin (using thioglycolic acid-capped cadmium telluride quantum 
dots (QDs) as nanocarrier) (Jeyadevi, Sivasudha et al. 2013). Administration of QDs-quercetin 
complex showed a reduction in inflammation and improvement in cartilage regeneration in AIA 
in rats. Histology of hind limb tissue confirmed the complete cartilage regeneration in AIA rats 
treated with QDs-quercetin complex. This treatment reduced the expressions lipid peroxidation 
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and showed increase in activities of antioxidant enzymes such as SOD, GSH, glutathione 
peroxidase (GPx), catalase (CAT) levels in paw tissue. C-reactive protein, rheumatoid factor, red 
blood cells and white blood cells count and erythrocyte sedimentation rate of experimental 
animals were also brought back to normal levels (Jeyadevi, Sivasudha et al. 2013). Oral 
administration of quercetin in rat model of AIA ameliorated all markers of inflammation such as 
MCP-1, IL-1β and C-reactive protein and markers of oxidative stress such as 13/15 LOX restoring 
plasma antioxidant capacity. A protective effect of quercetin was verified being that HO-1 
protein levels were upregulated in the animals treated. In this study, the authors deepened 
signalling pathways possibly involved, in this way, they demonstrated that quercetin was able 
to inhibit phosphorylation of ERK MAPKs and activation of NF-kB pathway (Gardi, Bauerova et 
al. 2015). On the other hand, kaempferol has also shown exert anti-inflammatory and anti-
arthritic proprieties. As describe Yoon et al., kaempferol inhibits IL-1β- induced proliferation of 
RA-SFs by apoptotic way. Likewise, kaempferol treatment downregulated the expression of 
MMP-1, MMP-3, COX-2 and the production of PGE2 in IL-1β-stimulated RA-SFs. According to the 
involved pathways, this flavonol inhibited the phosphorylation of p38, JNK and ERK MAPKs and 
the activation of NF-kB signalling pathways (Yoon, Lee et al. 2013).  
A recent study testing a possible immunomodulatory activity of kaempferol in arthritis 
showed that kaempferol could strengthen the suppression function of Treg cells and prevent 
the pathological symptom of CIA in a rat model. Mechanistically, kaempferol treatment could 
stabilize FOXP3 protein level in vivo and in vitro. Furthermore, this polyphenol could inhibit 
PIM1-mediated FOXP3 phosphorylation at S422 to promote FOXP3 transcriptional activity (Lin, 
Luo et al. 2015). Finally, Lee et al., demonstrated that myricetin was able to decreased IL-1β-
induced production of IL-6 and MMP-1 in SW982 syovial cells. Moreover, myricetin diminished 
the phosphorylation of p38 and JNK MAPKs (Lee and Choi 2010).  
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3.2.3. Flavanones  
Flavanones are polyphenolic compounds highly and almost exclusively present in citrus. 
Experimental observation have shown that these compounds, including hesperidin and naringin 
present anti-inflammatory and antiarthritic proprieties. Orally administration of hesperidin to 
CIA mice, result in improvement of clinical scores. Furthermore, hesperidin treatment was able 
to improve histological features such as reduced the damage of interchondral joints and 
supressed the increases of infiltration of inflammatory cells and pannus formation. This citrus 
flavonoid also, downregulated TNF-α mRNA expression in lesions (Kawaguchi, Maruyama et al. 
2006). Similarly results, have been demonstrated by Li et al., using a model of AIA in rats. 
Hesperidin supressed secondary paw swelling and reduced the polyarthritis index of AIA rats. 
These macroscopic results were companied by amelioration of joint destruction and inhibition 
of bone destruction, synovial hyperplasia and inflammatory cells infiltration. In addition, 
hesperidin enhanced concanavalin-A (ConA)-induced T-lymphocyte proliferation and recovered 
ConA-induced IL-2 production by solenocytes in comparison with AIA control group. Production 
of inflammatory cytokines such as IL-1, IL-6 and TNF-α were also determinate in peritoneal 
macrophages from treated rats and stimulated with LPS. In this way, hesperidin was able to 
inhibit the production of these pro-inflammatory cytokines (Li, Li et al. 2008). Other study of 
hesperidin in CIA model in rats reveals the anti-inflammatory and antioxidant effects of this 
molecule. Hesperidin treatment supressed the evolution of CIA rats and ameliorated the 
changes at histological level and was able to restore damage alteration to a great extent. 
Administration of hesperidin showed a significant reduction in neutrophil activation and 
infiltration in the joints, also decreased TBARS concentration by inhibiting lipid peroxidation in 
the cartilage tissue. The antioxidant enzymes GSH and SOD were upregulated by hesperidin, and 
cartilage catalase activity and nitrite content were lowered (Umar, Kumar et al. 2013).  
Finally, the anti-inflammatory and antiarthritic effect of naringin were shown using an 
AIA rat model. In this study, administration of naringin supressed the paw swelling in AIA rats 
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and decreased histopathological changes of joint tissues. Moreover, naringin suppressed the 
production of TNF-α, IL-1β and IL-6 in serum of arthritic rats. TUNEL assay demonstrated that 
naringin induced apoptosis of AIA synovial cells via regulation of the protein expression of Bcl-2 
and Bax (Zhu, Wang et al. 2015).  
3.2.4. Isoflavones  
Soy bean isoflavones have been identified as phytochemical therapeutic flavonoids for 
the treatment of RA. Genistein and daidzein possess structural similarities with selective 
estrogen receptor modulators such as tamoxifen and synthetic isoflavones (Mohammad-Shahi, 
Haidari et al. 2011). In vitro studies have revealed the anti-inflammatory and antiarthritic 
proprieties of genistein in human synovial fibroblasts. Genistein inhibited anchorage-dependent 
proliferation of synovial cells induced by IL-1β, TNF-α, or EGF, virtually inhibited S-phase entry, 
caused cell cycle arrest in G1 restriction point and inhibited colony growth of rheumatoid 
synovial cells induced by EGF. Genistein also downregulated MMP-2 and MMP-9 expression 
induced by IL-1β or TNF-α (Zhang, Dong et al. 2012). Genistein treatment decreased the 
secretion of IL-1β, IL-6, and IL-8 from TNF-α-stimulated MH7A cells. Furthermore, genistein 
prevented TNF-α-induced NF-κB translocation as well as phosphorylation of IκB kinase-α/β and 
IκBα, and also suppressed TNF-α-induced AMPK inhibition (Li, Li et al. 2014).  
In vivo studies have also shown antiarthritic effect of isoflavones. One study reported 
that genistein orally treatment in CIA rats, decreased primary paw inflammation. Dietary 
genistein exhibited a different pattern of immunomodulation, augmenting lymphocyte 
activation with increased IL-4 secretion, but decreased IFN-γ by cultured spleen lymphocytes 
subjected to CIA inflammation (Wang, Zhang et al. 2008). Treatment with genistein and daidzein 
in CIA rats resulted in not only a reduction in disease symptoms but also a delay in the onset of 
symptoms. The ear thickness in treated rats was lowered. Prevention of the tissue damage and 
joint inflammation was also observed following treatment with two soy isoflavones. Genistein 
and daidzein were able to reduce TNF-α, IL-6, adiponectin and leptin serum concentrations 
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(Mohammad-Shahi, Haidari et al. 2011). Mohammad-Shahi demonstrated that genistein and 
daidzein also played an important role on the extra-articular complications in CIA model in rats. 
In this model, both isoflavones were able to restore paraoxonase and arylesterase enzyme 
activity, which was decreased in serum from CIA rats. Paraoxonase low concentration is 
associated with a lower HDL- cholesterol and a higher level of malondialdehyde and C-reactive 
protein. Genistein and daidzein could also reverse the increased levels of malondialdehyde 
resulting from CIA (Mohammadshahi, Haidari et al. 2013).  
3.2.5. Antocyanins 
Anthocyanin belongs to a subgroup of bioactive flavonoids responsible for the blue, 
purple, and red colour of many fruits, flowers, and vegetables such as grapes, pommegranate 
and berries. It has been shown to have protective effects in in vitro and in vivo arthritis models. 
Malvidin, major grape anthocyanin, was able to improve AIA clinical score; both therapeutic and 
preventive oral protocols of malvidin were efficient in reducing arthritic signs. Finally, the level 
of nitrites was decreased following both therapeutic and preventive treatment with malvidin 
from peritoneal macrophages. Thus confirming the reduction of macrophages inflammatory 
state in vivo in the presence of malvidin (Decendit, Mamani-Matsuda et al. 2013). Delphinidin, 
presents in cranberries and Concord grapes, was found to be a specific inhibitor of histone 
acetyltransferase. Delphinidin treatment inhibited NF-kB function by inhibiting acetylation-
dependent nuclear translocation of p65 in TNF-α-stimulated human rheumatoid arthritis 
synovial cell line (MH7A). Furthermore, this antocyanin efficiently suppressed TNF-α-induced 
expression of IL-6, COX-2, and IL-1β in MH7A cells (Seong, Yoo et al. 2011). Cyanidin-3-glucoside 
inhibited receptor activator of RANKL-mediated osteoclast and formation and downregulated 
the expression of osteoclast differentiation marker genes (Acp5, CtsK, Oscar, Tm7sf4, Atp6v0d2, 
and Nfatc1) Pretreatment differentiation with cyanidin-3-glucoside considerably reduced the 
induction of ERK, JNK, and p38 MAPKs by RANKL in osteoclast precursor cells. Furthermore, 
cyanidin-3-glucoside dramatically inhibited the expression of c-Fos and Nfatc1, which are 
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important transcription factors for osteoclast differentiation and activation. The formation of 
osteoclasts in coculture of bone marrow cells and calvaria-derived osteoblasts was also inhibited 
by cyanidin-3-glucoside treatment (Park, Gu et al. 2015).  
3.2.6. Flavanols 
Tea polyphenols have received considerable public attention due to the positive 
association between tea consumption and beneficial health effects. The putative health benefits 
attributed to green tea (Camellia sinensis, Theaceace) is due to high concentrations of 
polyphenolic compounds known as catechins, including epigallocatechin-gallate (EGCG), 
epigallocatechin (EGC), epicatechin-gallate (ECG), and epicatechin (EC). 
One study showed that EGCG pretreatment inhibited both the constitutive and IL-1β-
induced chemokine MCP-1/CCL2 production, regulated upon activation, normal T-cell expressed 
and secreted (RANTES/CCL5) production, growth-regulated oncogene (Gro-α/CXCL1) 
production, and epithelial neutrophil-activating peptide 78 (ENA-78/CXCL5) production, and 
MMP-2 activation by RA-SFs (Ahmed, Pakozdi et al. 2006). This was achieved by EGCG via 
selective inhibition of the IL-1β-induced protein kinase Cδ and NF-κB pathways (Ahmed, Pakozdi 
et al. 2006). It was also shown, that EGCG was effective in inhibiting IL-1β-induced MMP-1, 
MMP-3, and MMP-13 in human tendon fibroblasts (Corps, Curry et al. 2004). Synovial fibroblast 
IL-6 production has been shown to inhibit bone formation and to concomitantly stimulate bone 
resorption and pannus formation (Cronstein 2007). Other study showed that EGCG 
pretreatment inhibits IL-1β-induced IL-6 and vascular endothelial growth factor synthesis in RA-
SFs (Ahmed, Marotte et al. 2008). Yun et al., showed that EGCG treatment resulted in inhibition 
of TNFα-induced production of MMP-1 and MMP-3 at the protein and mRNA levels in RA-SFs by 
inhibiting AP-1 DNA binding activity (Yun, Yoo et al. 2008). Ahmed et al., demonstrated that 
caspase-3 activation by EGCG suppressed RA-SFs growth, and this effect was mimicked by Akt 
and NF-κB inhibitors. Mcl-1 degradation by EGCG sensitized RA-SFs to TNFα- induced cleavage 
of poly ADP-ribose polymerase protein and apoptosis (Ahmed, Silverman et al. 2009).  
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EGCG-containing green tea extract in drinking water ameliorated CIA in mice. The reduced CIA 
incidence and severity was reflected in a marked inhibition of the inflammatory mediators COX-
2, IFN-γ, and TNF-α in arthritic joints of green tea-fed mice. Additionally, total IgG and type II 
collagen-specific IgG levels were found to be lower in serum and arthritic joints of green tea-fed 
mice (Haqqi, Anthony et al. 1999). Morinobu et al., showed that EGCG treatment reduced bone 
resorption as determined by tartrate-resistant acid phosphatase positive multinucleated cells, 
bone resorption activity, and osteoblast-specific gene expression of the transcription factor 
NFATc1. They also studied the in vivo effect of EGCG in CIA mice, where administration of EGCG 
inhibited inflammation (Morinobu, Biao et al. 2008). Another study showed that EGCG 
ameliorated arthritis and macrophage infiltration, and caused a reduction in the amount of 
MCP-1/CCL2-synthesizing osteoblasts in rat CIA model (Lin, Chang et al. 2008). EGCG orally 
treatment ameliorated clinical symptoms, reduced histological scores in arthritic mice and also 
lowered serum type-II collagen IgG2a antibodies. EGCG significantly suppressed T cell 
proliferation and relative frequencies of CD4 T cells, CD8 T cells and B cell subsets including 
marginal zone B cells, T1 and T2 transitional B cells, while increasing the frequency of CD4+ 
Foxp3+ regulatory T cells (Tregs) and indoleamine-2,3-dioxygenase (IDO) expression by CD11b+ 
dendritic cells (DC). Joint homogenates from EGCG-fed mice exhibited increased levels of Nrf-2 
and HO-1 compared with control CIA mice (Min, Yan et al. 2015). Intra-articular injection of EGCG 
in CIA mice, showed a significant reduction in cartilage degradation in prophylactic- and 
therapeutic-groups, by histomorphological scoring of the articular cartilage (Natarajan, Madhan 
et al. 2015). Administration of EGCG to rat adjuvant-induced arthritis resulted in an inhibition of 
IL-6 levels in the serum and joints of EGCG-treated animals. This study also showed that EGCG 
enhances the synthesis of soluble gp130 protein, an endogenous inhibitor of IL-6 signalling and 
trans-signalling. The inhibition of arthritis in EGCG-treated rats correlated to the reduction in 
MMP-2 activity in the joints compared with the activity level in arthritic rats (Ahmed, Marotte 
et al. 2008). Green tea extract administration in drinking water ameliorated rat adjuvant-
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induced arthritis via the inhibition of serum IL-17 levels, with a concomitant upregulation of 
serum IL-10 levels (Kim, Rajaiah et al. 2008). 
3.3. Diarylheptanoids and arylalkanones 
3.3.1. Gingerols 
Ginger (Zingiber officinale, Roscoe) is one of the most widely used spices and is a 
common condiment for a variety of foods and beverages. It contains a large number of 
phytochemical constituents. 
Ginger extract treatment was able to inhibit TNF-α-induced IL-8 and IL-6 of human 
synovial cells, showing similar anti-inflammatory effect than betamethasone (Ribel-Madsen, 
Bartels et al. 2012). Ginger extract intraperitoneally could ameliorate the clinical scores, disease 
incidence, joint temperature, swelling and cartilage destruction, accompanying with reduction 
of serum levels of IL-1β, IL-2, IL-6, TNF-α and anti-CII IgG in CIA rats (Fouda and Berika 2009). 
The arthritic score was decreased after adjuvant arthritis induction in rats that received ginger 
and turmeric rhizomes powder. Histological examination of the ankle joints from arthritic rats 
treated with ginger and turmeric rhizomes powder revealed that, the treatment resulted in 
improvement of histopathological changes characteristic from arthritic joints. On the other 
hand, the mixture powder administration was able to suppress changes in haematological 
parameters of arthritic rats, such as leucocytosis, thrombocytosis, iron deficiency anaemia, 
serum hypoalbuminemia or globulinemia; and also improves biochemical parameters in sera, 
like lipid profile, protein content, kidney functions and oxidative stress. Suggesting, that ginger 
and turmeric rhizomes powder has beneficial effects against not only articular complications but 
also against many extra-articular complications of experimentally induced RA (Ramadan and El-
Menshawy 2013).  
3.3.2. Curcumin 
Curcumin (diferuloylmethane) is a yellow pigment found in the rhizome of turmeric 
(Curcuma longa L., Zingiberaceae) which has a wide range of pharmacological and biological 
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activities. Curcumin has been shown protective effect against IL-1β-stimulated human 
chondrocytes. Treatment with curcumin relieved suppression of collagen type II (cartilage 
specific matrix marker) and β1-integrin synthesis and inhibited caspase-3 activation by IL-1β in 
human chondrocytes. Besides, chondrocytes treated with curcumin showed less severe cellular 
degeneration, caused by IL-1β stimulation, at the ultrastructural level; the chondrocytes 
regained a flattened shape and numerous microvilli-like cytoplasmic processes (Shakibaei, 
Schulze-Tanzil et al. 2005). Low concentration of curcumin was sufficient to inhibit IL-1β induced 
activation of NF-κB, caspase-3 and cyclooxygenase-2 in canine mesenchymal stem cells (MSCs), 
enabling growth factor induced chondrogenesis in MSCs. In IL-1β stimulated co-cultures of MSCs 
and primary chondrocytes, treatment with curcumin, enhanced the production of collagen type 
II, cartilage specific proteoglycans (CSPGs), β1-integrin, as well as activating MAPKs signalling 
and suppressing caspase-3 and cyclooxygenase-2, enabling co-culture induced chondrogenesis 
in MSCs (Buhrmann, Mobasheri et al. 2010). Studies of curcumin on RA SFs have been 
demonstrated that curcumin was able to inhibit proliferation of RA SFs through apoptotic way 
including inhibition of Blc-2 protein and X-linked inhibitors of the apoptosis protein (X-IAP) 
expression, proteolytic activation of caspase-3 and caspase-9, and the concomitant degradation 
of poly (ADP-ribose) polymerase protein (PARP). Furthermore, curcumin decreased the 
expression levels of COX-2 mRNA and protein, which was correlated with the inhibition of PGE2 
synthesis (Park, Moon et al. 2007). Other study has been shown that curcumin could inhibit IL-
1β and PMA-induced IL-6 of RA SFs and MH7A cells. Curcumin treatment also blocked PMA-
induced VEGF grow factor expression in RA SFs. Deepening signalling pathway, curcumin could 
inhibit IL-1β-induced phosphorylation of NF-kBp65 at SER536 and degradation of  IκB-α also 
inhibit phosphorylation of ERK MAPK in MH7A cells. Lastly, curcumin induced cell death through 
apoptosis (Kloesch, Becker et al. 2013). Curcumin also inhibited inflammatory processes through 
suppression of collagenase and stromelysin expression in HIG-82 synoviocytes (Jackson, Higo et 
al. 2006).  
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Regarding in vivo studies, administration of curcumin intraperitoneally, caused 
attenuation of the arthritic index in CIA mice. It was accompanied by a reduction of B-cell-
activating factor belonging to the TNF family (BAFF), IFN-γ and IL-6 sera levels after curcumin 
treatment (Huang, Xu et al. 2013). Other study shows that curcumin treatment ameliorated 
symptoms of arthritis in AIA rats and preserved radiological alterations in joints of arthritic rats. 
The blood of the treated rats presented less number of leukocytes in comparison with the 
control rats. Sera levels of TNF-α, MDA, nitrites, citrullinated protein antibodies and C-reactive 
protein were downregulated after curcumin administration. However, curcumin increase GSH, 
SOD and catalase activity (Arora, Kuhad et al. 2015).  Zheng et al., confirmed the protective effect 
of curcumin in an AIA model in rats, curcumin treatment showed a therapeutic effect on AIA rats 
similar to methotrexate. The polyphenol was able to improve the histopathological changes, 
including less inflammatory cell infiltration, less synovial thickening and less proliferation of 
synovial tissue and fibrous tissue. TNF-α and IL-1β levels were decreased in synovial fluid and 
blood and NF-kB expression was lowered in the synovial tissue after curcumin administration 
(Zheng, Sun et al. 2015).  
3.4. Stilbenes  
3.4.1. Resveratrol 
Resveratrol (trans-3,40,5-trihydroxystilbene) is a polyphenol found in various fruits and 
vegetables and is abundant in grape skins and red wines. 
A number of studies have shown the apoptotic effect of resveratrol in RA-SFs (Byun, Song et al. 
2008, Nakayama, Yaguchi et al. 2012). Byun et al., demonstrated for the first time that exposure 
to resveratrol caused apoptosis in RA-SFs through activation of caspase-9, caspase-3 and 
caspase-8 and PARP cleavage and mitochondrial cytochrome c release. Moreover, resveratrol 
induced apoptosis inducing the translocation of apoptosis-inducing factor (AIF) to the nucleus 
(Byun, Song et al. 2008). On the other hand, Nakayama et al., showed that resveratrol induces 
MH7A cell apoptosis by activating caspase-9 and the effector caspase-3 along mitochondrial 
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disruption as a result of reduced Bcl-XL expression, allowing cytochrome c release from the 
mitochondria into the cytosol, in a sirtuin 1-dependent manner (Nakayama, Yaguchi et al. 2012). 
Resveratrol also activated caspase-3/7, which has a pro-apoptotic effect and decreased the 
expression of genes related to cell proliferation and cell cycle in cultured IL-1β-stimulated RA-
FLS (Glehr, Fritsch-Breisach et al. 2013). Resveratrol supressed TNF-α induced PI3kinase/Akt 
pathway activation by decreasing p-Akt phosphorylation correlated with downregulation of IL-
1β and MMP-3 in RA-FLS (Tian, Chen et al. 2013). Additionally, a decreased of MMP-1, MMP-3 
and MMP-9 production in the cell culture supernatant and a reduction on the RANKL and 
osteoprotegrin gene expression were obtained when resveratrol was analysed in IL-1β-
stimulated RA-FLS (Glehr, Breisach et al. 2013). The anti-osteoclastogenic effect of resveratrol 
was prove by Shakibaei et al., they demonstrated that treatment with resveratrol inhibited the 
RANKL-induced formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated 
cells and inhibited NF-kB activation and suppressed the activation of IκBα kinase and IκBα 
phosphorylation and degradation. In addition, activation of Sirt-1 (a histone deacetylase) by 
resveratrol induced Sirt-1-p300 association in bone-derived and preosteoblastic cells, leading to 
deacetylation of RANKL-induced NF-κB, inhibition of NF-κB transcriptional activation, and 
osteoclastogenesis (Shakibaei, Buhrmann et al. 2011). Resveratrol also, has been tested on in 
vivo arthritis models. Intraarticular injection of resveratrol in lipopolysaccharide-induced 
arthritis in rabbits was able to reduce histopathological damage in arthritis rabbits including 
decreased cartilage destruction, reduced loss of matrix proteoglycan content in the cartilage 
and diminished synovial inflammation (Elmali, Baysal et al. 2007). Other study shows how 
resveratrol could reduce disease incidence, number of involved paws, footpad thickness and 
clinical index of CIA mice. Resveratrol also markedly reduced mononuclear and 
polymorphonuclear cell infiltration into the joint, synovial hyperplasia and adjacent cartilage 
and bone erosion at histological level in treated CIA mice. Consistent with the attenuated clinical 
parameters, resveratrol prevented the development of serum collagen-specific IgG2a and IgG1. 
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Among the serum cytokine levels, IFN-γ, TNF-α, IL-17, IL-6, IL-1 and IL-4 levels were reduced. 
Moreover, isolated draining popliteal lymph nodes (DLN) CD4 T cells from resveratrol-protected 
mice showed reduced expression of IL-17 and IFN-γ; resveratrol also decreased the numbers of 
total cells, CD4 IL-17+ Th17 cells and or CD4 IFN-γ + Th1 cells in DLN of CIA mice (Xuzhu, Komai-
Koma et al. 2012). Chen et al., demonstrated that resveratrol was able to reduce paw swelling 
and decrease the arthritis scores of AIA rats. Resveratrol also reduced the proliferation of 
concanavalin A-stimulated spleen cells. Articular cartilage degeneration with synovial 
hyperplasia and inflammatory cell infiltration was suppressed and the production of COX-2 and 
PGE2 in AIA rats was reduced by treatment with resveratrol (Chen, Lu et al. 2014).  
3.5. Other dietary polyphenols 
Besides dietary polyphenols described above, there are several non-flavonoid 
polyphenol found in foods that are considered important to human health. Among these, 
ellagitanins, hydrolysable tannins, and its derivates are found in berry fruits; on the other hand 
hydroxytyrosol, a phenolic alcohol and the secoiridoids oleuropein and oleocanthal are present 
in extra virgin olive oil (EVOO). 
The pomegranate-derived polyphenols, punicalagin and ellagic acid (ellagitanins), 
inhibited MMP- 13-mediated degradation of CII in vitro. Multiple binding interactions of 
punicalagin and ellagic acid with CII were demonstrated by surface plasmon resonance studies 
and molecular docking simulations. Punicalagin inhibited the degradation of proteoglycan and 
CII release on IL-1β-induced degradation bovine cartilage. Anti-inflammatory effects of 
punicalagin were tested in an AIA rat model. Punicalagin was able to diminish the disease 
development and paw volume of AIA rats (Jean-Gilles, Li et al. 2013). Topical treatment with 
ellagic acid resulted in reducing joint swelling and inflammation-induced morphological changes 
in histological analysis of AIA in rats. Consistent with the attenuated paw swelling and 
histopathological changes, ellagic acid-topical was able to supress the levels of the pro-
inflammatory cytokines TNF-α and IL1-β of arthritis rats (Mo, Panichayupakaranant et al. 2013).  
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Polyphenolics compounds of EVOO have also been shown antiarthritic effect in vitro and 
in vivo. In this way, oleocanthal decreased lipopolysaccharide-induced iNOS2 synthesis in ATDC-
5 murine chondrocytes without significantly affecting cell viability. Besides, oleocanthal pre-
treatment was able to inhibit LPS-induced iNOS protein (Iacono, Gomez et al. 2010).  
Other similar study, also showed that oleocanthal pre-treatment suppresses the 
expression of inflammatory mediators including IL-6 and MIP-1α at the protein and the mRNA 
level in LPS-stimulated ATDC-5 murine chondrocytes (Scotece, Gomez et al. 2012). Impellizzeri 
et al., confirmed the beneficial effects of oleuropein aglycone on an experimental model of CIA. 
Treatment with oleuropein aglycone ameliorated the clinical signs and improved histological 
status in the joint and paw of CIA mice. The degree of oxidative and nitrosative damage was also 
reduced in oleuropein aglycone-treated mice. Plasma levels of the proinflammatory cytokines 
(TNF-α, IL-1β and IL-6) and chemokine (MIP-1α and MIP-2) expression and neutrophil infiltration 
(MPO) were also reduced by oleuropein aglycone in arthritic mice (Impellizzeri, Esposito et al. 
2011). The protective effect of hydroxytyrosol in a CIA model in rats was carried out by Silva et 
al., in this study, they showed that hydroxytyrosol treatment decreased paw edema, histological 
damage, COX-2 and iNOS expression, and markedly reduced the degree of bone resorption, soft 
tissue swelling and osteophyte formation, improving articular function in treated animals (Silva, 
Sepodes et al. 2015).  
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Tabla 1. In vitro studies of dietary polyphenols in RA. 
Polyphenol Source 
Experimental 
System 
Mechanism/s of Action 
Efficac
ious [] 
Ref 
Phenolic acids 
Benzoic acid derived 
Gallic Acid 
Tea RA-FSL 
Gallic acid induces apoptosis of RA FLS through 
regulation of apoptosis related protein expressions 
(caspase-3, Bcl-2, Bax, p53 and pAkt) and reduces 
the expression of pro-inflammatory genes (IL-1β, IL-
6), chemokines (CCL-2/MCP-1, CCL-7/MCP-3), COX-2, 
and MMP-9. 
0.1 and 
1 µM 
(Yoon, 
Chung et al. 
2013) 
Cinnamic acid derived 
Rosmarinic 
Acid 
Basil, rosemary, 
thyme and 
peppermint 
RA PBMCs 
 
 
 
Murine bone 
marrow-derived 
macrophages 
Rosmarinic Acid induces the preferential apoptotic 
activity of activated T cells and effector T cells via 
mitochondrial pathway. 
 
Rosmarinic acid inhibits RANKL-mediated osteoclast 
differentiation by down-regulation MAPKs and NF-kB 
pathway and suppressing NFATc1, TRAP and OSCAR 
mRNA expression  
50 µM 
 
 
 
60 and 
120 
µM 
(Hur, Suh et 
al. 2007) 
 
 
 
(Hsu, Cheng 
et al. 2011) 
 
Chlorogenic 
acid 
Peach, prunes and 
green cofee 
Murine bone 
marrow-derived 
macrophages 
Chlorogenic acid inhibits RANKL-mediated osteoclast 
differentiation by down-regulation MAPKs and NF-kB 
pathway and suppressing NFATc1, TRAP and OSCAR 
mRNA expression 
28, 70 
and 
141 
µM 
(Kwak, Lee 
et al. 2013) 
Flavonoids 
Flavones 
Apigenin Parsley, celery 
and chamomile 
tea 
MH7A cells 
 
 
 
RA-FSL 
 
 
 
Apigenin induces apoptosis through activation of the 
effectors caspase-3 and caspase-7 and activation of 
ERK MAPK. 
 
Apigenin induces apoptosis of RA-FSL through 
increase caspase-3 expression and activity and 
decrease Bcl2/Bax ratio, mediated by 
downregulation of PI3-K/Akt activity 
100 
μM 
 
 
20 µM 
(Shin, Kim 
et al. 2009) 
 
 
 
(Sun, Jiang 
et al. 2012) 
 
Luteolin Celery, broccoli, 
green pepper, 
parsley and 
thyme. 
Rat synovial 
fibroblasts  
 
 
 
 
SW982 
 
 
 
 
 
 
Luteolin inhibits the proliferation of synovial 
fibroblasts in CIA rats. Decreases the secretion of 
MMP-1 and -3 and the expression of IL-6, IL-8, IL-15, 
and TGF-β, through inhibition of MAPK/ERKs and 
PI3K-Akt pathways. 
 
Treatment with luteolin significantly inhibited IL-1β-
induced MMPs (MMP-1 and -3) and cytokines (TNF-α 
and IL-6) production. Luteolin also inhibited JNK and 
p38 MAPKs activation and the transcription factors 
AP-1 and NF-κB. 
 
 
20 µM  
 
 
 
 
 
1 and 
10 µM 
(Hou, Wu 
et al. 2009) 
 
 
 
 
 
 
(Choi and 
Lee 2010) 
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Nobiletin Tangerine Rabbit synovial 
fibroblasts and 
articular 
chondrocytes. 
 
 
 
RAW264.7 
Nobiletin downregulates the production of MMP-1, 
MMP-3 and MMP-9 and PGE2 and COX-2 of IL--
stimulated rabbit synovial cells and inhibits 
proliferation of rabbit synovial fibroblasts in the 
growth phase. 
 
Nobiletin suppresses RANKL-induced 
osteoclastogenesis in macrophages through 
inhibition of MAPKs and the resultant regulation of 
transcription factors (AP-1 and NFκB) 
4, 8, 
16, 32 
µM  
 
 
 
4, 20 
and 50 
µM 
(Ishiwa, 
Sato et al. 
2000) 
 
 
 
 
 
(Murakami, 
Song et al. 
2007) 
 
Flavonols 
Quercetin Onion RA-FSL 
 
 
 
 
RA-FSL 
 
 
 
 
 
RA-FSL 
 
 
Quercetin suppresses TNF-α induced IL-8 and MCP-1 
mRNA. H2O2 mediated induction of IL-8 and MCP-1 
genes are inhibited by quercetin. Quercetin inhibites 
the activation of NF-kappa B by TNF-α. 
 
Quercetin inhibits IL-1β- induced proliferation of RA-
FSL and downregulates MMP-1, MMP-3, COX-2 
expression and PGE2 production. Through inhibition 
of ERK, p38, JNK phosphorylation and activation of 
NF-kB by IL-β 
 
Quercetin induces the apoptosis of RA-FSL, through 
enhances caspase-3 and caspase-9 cleavages and 
through mitochondrial pathway.  
50, 100 
and 
200 
µM 
 
100 
µM 
 
 
 
 
100, 
200 
and 
300 
µM 
(Sato, 
Miyazaki et 
al. 1997) 
 
 
 
 
(Sung, Lee 
et al. 2012)  
 
 
 
 
 
(Xiao, Hao 
et al. 2013) 
Kaempferol Apples, grapes, 
tomatoes, green 
tea, potatoes, 
onions, broccoli, 
Brussels sprouts, 
squash, 
cucumbers, 
lettuce, green 
beans, peaches, 
blackberries, 
raspberries, and 
spinach 
RA-FSL Kaempferol inhibites the proliferation of IL-1β-
stimulated RA-FSL, as well as the mRNA and protein 
expression of MMP-1, MMP-3, COX-2 and PGE2 
induced by IL-1β. Through inhibition of ERK, p38, JNK 
phosphorylation and activation of NF-kB by IL-β. 
100 
µM 
(Yoon, Lee 
et al. 2013) 
Myricetin Vegetables, fruits, 
nuts, berries, tea 
and red wine. 
SW982 Myricetin decreases IL-1β-induced production of IL-6 
and MMP-1 in synovial cells. Moreover, myricetin 
diminishes the phosphorylation of  
JNK and p38 MAPKs. 
10 µM (Lee and 
Choi 2010) 
Isoflavones 
Genistein Lupin, fava beans, 
soybeans, kudzu, 
and psoralen 
RA-FSL  
 
 
 
MH7A cells 
 
 
 
 
Genistein inhibits proliferation of RA-FSL induced by 
IL-1β, TNF-α and EGF; also inhibits MMP-2 and 
MMP-9 expression induced by IL-1β or TNF-α . 
 
Genistein decreases the secretion of IL-1β, IL-6, and 
IL-8 from TNF-α-stimulated MH7A cells. Genistein 
prevented TNF-α-induced NF-κB translocation as 
well as phosphorylation of IκB kinase-α/β and IκBα, 
and suppressed TNF-α-induced AMPK inhibition. 
37 µM  
 
 
 
5, 10 
and 20 
µM 
 
 
(Zhang, 
Dong et al. 
2012) 
 
 
(Li, Li et al. 
2014)  
Antocyanins 
Delphinidin Grapes MH7A cells Delphinidin inhibits TNF-α-induced NF-κB function 
and suppresses expression of IL-6, COX-2 and IL-1β. 
 
10 and 
30 µM 
(Seong, Yoo 
et al. 2011) 
 
Cyanidin Grapes, bilberry, 
blackberry, 
Osteoclast 
precursor cells  
Cyanidin inhibits osteoclasts formation and 
downregulates expression of osteoclast 
100 
µM 
(Park, Gu et 
al. 2015) 
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blueberry, cherry, 
cranberry 
differentiation marker genes, inhibiting 
phosphorylation of MAPKs 
Flavanols 
EGCG Green tea 
 
RA-FSL 
 
 
 
 
Human tendon 
fibroblast 
 
RA-FSL 
 
 
 
RA-FSL 
 
 
 
 
RA-FSL 
EGCG inhibits IL-1β-induced MCP-1/CCL2, 
RANTES/CCL5, Gro-α/CXCL1, ENA-78/CXCL5 
production ans MMP-2 activation, via inhibition of 
protein kinase Cδ and NF-κB pathway. 
 
EGCG inhibits IL-1β-induced MMP-1, MMP-3 and 
MMP-13 
 
EGCG inhibits IL-1β induced IL-6 and VEGF. 
 
 
 
EGCG inhibits TNF-α-induced MMP-1 and MMP-3 
expression by inhibiting AP-1 DNA binding activity. 
 
 
 
EGCG inhibits TNF-α induced Mcl-1 protein 
expression. EGCG actives caspase 3 activity, 
mediated via down-regulation of the TNFα-induced 
Akt and NF-κB pathways 
10 and 
20 µM 
 
 
 
2.5 and 
25 µM 
 
10 and 
200 
µM 
 
0.12, 
0.25 
and 0.5 
µM 
 
50 µM 
(Ahmed, 
Pakozdi et 
al. 2006) 
 
 
 
(Corps, 
Curry et al. 
2004) 
 
(Ahmed, 
Marotte et 
al. 2008) 
 
 
(Yun, Yoo 
et al. 2008) 
 
 
 
 
(Ahmed, 
Silverman 
et al. 2009) 
Diarylheptanoids and arylalkanones 
Gingerol Ginger (Zingiber 
officinale) 
RA-FSL Ginger extract inhibits TNF-α-induced IL-8 and IL-6  (Ribel-
Madsen, 
Bartels et 
al. 2012) 
Curcumin Curcuma longa Human 
chondrocytes 
 
 
Co-culture 
canine 
mesenchymal 
stem cells and 
primary 
chondrocytes 
 
RA-FSL 
 
 
 
 
RA-FSL, MH7A 
 
 
 
 
HIG-82 rabbit 
synoviocytes 
Curcumin relieves suppression of collagen type II, 
β1-integrin and caspase-3 activation. 
 
 
Curcumin enhances the production of collagen type 
II, CSPGs, β1-integrin and activating MAPKs signaling 
and suppressing caspase-3 and COX-2. 
 
 
 
 
Curcumin induces apoptosis in RA-FSL by inhibition 
of Blc-2 and X-IAP expression, activation of caspase-3 
and caspase-9 and degradation of PARP. Also, 
inhibits COX-2 expression and PGE2 production. 
 
Curcumin blocks IL-1β and PMA-induced IL-6 
expression, blocks PMA-induced VEGF expression, 
blocks activation of NF-κB and ERK1/2 and induces 
cell death through apoptosis. 
 
Curcumin inhibits inflammatory processes through 
suppression of collagenase and stromelysin 
expression. 
50 µM  
 
 
 
5 µM 
 
 
 
 
 
 
50, 75 
and 
100 
µM 
 
12.5, 
25 and 
50 µM 
 
 
1 and 
10 µM 
(Shakibaei, 
Schulze-
Tanzil et al. 
2005)  
 
(Buhrmann, 
Mobasheri 
et al. 2010) 
 
 
 
 
 
 
(Park, 
Moon et al. 
2007) 
 
 
 
(Kloesch, 
Becker et 
al. 2013) 
 
 
 
(Jackson, 
Higo et al. 
2006) 
 
Stilbenes 
Resveratrol Grapes RA-FSL  
 
 
Resveratrol induces apoptosis through caspase-3, 
caspase-9, caspase-8 and PARP cleavage, 
100 
µM 
 
(Byun, Song 
et al. 2008) 
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Table 2. In vivo studies of dietary polyphenols in RA. 
Polyphenol Source 
Experimenta
l System 
Mechanism/s of Action 
Efficacious 
[] 
Ref 
Phenolic acids 
Bezoic acid derived 
Protocatechuic 
acid 
Onions, 
mushroom. 
AIA in rats Protocatechuic acid inhibits arthritis index, 
decreases LPO and NO and increases 
antioxidants, SOD, catalase and GSH in liver. 
50 and 100 
mg/Kg orally 
(Lende, 
Kshirsagar 
et al. 2011) 
 
Cinnamic acid derived 
p-Coumaric Acid Peanuts, 
tomatoes, 
carrots and 
garlic. 
AIA in rats p-coumaric acid reduces the serum circulating 
immune complex levels. Synovial tissue of 
arthritic rat treated with p-coumaric acid showed 
a reduction in immunostaining for TNF-α. 
100 mg/kg 
i.p. 
(Pragasam, 
Venkatesan 
et al. 2013) 
 
Chlorogenic 
Acid 
Peach, 
prunes and 
green coffee 
AIA in rats Chlorogenic acid controls the total (CD3) and 
differentiated (CD4 and CD8) T cells count, 
suppresses CD80/86 and suppresses the Th1 
cytokines but elevates Th2 cytokines. 
2.5, 5, 10, 20 
and 
40mg/kg. 
orally 
(Chauhan, 
Satti et al. 
2012) 
 
Rosmaric acid Basil, 
rosemary, 
thyme and 
peppermint 
CIA in mice Rosmaric acid reduces the arthritic index, 
histological damage and COX-2 expression. 
50 mg/Kg 
i.p. 
(Youn, Lee 
et al. 2003) 
 
Flavonoids 
Flavones 
 
 
 
MH7A cells 
 
 
 
 
 
 
RA-FSL  
 
 
 
 
RA-FLS  
 
 
mitochondrial cytochrome c release and AIF 
translocation to the nucleus. 
 
Resveratrol induces apoptosis through activation of 
caspase-3 and caspase-9, disrupts mitochondrial 
membrane potentials as a result of decreased Bcl-XL 
expression, allowing cytochrome c from the 
mitochondria into the cytosol, in a sirtuin 1-
dependent manner. 
 
Resveratrol attenuates IL-1β-induced production of 
MMP-1, MMP-3 and MMP-9. qRT-PCR showed a 
significant reduction in the relative abundance of the 
transcripts of OPG and RANKL. 
 
Resveratrol attenuates TNF-α-induced production of 
IL-1β and MMP-3 via inhibition of PI3K-Akt signaling 
pathway in RA FLS. 
 
 
 
100 
µM 
 
 
 
 
 
6.25, 
12.5, 
25 and 
50 µM 
 
100 
µM 
 
 
 
 
 
(Nakayama, 
Yaguchi et 
al. 2012) 
 
 
 
 
 
 
(Glehr, 
Breisach et 
al. 2013) 
 
 
 
(Tian, Chen 
et al. 2013) 
Other dietary polyphenols 
Oleocanthal EVOO ATDC-5 
 
 
ATDC-5 
Oleocanthal inhibits LPS-induced NO production and 
iNOS expression 
 
Oleocanthal suppresses LPS-induced IL-6 and MIP-1α 
expression. 
10 and 
25 µM 
 
15 µM 
(Iacono, 
Gomez et 
al. 2010) 
 
(Scotece, 
Gomez et 
al. 2012) 
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Nobiletin Tangerine CIA in mice 
 
 
CIA in mice 
 
 
Nobiletin suppresses arthritic index. 
 
 
Nobiletin improves arthritic progression and joint 
histology and exerts a chondroprotective action 
from the aggrecanase-mediated cartilage 
destruction according to the inhibition of gene 
expression and production of ADAMTS-4 and -5 
2 and 20 
mg/Kg i.p. 
 
15, 30 and 
60 mg/Kg 
i.p. 
(Murakami, 
Song et al. 
2007) 
 
(Imada, Lin 
et al. 2008) 
 
Flavonols 
Quercetin Onions AIA in rats 
 
 
 
 
 
 
 
 
AIA in rats 
Quercetin improves arthritic progression and 
joint histology, decreases lipid peroxidation and 
increases antioxidants, SOD, catalase, GSH and 
GPx. 
 
 
 
 
 
Quercetin reduces MCP-1, IL-1β, C-reactive 
protein and 13/15 LOX. Upregulates HO-1 
expression and inhibits ERK phosphorylation and 
NF-κB activation. 
0.2 and 0.4 
mg/Kg into 
thioglycolica
cid-
cappedcadm
iumtelluride
quantumdot
s. Orally 
 
150 mg/Kg 
Orally 
(Jeyadevi, 
Sivasudha 
et al. 2013) 
 
 
 
 
 
 
 
 
 
(Gardi, 
Bauerova 
et al. 2015) 
 
Kaempferol Apples, 
grapes, 
tomatoes, 
green tea, 
potatoes, 
onions, 
broccoli, 
Brussels 
sprouts, 
squash, 
cucumbers, 
lettuce, green 
beans, 
peaches, 
blackberries, 
raspberries, 
and spinach 
CIA in rats Kaempferol inhibits PIM1-mediated FOXP3 
phosphorylation at S422 to promote FOXP3 
transcriptional activity. 
100 mg/Kg (Lin, Luo et 
al. 2015) 
Flavanones 
Hesperidin Orange and 
lemon 
CIA in mice 
 
 
 
AIA in rats 
 
 
 
 
 
 
CIA in rats 
Hesperidin improves clinical socore, histological 
features and downregulates TNF-α mRNA 
expression. 
 
Hesperidin reduces polyarthritis index and 
histological features. Enhances CoA-induced T-
lymphocyte proliferation and recovers IL-2 
production in solenocytes; also, inhibits IL-1, IL-6 
and TNF-α level in peritoneal macrophages from 
treated rats. 
 
Hesperidin improves clinical socore, histological 
features and decrases TBARS concentration by 
inhibition of lipid peroxidation in the cartilage. 
Upregulates GSH and SOD antioxidant enzymes 
and downregulates cartilage catalase activity and 
nitrite level. 
150 mg/Kg 
Orally 
 
 
40, 80 and 
160 mg/Kg 
Intragastrica
lly 
 
 
 
160 mg/Kg 
Orally 
(Kawaguchi
, 
Maruyama 
et al. 2006) 
 
(Li, Li et al. 
2008) 
 
 
 
 
 
 
 
(Umar, 
Kumar et 
al. 2013) 
 
 
 
 
Naringin Grapes  AIA in rats Naringin suppresses paw swelling and 
histopathological changes of joint tissue. 
Downregulates TNF-α, IL-1β and IL-6 serum level 
20 and 40 
mg/Kg  
Orally 
(Zhu, Wang 
et al. 2015) 
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and induces apoptosis via regulation of Bcl-2 and 
Bax protein expression.  
Isoflavones 
Genistein 
 
Lupin, fava 
beans, 
soybeans, 
kudzu, and 
psoralen 
CIA in rats 
 
 
 
CIA in rats 
 
 
 
CIA in rats 
 
Genistein modulates immune responses in CIA 
model. Suppresses the secretion of IFN-γ and 
augments the IL-4 production. 
 
Genistein improves disease symptoms and 
reduces TNF-α, IL-6, adiponectin and leptin 
serum concentration. 
 
Genistein restores paraoxonase and arylesterase 
activity and decreases MDA levels.  
80 mg/Kg  
Orally 
 
 
20 mg/Kg  
Orally 
 
 
20 mg/Kg  
Orally 
(Wang, 
Zhang et al. 
2008) 
 
 
(Mohamma
d-Shahi, 
Haidari et 
al. 2011) 
 
(Mohamma
dshahi, 
Haidari et 
al. 2013) 
Daidzein Soybeans CIA in rats 
 
 
 
CIA in rats 
 
Daidzein improves disease symptoms and 
reduces TNF-α, IL-6, adiponectin and leptin 
serum concentration. 
 
Daidzein restores paraoxonase and arylesterase 
activity and decreases MDA levels.  
20 mg/Kg  
Orally 
 
 
20 mg/Kg  
Orally 
(Mohamma
d-Shahi, 
Haidari et 
al. 2011)  
 
(Mohamma
dshahi, 
Haidari et 
al. 2013) 
Antocyanins 
Malvidin Red wine AIA in rats Malvidin is efficient in reducing arthritis sings and 
decreases nitrites level from peritoneal 
macrophages from treated rats. 
25 mg/Kg 
Orally 
(Decendit, 
Mamani-
Matsuda et 
al. 2013) 
Flavanols 
EGCG Green tea CIA in mice 
 
 
 
 
 
 
 
 
 
CIA in mice 
 
 
 
 
 
CIA in rats 
 
 
 
 
CIA in mice 
 
 
 
 
CIA in mice 
 
 
 
EGCG-containing green tea extract reduces 
disease symptoms, inhibits COX-2, IFN-γ and TNF-
α level in arthritic joint and decreases anti-CII IgG 
serum level. 
 
 
 
 
 
 
EGCG ameliorates arthritis during the disease 
course and reduces histologic scores of arthritis. 
Also reduces the number of osteoclasts in the 
pannus of  
arthritic paw joint. 
 
EGCG reduces the severity of CIA and alleviates 
joint destruction. Moreover, diminishes the 
number of CCL2-producing osteoblasts and 
recruitment of CD68+ macrophages. 
 
EGCG ameliorates clinical symptoms, histological 
scores in arthritis, IL-1β, IL-6, TNF-α, IFN-γ, IL-10 
and anti-CII IgG serum level. Also supresses T cell 
proliferation and increases Nrf2 and HO-1 levels. 
 
EGCG reduces histopathological cartilage 
degradation. 
 
 
2 g/L of 
green tea 
extract in 
water, ad 
libitum as 
the sole 
source of 
drinking 
water. 
 
20 mg/Kg 
i.p. 
 
 
 
 
20 mg/Kg 
i.p. 
 
 
 
10 mg/Kg  
Orally  
 
 
 
12 mg/Kg 
Intra-
articular 
injection 
(Haqqi, 
Anthony et 
al. 1999) 
 
 
 
 
 
 
 
 
 
 
(Morinobu, 
Biao et al. 
2008) 
 
 
 
 
(Lin, Chang 
et al. 2008) 
 
 
 
 
 
(Min, Yan 
et al. 2015) 
Min 201 
 
 
 
(Natarajan, 
Madhan et 
al. 2015) 
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AIA in rats 
 
 
 
AIA in rats 
 
EGCG inhibits IL-6 and MMP-2production. EGCG 
enhances the synthesis of gp130 protein and 
endogenous inhibitor of IL-6 signalling. 
 
Green tea extract ameliorates arthritic damage 
via inhibition of IL-17 and upregulation of IL-10 
serum level. 
 
100 mg/Kg 
i.p. 
 
 
8 and 12 g/L 
green tea 
extract in 
drinking 
warter 
 
(Ahmed, 
Marotte et 
al. 2008) 
 
 
 
(Kim, 
Rajaiah et 
al. 2008) 
 
Diarylheptanoids and arylalkanones 
Ginger  Ginger 
(Zingiber 
officinale) 
CIA in rats Ginger ameliorates the clinical score, cartilage 
destruction and decreases serum levels of IL-1β, 
TNF-α, IL-2, IL-6 and anti-CII IgG.  
50, 100 and 
200 mg/Kg  
i.p. 
(Fouda and 
Berika 
2009) 
 
Curcumin Curcuma 
longa 
CIA in mice 
 
 
AIA in rats 
 
 
 
 
 
 
 
AIA in rats 
 
Curcumin attenuates arthritic index and reduces 
BAFF, IFN-γ and IL-6 sera levels. 
 
Curcumin ameliorates symptoms of arthritis and 
preserves radiological alterations. Curcumin 
reduces TNF-α, MDA, nitrites C-reactive protein 
and citrullinated peptide antibody sera levels. 
 
 
 
 
Curcumin improves histopathological changes, 
decreases IL-1β and TNF-α synovial and sera 
levels and inhibit NF-κB pathway. 
50 mg/Kg 
i.p. 
 
10 and 30 
mg/Kg 
Curcumin 
loaded solid 
lipid 
nanoparticle
s. Orally 
 
50 mg/Kg 
i.v. or orally 
(nanoformul
ation) 
(Huang, Xu 
et al. 2013) 
 
 
(Arora, 
Kuhad et al. 
2015) 
 
 
 
 
 
 
 
(Zheng, Sun 
et al. 2015) 
 
 
Stilbenes 
Resveratrol Grapes Intraarticular 
injection of 
LPS in rabbits 
 
CIA in mice 
 
 
 
 
 
AIA in rats 
Resveratrol decreases cartilage destruction and 
loss of matrix proteoglycan content in the 
cartilage. 
 
Resveratrol attenuates clinical parameters and 
bone erosion; associated with markedly reduced 
serum levels of pro-inflammatory cytokines and 
collagen-specific IgG and with reduced numbers 
of Th17 cells and the production of IL-17 in DLN. 
 
Resveratrol reduces cartilage degeneration, 
reduces the production of COX-2 and PGE2 and 
inhibits the proliferation of Con-A spleen cells 
 
2.3 mg/Kg 
Intraarticula
r injection 
 
20 mg/Kg 
i.p. 
 
 
 
 
10 and 50 
mg/Kg 
Intragastrica
lly 
(Elmali, 
Baysal et al. 
2007) 
 
 
(Xuzhu, 
Komai-
Koma et al. 
2012) 
 
 
 
 
(Chen, Lu 
et al. 2014) 
 
Other dietary polyphenols 
Punicalagin Pomegranate  AIA in rats Punicalagin diminishes disease development and 
paw edema 
10 and 50 
mg/Kg  
i.p. 
(Jean-
Gilles, Li et 
al. 2013) 
Ellagic acid Blackberries, 
cranberries, 
pecans, 
pomegranate
s, raspberries, 
strawberries, 
walnuts, 
wolfberries, 
and grapes 
CFA-induced 
polyarthritis in 
rats 
Ellagic acid reduces joint inflammation and 
histopathological changes; also suppresses TNF-α 
and IL-1β production. 
0.13, 0.325 
and 0.65% 
Topically 
(Mo, 
Panichayup
akaranant 
et al. 2013) 
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Oleuropein EVOO CIA in mice Oleuropein ameliorates clinical symptoms and 
histological scores in arthritis; also decreases pro-
inflammatory cytokines and chemokine plasma 
levels and MPo activity. 
40 mg/Kg 
i.p. 
(Impellizzer
i, Esposito 
et al. 2011) 
Hydroxytyrosol  EVOO CIA in rats Hydroxytyrosol decreases paw edema and 
histological damage and reduces COX-2 and iNOS 
expression. 
5 mg/Kg 
Orally 
(Silva, 
Sepodes et 
al. 2015) 
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Según la Organización Mundial de la Salud, las enfermedades reumáticas son la causa 
más frecuente de incapacidad, de origen no mental, en el mundo. En España estas patologías 
están relacionadas con el 50.7% de las incapacidades laborales y son la principal causa de bajas 
laborales permanentes. Especial relevancia tiene la artritis reumatoide (AR), por sus 
repercusiones sobre la calidad de vida de los pacientes y el deterioro progresivo que produce 
esta enfermedad. Entre el 20% y el 30% de los pacientes con AR se convierten en incapacitados 
permanentes. Demográficamente, la AR es la forma más común de artritis inflamatoria y 
afecta aproximadamente al0.5 - 1% de la población mundial, con un impacto económico 
comparable con el de la enfermedad arterial coronaria. Esta patología puede aparecer en 
cualquier etapa de la vida,  sin  embargo la prevalencia aumenta con la edad de tal forma que 
el 80% de todos los pacientes inician la enfermedad entre los 35 y 50 años de edad y es unas 3 
veces mayor en mujeres que en hombres (Gonzalez Cernadas, Rodriguez-Romero et al. 2014).  
La AR es una enfermedad autoinmunológica inflamatoria, crónica y sistémica que se 
caracteriza por una sinovitis erosiva simétrica, en la cual el tejido de granulación de origen 
sinovial (pannus), invade y erosiona el cartílago y el hueso de las articulaciones diartrodiales. 
La enfermedad se desarrolla con cifras elevadas de la velocidad de sedimentación eritrocitaria, 
proteína C reactiva, presencia de inmunocomplejos y el factor reumatoide. Los pacientes con 
AR presentan afectación generalmente de las articulaciones diartrodiales de forma simétrica. 
Dicha enfermedad tiene, en ocasiones, un componente extraarticular, afectando a diversos 
órganos y sistemas. El deterioro progresivo, articular o extraarticular, acaba provocando que 
estos pacientes presenten deformidad, dolor, incapacidad funcional y disminución de la 
expectativa de vida (Fauci 2010).   
La etiología de AR se desconoce aunque factores genéticos, infecciosos (infección viral, 
e.g. Virus Epsein-Barr, Proteus, rubeola,) ambientales (tabaco, situaciones de estrés y 
traumatismo, obesidad, dieta) y hormonales  parecen estar involucrados en vías relacionadas y 
complejas (Suzuki and Yamamoto 2015). Se han identificado múltiples genes que contribuyen 
a la predisposición y susceptibilidad a la enfermedad fundamentalmente el gen HLA-DRB1 del 
complejo mayor de histocompatibilidad, PADI4, PTPN22, CCR6 y FCRL3, entre otros 
(Yamamoto, Okada et al. 2015).  
Aunque la AR ha sido considerada como una patología autoinmune, no existe consenso  
sobre la naturaleza del autoantígeno(s) o factores ambientales que inicia la desregulación de la 
respuesta inmune, mayormente orquestados por macrófagos, células T reguladoras (Treg),  T 
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cooperadoras, (Th1 y Th17) y celulas T citotóxicas. Estos procesos incluyen el desbalance  de la 
producción de citocinas  Th1: interferón (IFN)-γ,  (TNF)-α y las interleuquinas (IL)-1β, IL-2 , IL-4, 
IL-6, IL-13, IL-15, IL-6, IL-23e IL-27; Th17 (IL-17), de citocinas Th2: (IL-10, IL-20, IL-22),  
quimioquinas (CXCR4, IP-10, SDF1, MCP-1) y metaloproteasas  (MMP-3 y MMP-9), capaces de 
digerir el cartílago (Brzustewicz and Bryl 2015). Entre las vías de señalización moleculares 
comprometidas se incluyen los factores nucleares de transcripción NF-κB y FOXP3 y las 
proteínas cinasas activadas por mitógenos (MAPK): c-Jun NH2 –terminal cinasa (JNK), p38 
cinasa  y cinasa regulada por señal extracelular (ERK) fundamentalmente (Han, Boyle et al. 
2001, McInnes and Schett 2011, Nie, Zheng et al. 2013).  
La secreción de citocinas proinflamatorias a sangre amplifica la respuesta 
inmunológica, produciéndose una expresión clonal de linfocitos B sobre todo del tipo IgG y una 
intensa reacción inflamatoria vía receptores Toll-like  acompañada de la liberación de citocinas, 
quimioquinas, mediadores lipídicos, como el factor activador de plaquetas (PAF), leucotrienos 
(LT), prostaglandinas (PG) y  activación de polimorfonucleares (PMN) substancialmente, 
neutrófilos, los cuales secretan proteasas, radicales libres derivados del oxígeno (RLO) y 
mieloperoxidasa (MPO),  contribuyendo de esta forma al daño celular (Anderson, Pratt et al. 
2015).  
 El abordaje terapéutico de la AR es multidisciplinar, y está dirigido principalmente a la 
supresión inespecífica del proceso inflamatorio con el objetivo de mitigar los síntomas y signos 
de la enfermedad englobando tratamiento médico, fisioterápico y otro grupo de métodos 
dentro del cual se incluyen las medidas dietéticas (Fauci 2010).   
En este contexto, la terapia nutricional en la actualidad, más allá de su soporte 
dietético, puede ejercer efectos profilácticos y terapéuticos carentes de los efectos 
indeseables que acompañan a la farmacoterapia clásica en determinadas enfermedades. En los 
últimos años, se ha puesto de manifiesto el potencial terapéutico de los alimentos funcionales 
o aquellos alimentos que, independientemente de sus propiedades nutritivas, poseen un 
efecto beneficioso para el organismo; es decir, su ingesta diaria, dentro de una dieta 
equilibrada, contribuye a mantener o mejorar el estado de salud y bienestar. 
Diversos estudios epidemiológicos indican que la dieta Mediterránea, que posee al 
aceite de oliva (AO) como principal fuente de grasa, está asociada a una menor incidencia de 
un buen número de patologías. Efectos beneficiosos se han observado en particular en: 
enfermedades cardiovasculares, digestivas (Alarcon de la Lastra, Barranco et al. 2001, Alarcon 
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de la Lastra, Barranco et al. 2002, Perez-Jimenez, Alvarez de Cienfuegos et al. 2005, Motilva, 
Talero et al. 2008, Sanchez-Fidalgo, Villegas et al. 2010), neurodegenerativas, diversos tipos de 
cáncer, principalmente cáncer colorrectal, pulmón y estómago, pero también de mama, 
endometrio, ovario, y próstata, entre otros (La Vecchia 2009, Pelucchi, Bosetti et al. 2009). 
Igualmente, en diferentes ensayos clínicos se ha puesto de manifiesto una mejoría de la 
sintomatología clínica de los pacientes con patología reumática que siguieron una dieta con AO 
como fuente de triglicérido, así como una reducción del uso de antiinflamatorios y en 
consecuencia una menor incidencia de reacciones adversas (Smedslund, Byfuglien et al. 2010).  
Por tanto, el AO podría ser definido desde un punto de vista estrictamente inmunológico y a la 
luz de los resultados obtenidos, como un componente de la dieta capaz de ejercer un efecto 
inmunomodulador (Puertollano, Puertollano et al. 2010).  
 En el mercado nos encontramos con diferentes tipos de AO en virtud de unos 
determinados parámetros de calidad: acidez, índice de peróxidos, absorbancia en el 
ultravioleta, características organolépticas y contenidos en ceras. Según el reglamento (CE) nº 
1989/2003  los AO se clasifican en aceite de oliva virgen, aceite de oliva virgen extra (AOVE), 
aceite de oliva virgen lampante, aceite de oliva refinado, aceite de oliva,  aceite de orujo de 
oliva crudo, aceite de orujo de oliva refinado y aceite de orujo de oliva. Concretamente, el 
AOVE es obtenido de la aceituna tras aplicar solamente procedimientos mecánicos o medios 
físicos en condiciones sobre todo térmicas y cuya acidez libre expresada en ácido oleico es 
como máximo 0.8%.  
 Hasta hace relativamente poco tiempo, las propiedades beneficiosas del AOVE, han 
sido atribuidas casi exclusivamente a su fracción saponificable caracterizada por el alto 
contenido en ácidos grasos monoinsaturados (ácido oleico).  Las fracciones insaponificable (FI) 
y polifenólica (FP), a pesar de ser minoritarias, están constituidas por un amplio número de 
compuestos de alto valor biológico. En concreto, la FI incluye en su composición: esteroles, 
alcoholes y dioles terpénicos (eritrodiol, uvaol, ácido oleanólico y maslínico) entre otros, 
alcoholes alifáticos (dicosanol, tetraconasol, etc.), tocoferoles (α, β, γ y δ), hidrocarburos 
esteroideos (etigmasta-3,5-dieno), hidrocarburos terpénicos (escualeno), 4,4-metil-esteroles 
(obtusifoliol, gramisterol, cicloeucalenol, etc.), pigmentos (clorofila, carotenos) y compuestos 
volátiles responsables de los aromas de los aceites (Sanchez-Fidalgo, Sanchez de Ibarguen et 
al. 2012).  
La FP está constituida por más de 30 compuestos aunque su composición cuali- y 
cuantitativa depende de la variedad de la aceituna, el grado de maduración y la climatología.  
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Destacan la oleaceína y el oleocantal y los aglicones monoaldehídicos de la oleuropeína y del 
ligustrósido (Franco, Galeano-Diaz et al. 2014). Otros componentes fenólicos minoritarios 
incluyen el hidroxitirosol, el acetato de hidroxitirosol y el dihidroxifenilglicol (Medina, de 
Castro et al. 2006). Entre los efectos biológicos de los fenoles del AOVE destacamos sus 
propiedades antioxidantes, antiaterogénicas y antiinflamatorias relacionadas con la génesis de 
las patologías crónicas más relevantes como la enfermedad cardiovascular, la 
neurodegeneración, el síndrome metabólico o el cáncer, entre otras. Además, son partícipes 
de importantes actividades farmacológicas i.e. antiarrítmica, antiagregante plaquetaria, 
vasodilatadora, antimicrobiana y quimiopreventiva (Cardeno, Sanchez-Hidalgo et al. 2013, 
Aparicio-Soto, Sanchez-Fidalgo et al. 2015, Sanchez-Fidalgo, Villegas et al. 2015). 
  En estudios previos, hemos puesto de manifiesto, mediante modelos experimentales 
de enfermedad inflamatoria intestinal (EII) y cáncer colorrectal, un importante efecto 
beneficioso de dietas enriquecidas con AOVE. Se confirmó  una reducción estadísticamente 
significativa del  daño colónico, de la incidencia de tumores, de la liberación de citocinas y de la 
inmunoreactividad de las proteínas ciclooxigenasa 2 (COX-2), óxido nítrico sintasa indicible 
(iNOS) y β- catenina en las mucosas procedentes de animales alimentados con AOVE (Sanchez-
Fidalgo, Villegas et al. 2010).  
De forma similar, en posteriores investigaciones evaluamos el potencial 
antiinflamatorio e inmunomodulador de las fracciones FI y FP del AOVE y subfracciones de 
éstas, en modelos animales de inflamación colónica y en células inmunocompetentes humanas 
y de ratón, y se dilucidaron los mecanismos de acción implicados. Los resultados revelaron que 
ambas fracciones (FI y FP) inducían significativos efectos antiinflamatorios e 
inmunomoduladores en los modelos in vitro e in vivo experimentales ensayados. Pudimos 
constatar que dietas elaboradas con AOVE minimizaron el daño colónico, reduciendo la 
expresión de las proteínas pro-inflamatorias COX-2 y iNOS, y generando un aumento de la 
expresión del receptor activador de la proliferación de los peroxisomas gamma (PPAR-γ) hasta 
niveles basales a través de la inhibición de las vías del NF-kB y las MAPK cinasas. Además, estos 
efectos beneficiosos fueron potenciados tras el enriquecimiento del aceite con las FI y FP.  
Estos resultados sugerían que una dieta suplementada con FI y FP podría constituir una 
estrategia terapéutica novedosa para el tratamiento nutricional de la EII y otras patologías de 
etiología inmunoinflamatoria (Sanchez-Fidalgo, Sanchez de Ibarguen et al. 2012, Sanchez-
Fidalgo, Cardeno et al. 2013, Aparicio-Soto, Sanchez-Fidalgo et al. 2015, Sanchez-Fidalgo, 
Villegas et al. 2015). Con la finalidad de extrapolar estos resultados a la clínica, nuestro grupo 
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puso de manifiesto actividad inmunomoduladora de la FI del AOVE en linfocitos aislados de 
sangre periférica procedente de pacientes con EII recidivante en comparación con un grupo de 
sujetos sanos  (Cardeno, Magnusson et al. 2014) gracias a la  colaboración con el Department 
of Microbiology and Immunology de Sahlgrenska Academy  (Universidad de Gothenburg, 
Suecia) bajo la dirección de la Dra. Lena Ohman. 
Como se ha comentado, existen datos epidemiológicos que relacionan una menor 
prevalencia de enfermedades reumáticas en países mediterráneos en comparación con los del 
norte de Europa. En consecuencia, estas evidencias sugieren un papel del AO de la dieta en el 
desarrollo y progresión de procesos inflamatorios reumáticos articulares.  
La efectividad de la dieta mediterránea en pacientes con AR se ha evaluado en varios 
ensayos y revisiones, aunque la evidencia todavía es inconclusa. En concreto, la evidencia 
obtenida a partir de los ensayos clínicos revisados permite afirmar que los principales 
beneficios clínicos de la dieta mediterránea en la AR están relacionados con el dolor, la rigidez 
matutina, el número de articulaciones inflamadas, una mejora de la percepción de salud de los 
pacientes (medida a través de cuestionarios como el SF-36 y el HAQ), y una disminución de la 
actividad de la enfermedad (valorada mediante escalas tipo EVA, o el cuestionario DAS2833-
36) (Abendroth, Michalsen et al. 2010). En línea con estos hallazgos se encuentran las 
conclusiones de las revisiones sistemáticas donde se afirma que la dieta mediterránea reduce 
el dolor (Smedslund, Byfuglien et al. 2010) y produce una mejora en la función física (Gonzalez 
Cernadas, Rodriguez-Romero et al. 2014). 
No obstante, no existen hasta la fecha, estudios experimentales in vitro e in vivo que 
validen el potencial antirreumático del AOVE, de los componentes bioactivos posibles 
responsables así como de los mecanismos bioquímicos y moleculares implicados.   
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 Por ello el objetivo general de esta Tesis Doctoral ha sido investigar el funcionalismo 
del AOVE en la artritis reumatoide experimental. 
 En concreto, nos hemos centrado en los siguientes objetivos específicos:  
1.  Caracterización química cuali y cuantitativa del AOVE seleccionado: Extracción y análisis 
químico de la fracción polifenólica. 
2. Valoración  en  un  modelo experimental in vivo de AR inducida por colágeno tipo II en  
ratones DBA/1 los efectos de :  
 2a. Diferentes dietas elaboradas con AOVE y aceite de girasol (AG)   y explorar las rutas 
bioquímicas y vías de señalización intracelulares posiblemente comprometidas. 
2b. La administración oral de la FP del AOVE en estudio,   estudiar las rutas bioquímicas y 
mecanismos de señalización moleculares implicados más significativos. 
2c. Dietas enriquecidas con dos compuestos fenólicos del AOVE: Hidroxitirosol y acetato 
de hidroxitirosol y dilucidar los mecanismos moleculares y vías de señalización 
intracelulares implicados. 
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LA DIETA DE ACEITE DE OLIVE VIRGEN EXTRA PREVIENE LA RESPUESTA INFLAMATORIA Y LA 
DEGRADACIÓN DE LA MATRIZ DEL CARTÍLAGO EN UN MODELO DE ARTRITIS INDUCIDA POR 
COLÁGENO TIPO II EN RATONES 
MªÁngeles Rosillo, Marina Sánchez-Hidalgo, Susana Sánchez-Fidalgo, Marina Aparicio-Soto, 
Isabel Villegas, Catalina Alarcón-de-la-Lastra 
Departamento de Farmacología, Facultad de Farmacia, Universidad de Sevilla, España 
 
RESUMEN 
Antecedentes del tema: Aunque la patogenia de la artritis reumatoide (AR) sigue sin conocerse 
en su totalidad, actualmente se ha descrito la existencia de una desregulación en el balance 
Th1/Th2 y Th17/células T reguladoras en pacientes con AR. En las articulaciones artríticas, se 
produce un incremento en la expresión de citocinas proinflamatorias, tales como TNF-α, IL-1β o 
IL-17, que juegan un papel destacado en el desarrollo y progresión de la enfermedad. Este 
aumento se atribuye, al menos en parte, a una desregulación en las rutas de señalización celular 
protagonizadas por las MAP cinasas (MAPKs), JAK/STAT y el factor nuclear NF-κB. Por otro lado, 
el factor nuclear Nrf2, es una pieza clave en la transcripción de distintas enzymas antioxidantes 
como la hemo oxigenasa 1 (HO-1), se ha demostrado que la activación de la expresión génica de 
esta proteína es capaz de modular la respuesta inflamatoria. El hecho de que el abordaje 
farmacológico de la AR implique severos efectos secundarios, ha generado en los últimos años 
un auge en el uso de otras estrategias terapéuticas, entre las que destaca la terapia nutricional. 
Recientes estudios epidemiológicos han confirmado que el consumo de aceite de oliva virgen 
extra (AOVE), dentro del contexto de la dieta Mediterránea, resulta eficaz en la prevención de 
ciertas patologías relacionadas con el estrés oxidativo, la inflamación y el sistema inmune. Por 
otro lado, recientes publicaciones de nuestro grupo de investigación, así como de otros autores, 
han demostrado las propiedades antiinflamatorias e inmunomoduladoras de la dieta de AOVE 
en distintos modelos experimentales de inflamación. 
Objetivos: En base a los anteriores antecedentes, nos planteamos evaluar la influencia de una 
dieta de AOVE de la variedad picual, en un modelo de artritis experimental inducida por 
colágeno tipo II en ratones. 
Material y Métodos: Ratones DBA-1/J recién destetados, fueron distribuidos en cuatro grupos 
experimentales: (1) Ratones sanos alimentados con dieta de aceite de girasol (CS-AG), (2) 
Ratones artríticos alimentados con dieta de aceite de girasol (CIA-AG), (3) Ratones sanos 
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alimentados con dieta de AOVE (CS-AOVE), (4) Ratones artríticos alimentados con dieta de 
AOVE. Después de seis semanas, la artritis fue inducida. El día 0, los ratones fueron inmunizados 
con una inyección en la base de la cola de 100 mg de colágeno II. El día 21, recibieron una 
inyección de refuerzo intraperitoneal, con la misma cantidad de colágeno. El grado de desarrollo 
de la enfermedad fue valorado de forma visual siguiendo una escala de 0-2, dónde 0=sin 
inflamación; 1=inflamación leve; 1.5=inflamación marcada; 2=inflamación severa y según el 
estudio histológico de las articulaciones. Los niveles en suero de la proteína oligomérica de la 
matriz del cartílago (COMP) y de metaloproteasa 3 (MMP-3) así como los niveles de citocinas 
proinflamatorias como TNF-α, IL-1β e IL-17 en el homogenado de pata fueron determinados 
mediante la técnica de ELISA. Los cambios en la expresion proteica de HO-1, Nrf2 y de las 
proteínas implicadas en las vías de señalización celular MAPKs, JAK/STAT y NF-κB fueron 
estudiadas mediante western blot. 
Resultados: la dieta de AOVE redujo de forma significativa el edema articular y la destrucción 
del cartílago, previniendo el desarrollo de la AR. Los niveles séricos de COMP y MMP-3, los 
encontramos disminuidos en aquellos animales alimentados con la dieta de AOVE. La expresión 
de las citocinas proinflamatorias TNF-α, IL-1β e IL-17 fue menor el tejido articular de los ratones 
artríticos que recibieron la dieta de AOVE, en comparación con los CIA-AG. Además la activación 
de las vías de señalización MAPKs, JAK/STAT y NF-κB fue inhibida por la dieta de AOVE. De 
acuerdo con la expresión proteica de Nrf2 y HO-1, estuvo aumentada en las articulaciones de 
los ratones pertenecientes al grupo CIA-AOVE. 
Conclusión: Estos resultados confirman, por primera vez, que el AOVE muestra un elevado 
efecto protector en la prevención y la progresión de la AR experimental, probablemente a través 
de la activación de la vía Nrf2/HO-1, e inactivación de las vías MAPKs, JAK/STAT y NF-κB, con los 
que podría ser considerado como un alimento funcional de primera magnitud dentro de la 
terapia nutricional de pacientes con AR, si futuros ensayos clínicos confirmasen estos resultados 
experimentales. 
1 3
Eur J Nutr
DOI 10.1007/s00394-015-0850-0
ORIGINAL CONTRIBUTION
Dietary extra‑virgin olive oil prevents inflammatory response 
and cartilage matrix degradation in murine collagen‑induced 
arthritis
María Angeles Rosillo · Marina Sánchez‑Hidalgo · 
Susana Sánchez‑Fidalgo · Marina Aparicio‑Soto · 
Isabel Villegas · Catalina Alarcón‑de‑la‑Lastra 
Received: 28 August 2014 / Accepted: 13 November 2014 
© Springer-Verlag Berlin Heidelberg 2015
of JAK/STAT, MAPKs and NF-κB pathways was drasti-
cally ameliorated. According to Nrf2 and HO-1, the pro-
tein expressions were up-regulated in those mice fed with 
EVOO.
Conclusion These results support the interest of EVOO as 
a beneficial functional food to prevent the development of 
the rheumatoid arthritis (RA).
Keywords CIA · EVOO · Inflammatory response · Olive 
oil · Rheumatoid arthritis
Introduction
Rheumatoid arthritis (RA) is an autoimmune disease char-
acterized by chronic inflammation of synovial membranes 
and proliferation of the synovial lining leading to synovial 
hyperplasia and massive infiltration of immune cells, vas-
culogenesis, cartilage and bone destruction and progressive 
joint damage [1]. Although the pathogenesis of RA is not 
fully understood, genetic and immunologic factors clearly 
contribute to the joint damage during RA [2]. In fact, dys-
regulated balances of Th1/Th2 and Th17/Treg cells have 
been demonstrated in RA patients [3].
RA synovium is characterized by up-regulated proin-
flammatory cytokines levels such as tumor necrosis fac-
tor alpha (TNF-α) and interleukin (IL)-1β, the two key 
cytokines involved in destructive arthritis in addition to 
IL-17, IL-21, IL-23 and IL-6, among others. In fact, IL-17 
plays important roles in the additive/synergistic effects 
induced together with TNF-α and IL-1β, and cartilage 
matrix breakdown induction through the chondrocyte 
metabolism dysregulation. Besides, cytokines contribute 
to the osteoclasts and macrophages activation and also pro-
motion of recruitment of both neutrophils and monocytes 
Abstract 
Purpose Current experimental studies support a benefi-
cial role of extra-virgin olive oil (EVOO) in several inflam-
matory diseases. The present study was designed to evalu-
ate the effects of dietary EVOO on type II collagen-induced 
arthritis (CIA) in mice.
Methods  DBA-1/J mice were randomized in four experi-
mental groups (10 or 15 animals per group): (1) Sham sun-
flower diet (SO-Sham), (2) CIA sunflower diet (SO-CIA), 
(3) Sham EVOO diet (EVOO-Sham) and (4) CIA EVOO 
diet (EVOO–CIA) group. After 6 weeks, arthritis was 
induced by type II collagen. Mice were sacrified 42 days 
after first immunization. In addition to macroscopic and 
histological analyses, serum levels of cartilage olimeric 
matrix protein (COMP), metalloproteinase-3 (MMP-3) 
and pro-inflammatory cytokines levels were evaluated by 
ELISA. The expressions of heme oxygenase-1 (HO-1), 
nuclear factor E2-related factor 2 (Nrf2), mitogen-activated 
protein kinases (MAPKs), Janus kinase-signal transducer 
and activator of transcription (JAK/STAT) and nuclear tran-
scription factor-kappa B (NF-κB) pathways were studied 
by western blotting.
Results EVOO diet significantly reduced joint edema and 
cartilage destruction, preventing the arthritis development. 
Dietary EVOO significantly decreased serum COMP and 
MMP-3 levels, as well as, the pro-inflammatory cytokines 
levels (TNF-α, IL-1β and IL-17). Moreover, the activation 
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by means of inducing various chemokines. The infiltrated 
leukocytes produce more cytokines and tissue-destructive 
enzymes leading to chronic inflammation, cartilage damage 
and bone erosion [4].
The process of gene expression of these pro-inflam-
matory mediators involves multiple signal transduction 
pathways including mitogen-activated protein kinases 
(MAPKs) [5, 6] and nuclear transcription factor-kappa 
B (NF-κB) pathways [6, 7]. Actually, NF-κB activation 
results in metalloproteinases (MMPs) production, which 
degrade articular extracellular matrix constituents and 
subsequently cause articular destruction. In addition, the 
Janus kinase–signal transducer and activator of transcrip-
tion (JAK-STAT) is another relevant inflammatory pathway 
activated in response to cytokines [8]. In particular, STAT-3 
overexpression has been reported in synovial membranes 
from RA patients [9]. Likewise, nuclear factor E2-related 
factor 2 (Nrf2) is a key transcription factor orchestrator of 
the induction of several antioxidant enzymes, such as heme 
oxygenase (HO)-1. The activation of HO-1 gene expres-
sion is considered to be an adaptive cellular response to 
survive exposure to environmental stresses. More recently, 
HO-1 has also been reported to modulate inflammatory 
responses, cell proliferation and prevent apoptosis [10, 11].
Recent research has suggested that dietary patterns, such 
as the traditional Mediterranean diet, which is character-
ized by large amounts of foods naturally derived, in par-
ticular, vegetables, fruits, nuts, fish and grains, may confer 
protection from certain chronic diseases related to oxida-
tive stress, inflammation and the immune system. In com-
parison with other healthy diets, Mediterranean diet has a 
high content of total fat as its most distinctive feature due 
to the usual high intake of olive oil from olive tree, Olea 
europaea [12].
Extra-virgin olive oil (EVOO) is obtained from the fruit 
of the olive tree solely by mechanical or other physical 
means under conditions that do not lead to oil alteration. 
Traditionally, the beneficial effects of EVOO have been 
attributed to its high MUFA content (oleic acid) as it pro-
tects lipoproteins and cellular membranes, from oxidative 
damage [13]; however, nowadays, there is increasing evi-
dence to support the beneficial effects of EVOO intake that 
are due to its minor highly bioactive components (about 
1–2 % of oil weight) including phenolic compounds, trit-
erpene alcohols, sterols, hydrocarbons (squalene), vitamins 
(α- and γ-tocopherols), β-carotene, phytosterols, among 
others [12, 14]. Particularly, current experimental studies 
support a beneficial role of polyphenols from EVOO in sev-
eral inflammatory diseases, including RA [15–18]. In fact, 
our research group has previously demonstrated that an 
EVOO diet enriched with hydroxytyrosol, a phenolic com-
pound present in the oil, and a dietary EVOO-polyphenol 
extract supplementation could improve the inflammatory 
responses associated with a chronic experimental colitis 
model [19, 20]. Furthermore, we also confirmed beneficial 
effects of dietary EVOO-unsaponifiable supplementation 
on an acute experimental colitis model [21].
Although dietary EVOO has demonstrated immunomod-
ulatory and antiinflammatory properties in several inflam-
mation experimental models [22–24], nevertheless its pos-
sible contribution to RA remains unknown.
Taken this background into account, the present study 
was designed to evaluate the potential protective effects of 
dietary EVOO in collagen-induced arthritis (CIA) model, 
a well-studied animal model of RA useful in the devel-
opment of new therapies for RA [10], and to identify its 
underlying molecular mechanisms. The severity of arthri-
tis was assessed by macroscopic and histology param-
eters. Inflammatory mediators and the signaling pathways 
involved were also explored.
Materials and methods
Animals and diets
A total of 50 three-week-old male DBA-1/J mice (Janvier®, 
Le Genest St Isle, France) were maintained in our Animal 
Laboratory Center under standard conditions (temperature, 
24–25 °C; humidity, 70–75 %; lighting regimen, 12L/12D). 
They were fed pellet diets and water ad libitum. Mice were 
randomized into four experimental groups (10 or 15 ani-
mals per group) during all experimental period: (1) Sham 
sunflower diet (SO-Sham) group received a diet elaborated 
with a marketable sunflower oil (Koipesol®, DEOLEO, 
Spain), (2) CIA sunflower diet (SO-CIA) group received 
a diet elaborated with a marketable sunflower oil (Koipe-
sol®, DEOLEO, Spain), (3) Sham EVOO diet (EVOO-
Sham) group were fed with a diet made with a marketable 
EVOO picual variety characterized by a high content of 
polyphenolic compounds (600 ppm) (Oleoestepa®, Seville, 
Spain) and (4) CIA EVOO diet (EVOO-CIA) group were 
fed with a diet made with a marketable EVOO picual vari-
ety, containing high levels of polyphenolic compounds 
(600 ppm) (Oleoestepa®, Seville, Spain). All diets were 
formulated on the basis of the American Institute of Nutri-
tion (AIN) standard reference diet with the modification of 
various sources of carbohydrate (Table 1), at 10 % of total 
oil (Table 2) and were prepared by mixing the respective 
compounds under yellow light and stored at −80 °C. Fresh 
diets were provided daily. The animals were fed with the 
corresponding diet during 6 weeks previous to the CIA 
induction and during the experiment time. Experiments fol-
lowed a protocol approved by the Animal Ethics Commit-
tee of the University of Seville, and all experiments were 
in accordance with the recommendations of the European 
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Union regarding animal experimentation (Directive of the 
European Counsel 2010/630/EU).
Induction of CIA
Arthritis was induced in 10-week-old male DBA-1/J mice. 
Bovine type II collagen (CII) 2 mg/mL in dilute acetic acid 
(MD Bioproducts®, Zürich, Switzerland) was emulsified 
in equal volumes of Freund’s complete adjuvant (2 mg/
mL Mycobacterium tuberculosis, strain H37Ra; Difco®, 
Detroit, Michigan, USA). On day 0, DBA-1/J mice were 
immunized at the base of the tail with 100 mg of bovine 
CII. On day 21, mice received an intraperitoneal booster 
injection of 100 mg of CII dissolved in phosphate-buffered 
saline (PBS). Mice were considered to have arthritis when 
significant changes in redness and/or swelling were noted 
in the digits or in other parts of the paws. Joint inflam-
mation was scored visually in each paw, using a scale of 
0–2 where 0 = uninflamed, 1 = mild, 1.5 = marked and 
2 = severe. Scoring was performed by two independent 
observers without knowledge of the experimental groups. 
Animals were euthanized on day 42 by overdoses of 
pentobarbital.
Histological analysis
After mice were killed, knee joints were removed and 
fixed in 4 % formalin. After decalcification in 10 % EDTA, 
specimens were processed for paraffin embedding. Tissue 
sections (7 mm) were stained with hematoxylin and eosin 
(H&E) to perform histological analysis.
Measurement of inflammatory markers
Enzyme-linked immunoassay (ELISA) kits were used 
to determine serum levels of cartilage oligomeric matrix 
protein (COMP) levels, with sensitivity of 0.2 U/L (MD 
Biosciences®, Zurich, Switzerland) and matrix metallo-
proteinase-3 (MMP-3) (sensitivity of 10 pg/mL) (R&D 
Systems®, Abingdon, UK). Hind paws were amputated 
above the ankle and homogenized in 1 mL of 10 mM 
Table 1  Composition of experimental diets (g/kg diet)
Diet was formulated on the basis of the AIN standard reference diet 
with the modification of various sources of carbohydrate
a
 Sunflower oil from Koipesol® (Spain)
b
 EVOO from picual variety, Oleoestepa®, Seville, Spain
c
 Mineral mix provided the following (g/kg diet): calcium carbon-
ate, 35.7; monopotassium phosphate, 25.0; sodium chloride, 7.4; 
potassium sulfate, 4.66; potassium citrate monohydrate, 2.8; mag-
nesium oxide, 2.4; ferric citrate, 0.606; zinc carbonate, 0.165; man-
ganese carbonate, 0.063; copper carbonate, 0.03; potassium iodate, 
0.001; sodium selenate, anhydrous, 0.001025; ammonium molyb-
date-4H2O, 0.000795; sodium metasilicate-9H2O, 0.145; chromium 
potassium sulfate-12H2O, 0.0275; boric acid, 0.00815; sodium fluo-
ride, 0.00635; nickel carbonate, 0.00318; lithium chloride, 0.00174; 
ammonium vanadate
d
 Vitamin mix provided the following (g/kg diet): nicotinic acid, 
30 mg; D-calcium pantothenate, 16 mg; pyridoxine HCL, 7 mg; thia-
mine HCL, 6 mg; riboflavin, 6 mg; folic acid, 2 mg; D-biotin, 0.2 mg; 
vitamin B12, 25 mg; α-tocopherol powder (250 U/g), 300 mg; vita-
min A palmitate (250,000 U/mg), 16 mg; vitamin D3 (400,000 U/g), 
2.5 mg; phylloquinone, 0.75 mg
Ingredients SO diet EVOO diet
Casein 200 200
DL-methionine 3 3
Corn starch 150 150
Sucrose 447.3 447.3
Cellulose 50 50
Sunflower oila 100 –
EVOOb – 100
Mineral mixc 35 35
Vitamin mixd 10 10
Choline bitarate 2 2
Table 2  Fatty acid, sterols, squalene, triterpene alcohols and tocoph-
erol composition of EVOO and SO
Parameters EVOO SO
Fatty acid composition as determined by GC (% m/m methyl esters)
 Myristic C-14:0 0.01 0.08
 Palmitic C-16:0 11.00 6.62
 Palmitoleic C-16:1 0.90 0.12
 Margaric C-17:0 0.10 0.04
 Margaroleic C-17:1 0.10 0.03
 Stearic C-18:0 3.10 4.27
 Oleic C-18:1 79.40 24.83
 Linoleic C-18:2 3.90 62.62
 Linolenic C-18:3 0.70 0.17
 Araquic C-20:0 0.40 0.27
 Eicosenoic C-20:1 0.20 0.22
 Behenic C-22:0 0.10 0.58
 Lignoceric C-24:0 0.10 0.17
Sterols as determined by GC, relative amounts (%)
 Cholesterol 0.10 0.20
 Brassicasterol 0.00 0.10
 Campesterol 3.30 10.70
 Stigmasterol 0.50 8.80
 β-sitosterol 95.40 63.40
 Δ7-Stigmastenol 0.40 10.50
 Δ5-Avenasterol 0.00 6.2
 Total sterols (mg/kg) 1,351 3,832
Squalene as determined by GC (mg/kg) 5,772 –
Triterpene alcohols (mg/kg) 542 –
Tocopherols and tocotrienols as determined by HPLC (mg/kg)
 α-Tocopherol (Vitamin E) 85 575
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4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) buffer, pH 7.4. Supernatants were used for the 
determination of IL-17, TNF-α and IL-1β levels, using 
the ELISA kit with sensitivities of 4.6 (Diaclone®, Besan-
con Cedex, France), 25 (Diaclone®, Besancon Cedex, 
France) and 5.1 (R&D Systems®, Abingdon, UK) pg/mL, 
respectively.
Isolation of cytoplasmic and nuclear proteins 
and immunoblotting detection
Frozen hind paws were homogenized in liquid N2. Isola-
tion of cytoplasmic and nuclear proteins was performed as 
described by Rosillo et al. [25] with some modifications. 
Protein concentration of the homogenate was determined 
following Bradford’s colorimetric method [26]. Aliquots of 
supernatant that contains equal amount of protein (50 µg) 
were evaluated to determine HO-1 (Enzo®, Madrid, Spain), 
Nrf2, p-p38, p-JNK, p-STAT3, p65 (Santa Cruz Biotec-
nology®, CA, USA) and IκB-α (Cell Signalling Technol-
ogy®, MA, USA) proteins by Western blot as described by 
Rosillo et al. [25]. The signals were analyzed and quanti-
fied by a scientific imaging systems (ImageJ software®, 
Maryland, USA).
Data analysis
All values in the figures and text are expressed as arithme-
tic mean ± standard error (SEM). Data were evaluated with 
Graph Pad Prism version 5.04 software. The statistical sig-
nificance was evaluated by two-way (time course) or one-
way (rest of parameters) analysis of variance (ANOVA), 
followed by Newman–Keuls’ test. P values < 0.05 were 
considered statistically significant.
Results
Effects of dietary EVOO on CIA model
The development of arthritis was monitored until day 42. 
The time course of arthritic score (Fig. 1a) indicates that 
control mice fed with SO presented a progressive devel-
opment of arthritis observed from day 29. However, mice 
feeding with EVOO showed a significant (p < 0.05 vs. SO-
CIA) delayed onset and decreased the disease severity of 
CIA reducing disease incidence, number of involved paws, 
footpad thickness and clinical index from days 30 to 42. 
These results suggested that dietary EVOO not only could 
retard the development but it also may have a therapeutic 
effect on ongoing inflammatory arthritis. Representative 
photographs of hind paws from the different experimental 
animal groups are shown in Fig. 1b.
In addition, H&E staining revealed that histological fea-
tures of the joint from sham animals were typical of normal 
structure with synovial membrane composed of synovial 
cells and collagen and a clear synovial space (Fig. 2a,b). On 
the contrary, joint from SO-CIA mice exhibited histologi-
cal changes indicative of severe arthritis, characterized by 
an extensive infiltration of inflammatory cells into articular 
tissues, exudation into the synovial space, synovial hyper-
plasia and cartilage erosion (Fig. 2c). These histological 
features were less evident in EVOO-CIA group (Fig. 2d).
Effects of dietary EVOO on serum biomarkers
MMP-3 is well known as a predictor for joint destruction 
in early or established RA. In the present study, we deter-
mined serum MMP-3 levels, as synovial inflammatory bio-
marker, in CIA mice to investigate the potential beneficial 
effects of our nutritional therapeutic strategy. Circulating 
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Fig. 1  Time course of the arthritis macroscopic score (a), representa-
tive photographs (b) of hind paws at the end of the experiment (day 
42). SO-Sham (a), non-arthritic mice feed with SO diet; EVOO-Sham 
(b), non-arthritic mice feed with EVOO diet; SO-CIA (c), control 
arthritic group feed with SO diet; EVOO-CIA (d), arthritic mice feed 
with EVOO diet. Data represent mean ± SEM n = 10. *p < 0.05 and 
**p < 0.01 vs Sham (SO and EVOO); +p < 0.05 vs SO-CIA
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MMP-3 level was markedly increased (p < 0.001 vs. 
Sham) in serum from CIA animal group fed with SO diet 
(Fig. 3). By contrast, a strong reduction in MMP-3 serum 
levels was observed in those arthritic animals feeding with 
EVOO (p < 0.001 vs. SO-CIA) reaching levels comparable 
to those described in sham animals. In addition, serum lev-
els of the cartilage degradation marker, COMP, were sig-
nificantly elevated in SO-CIA animals when compared to 
sham controls. On the contrary, dietary EVOO significantly 
decreased serum COMP levels in CIA mice in compari-
son with those SO-CIA animals (p < 0.001 vs. SO-CIA) 
(Fig. 3).
Effects of dietary EVOO on joint mediators
It has been reported that TNF-α, IL-1β and IL-17 are criti-
cal cytokines involved in the pathogenesis of RA [27]. 
To explore whether cytokines joint levels were paralleled 
to the disease severity of CIA, concentration of these 
cytokines was examined in paw homogenates by ELISA. 
As shown in Fig. 4, TNF-α, IL-1β and IL-17 levels were 
significantly increased in paw homogenates from SO-CIA 
animals when compared with sham mice (p < 0.001 and 
p < 0.5 vs. Sham), suggesting its relationship with the syn-
ovial tissue inflammation. Conversely, our results indicate 
that animals fed with EVOO diet showed a significant 
reduction in all those pro-inflammatory cytokines produc-
tion in comparison with SO-CIA group (TNF-α: p < 0,01, 
IL-1β: p < 0.001 and IL-17: p < 0.05 vs. SO-CIA). Impor-
tantly, IL-1β and IL-17 cytokines values were similar to 
those obtained from control sham animals.
Effect of dietary EVOO on p-STAT3 protein expression
STAT-3 has been described as a critical transcription fac-
tor involved in the pathogenesis of RA by steering the 
abnormal activation, automaticity and prolonged survival 
of synovial cells. Besides, STAT-3 is a key transcription 
factor involved in Th17 cell differentiation [28]. We evalu-
ated p-STAT3 protein expression by Western blot from 
hind paw homogenates. Statistical analysis revealed a sig-
nificant p-STAT-3 overexpression in SO-CIA group when 
compared to the sham control groups (p < 0.01 vs. Sham), 
whereas nutritional therapy with EVOO significantly sup-
pressed STAT3 phosphorylation in arthritic CIA mice 
(p < 0.01 vs. SO-CIA) (Fig. 5). These results are in accord-
ance with those obtained in the measurement of pro-inflam-
matory cytokines levels suggesting that dietary EVOO may 
repress IL-17 production via negatively interfering with 
STAT3 signaling pathway.
Fig. 2  Histological analysis of the frontal sections of knee joints on 
day 42. Sections were stained with hematoxylin and eosin. Origi-
nal magnification x200. SO-Sham (a), non-arthritic mice feed with 
SO diet; EVOO-Sham (b), non-arthritic mice feed with EVOO diet; 
SO-CIA (c), control arthritic group feed with SO diet; EVOO-CIA. 
Arrows the infiltration of inflammatory cells and the cartilage erosion. 
d Arthritic mice feed with EVOO diet. The arrow less damage at the 
cartilage. The images are representative of at least six experiments
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Effect of dietary EVOO on HO-1 and Nrf2 protein 
expression
The expression of the proteins HO-1 and Nrf2 was also 
evaluated in paw homogenates by western blotting. Our 
data show that HO-1 was significantly downregulated in 
SO-CIA mice during the maintenance of chronic inflam-
mation (p < 0.001 vs. Sham); however, dietary EVOO treat-
ment induced a strong HO-1 overexpression in comparison 
with SO-CIA arthritic control group (p < 0.01 vs. SO-CIA) 
(Fig. 6). Nrf2 activation has been reported to play an 
important role in HO-1 expression. According to our results, 
nuclear Nrf2 expression was reduced in those arthritic ani-
mals feed with SO diet (p < 0.05 vs. Sham), whereas a sig-
nificant increase in nuclear Nrf2 protein levels was observed 
in EVOO-CIA animals (p < 0.05 vs. SO-CIA) (Fig. 6).
Effect of dietary EVOO on JNK and p38 MAPKs 
phosphorylation
MAPKs play a key role inducing the pro-inflammatory 
gene expression, which initiates inflammatory responses. 
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Fig. 3  Measurement of serum COMP and MMP-3 levels. These were measured by ELISA kits. Data represent mean ± SEM, n = 10. 
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We investigated the effect of dietary EVOO on MAPKs 
(JNK and p38) signaling pathway activation in CIA mice. 
In the present study, phosphorylation of JNK and p38 pro-
teins increased in cytosolic extracts from SO-CIA mice 
paw homogenates. Nonetheless, the protein expression 
of both p-JNK and p-p38 was significantly ameliorated 
in EVOO-CIA mice (p < 0.05 and p < 0.01 vs. CIA-SO) 
(Fig. 7).
Effects of dietary EVOO on NF-κB signaling pathway
We also investigated the effects of EVOO on IkB-α degra-
dation in cytoplasmic extracts from mice joints. As shown 
in Fig. 8, IκB-α expression was significantly reduced in 
CIA-induced arthritis mice when compared with sham 
mice, in the SO treatment. The IκB-α expression observed 
in CIA mice is consistent with an increase in IκB-α degra-
dation, thus allowing NF-κB translocation into the nucleus 
to bind specific DNA sequences leading to pro-inflam-
matory genes transcription. On the contrary, the effect 
observed in arthritic control group on IκB-α protein expres-
sion was prevented by dietary EVOO treatment. Accord-
ing to the results obtained, the nuclear p65 protein levels 
were increased in SO-CIA group (p < 0.001 vs. Sham), 
whereas dietary EVOO treatment prevented the CIA-
induced nuclear translocation level of p65 in paw homoge-
nate in comparison with those arthritic animals feed with 
SO (p < 0.01 vs. SO-CIA) (Fig. 8) avoiding the NF-κB-
mediated transcriptional activation.
Discussion
The focus of this study has been to demonstrate the poten-
tial protective role of a diet elaborated with EVOO in the 
prevention and development of inflammatory arthritis and 
joint damage in a murine CIA-induced experimental arthri-
tis model. This model is commonly used to investigate 
mechanisms relevant to RA as well as new antiarthritic 
treatments [10]. CIA induction resulted in the development 
of a pronounced synovitis associated with an autoimmune 
response against cartilage and production of matrix-degrad-
ing enzymes accompanying cartilage degradation and bone 
erosions [29]. The results of the present work clearly indi-
cate, for the first time, that EVOO, as the lipid component 
of the diet, effectively exhibited preventive and therapeu-
tic effects in the development of inflammatory arthritis 
and joint damage in CIA arthritic mice in comparison with 
those CIA mice fed with SO. This effect was well corre-
lated to an improved arthritis score, a minor inflammatory 
cells infiltration into articular tissues, reduced exudation 
into the synovial space, synovial hyperplasia and cartilage 
erosion.
The pathogenesis of RA is closely related to an imbal-
ance of cytokine network contributing to the development 
and progression of both CIA and RA [30]. Actually, over-
expression of pro-inflammatory cytokines, such as IL-1β, 
Sham CIA Sham CIA
0.0
0.5
1.0
1.5
***
++
SO EVOO
D
en
si
to
m
er
y 
A
na
ly
si
s
(A
rb
itr
ar
y 
un
its
)
Sham CIA        Sham CIA
SO                         EVOO
Fig. 5  Changes in p-STAT3 protein expression in hind paws 
homogenate. The expression of p-STAT3 was quantified by den-
sitometry and normalized with respect to β-actin. Data repre-
sent mean ± SEM, n = 4.***p < 0.001 vs Sham (SO and EVOO); 
++p < 0.01 vs SO-CIA
Sham CIA Sham CIA 
0
1
2
3
4 Nrf2 HO-1
SO EVOO
***
*
+++
D
en
si
to
m
et
ry
 A
na
ly
si
s
(A
rb
itr
ar
y 
un
its
)
Sham CIA           Sham CIA
SO  EVOO
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TNF-α and IL-17, may activate osteoclasts and mac-
rophages and also recruit leukocytes in inflamed joints. 
The infiltrated leukocytes produce cytokines, chemokines 
and tissue-destructive enzymes leading to chronic inflam-
mation, cartilage damage and bone erosion. Besides, IL-17 
is able to induce the release of IL-8 and IL-6, and plays a 
remarkable role in the additive/synergistic effects induced 
by TNF-α and IL-1β [31]. Importantly, targeting IL-17 
has demonstrated therapeutic effects in animal models of 
inflammatory and autoimmune diseases, including RA [32]. 
Cytokines also up-regulate MMPs expression by chondro-
cytes and synoviocytes at the pannus cartilage junction 
leading to cartilage degradation [3, 4, 33]. Therefore, we 
examined TNF-α, IL-1β and IL-17 levels in paw homoge-
nates from CIA animals in comparison with sham control 
group. Our results indicate that animals fed with EVOO 
diet showed a significant reduction in all pro-inflammatory 
cytokines levels. Consequently, EVOO intake would con-
tribute to reduce the inflammatory response and joint dam-
age by suppressing the production of the key Th17 polari-
zation cytokines, TNF- α and IL-1β, in CIA arthritic mice.
COMP is a matrix protein with a great potential as 
a biological marker of cartilage metabolism in arthritis 
[34]. Increased fragments of COMP have been reported in 
patients with osteoarthritis, RA and joint injury; thus, the 
monitoring of COMP levels in synovial fluid or serum has 
been suggested to be a helpful method for assessing the 
presence and progression of the inflammatory disease. In 
this sense, serum COMP levels are reduced in RA patients 
in remission [34, 35]. In addition, COMP is a putative 
substrate for MMPs. Particularly, MMP-3 is a proteinase 
secreted by synovial fibroblasts and chondrocytes. Its activ-
ity results in degradation of aggrecan core protein, cartilage 
link protein, fibronectin and collagen types IV, VII, IX and 
XI. MMP-3 is present in RA synovial fluid, overexpressed 
in rheumatoid synovium and then associated with higher 
joint damage in RA [36]. Likewise, serum MMP-3 level is 
suggested as a predictor for joint destruction in early RA 
or established RA and should be used in association with 
usual inflammatory markers to follow therapy efficiency 
[37]. Our data are in agreement with above studies and 
showed that high serum COMP and MMP-3 levels were 
associated with disease activity and joint progression in 
CIA mice; by contrast, the production of both cartilage and 
synovial biomarkers was significantly inhibited by dietary 
EVOO treatment in CIA mice.
Abnormal signaling pathways play an important role 
in the inflammatory process and can lead to dysregula-
tion of the inflammatory response being crucial in RA 
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pathogenesis. Signal transduction pathways closely 
involved in inflammation included the MAPKs, JAK-STAT 
and NF-κB pathways [9]. NF-κB is a crucial transcrip-
tional activator for the expression of multiple proinflamma-
tory genes in the microenvironment of the arthritic joints, 
including TNF-α, IL-1β, IL-6 and IL-17, that exert their 
influences on both osteoclasts and osteoblasts differentia-
tion and thereby contributing to progressive joint destruc-
tion in RA patients and CIA mice [38, 39] as mentioned 
above. In fact, several anti-rheumatic drugs, currently in 
clinical use, inhibit NF-κB activation [40]. Interestingly, 
intra-articular or systemic blockade of NF-κB signaling 
is an effective target in the treatment of arthritis in animal 
models of RA [41]. Taken together, these studies confirm 
the importance of NF-κB activation in the development of 
RA. Consequently, NF-κB pathway suppression could be a 
novel strategy for delaying the progress of RA. Our results 
suggested that dietary EVOO treatment suppressed NF-κB 
activation, down-regulating pro-inflammatory cytokines 
and MMP-3 expression, thus minimizing joint destruction 
in CIA-induced arthritic mice.
MAPK family members, including p38 kinases, ERKs 1 
and 2 and JNKs, play critical roles in many important cell 
processes, including cell division, differentiation, inflam-
mation and apoptosis. They are especially drawing atten-
tion in RA because of the involvement in regulating both 
cytokine production and cytokine action [5, 6]. In fact, JNK 
MAPK regulates MMPs production by synovial fibroblasts 
and drives osteoclast differentiation in RA [42], and p38 
MAPK regulates MMP-3 induction in fibroblasts [43] and 
osteoclast differentiation [44]. Moreover, MAPKs phos-
phorylate the JAK-STAT important in pro-inflammatory 
cytokine-mediated signaling pathway leading to STAT-3 
activation [8]. STAT-3 has been described as a critical tran-
scription factor involved in Th17 cell differentiation [28]. 
In this line, STAT-3 overexpression has been also detected 
in synovial membranes from RA patients and it has been 
reported to contribute to the chronicity of inflammation in 
a murine zymosan-induced arthritis model [45]. Recently, 
STA-21, a promising STAT-3 inhibitor, has shown antiar-
thritic effects in interleukin-1 receptor antagonist knock-
out (IL-1Ra-KO) mice, an animal model of RA [46]. Our 
study showed that p38 and JNK MAPKs phosphorylations 
were increased in SO-CIA mice. Similarly, STAT-3 overex-
pression was also evidenced in RA synovium of SO-CIA 
mice and was positively related to the severity of synovi-
tis, whereas EVOO diet intake reduced significantly both 
MAPKs and STAT-3 activation at transcriptional level. 
Altogether, our results suggest that dietary EVOO may 
repress IL-17 production interfering negatively with JNK 
and p-38 MAPKs and STAT-3 signaling pathways.
HO-1 activity catabolizes heme to carbon monoxide, 
iron and biliverdin, and the latter being reduced to bilirubin 
by biliverdin reductase. Nrf2 plays a central role for expres-
sion of HO-1. In basal conditions, Nrf2 is sequestered in 
the cytoplasm by Kelch-likeECH-associated protein1 
(Keap1) and degraded by the ubiquitin-dependent 26S 
proteasome system. Under activation, Nrf2 released from 
Keap1 inhibition, translocates to the nucleus, heterodimer-
izes with Maf and binds antioxidant response elements 
(AREs) located in the promoter regions of many detoxify-
ing/antioxidant genes, including HO-1 [47]. In inflamma-
tory and immune conditions, the expression of this protein 
could be part of an adaptative mechanism to limit cytotox-
icity via several mechanisms including scavenging of reac-
tive oxygen or nitrogen species, regulation of cell prolifera-
tion and prevention of apoptosis [10]. Likewise, it has been 
reported that HO-1 deficiency in mice results in a chronic 
inflammatory state [48]. Our data showed that HO-1 could 
represent a potential molecular target susceptible to EVOO 
modulation, which has not been demonstrated previously, 
since dietary EVOO treatment strongly augmented Nrf2 
and HO-1 expression conferring a role of HO-1 in the ben-
eficial effects of EVOO in this murine model of chronic 
inflammation.
Since our results show that EVOO diet was more effec-
tive in reducing arthritis severity in comparison with SO 
diet, we could suggest that the responsibility for such ben-
eficial properties could to be assigned to both an adequate 
fatty acid profile of EVOO and the presence of a high 
proportion of phenolic compounds. In this sense, a recent 
report showed that oleuropein aglycone, a polyphenol 
found in olive oil, exerted an anti-inflammatory effect and 
ameliorated the joint damage associated with CIA [15]. 
In addition, these improved effects observed could be due 
to a possible synergistic effect among EVOO constitu-
ents, since it is not clear whether all the possible beneficial 
mechanisms act independently of each other or whether 
they have a synergistic or competitive action [14, 49]. Col-
lectively, our results confirm, for the first time, that EVOO 
intake dramatically attenuated the progression and severity 
of arthritis in CIA DBA/1 J mice. The mechanisms under-
lying these protective effects involved JAK/STAT, NFκB 
and MAPK signaling pathways inhibition, which decreased 
the production of the pro-inflammatory cytokines TNF-α, 
IL-1β and IL-17 accompanied by an important reduction 
of the serum synovial and cartilage biomarkers COMP 
and MMP-3 and a significant Nrf2 and HO-1 up-regula-
tion, conferring a role of HO-1 in the beneficial effects of 
EVOO in this murine model of chronic inflammation. We 
concluded that EVOO diet could be a beneficial functional 
food on RA if subsequent randomized trials in humans con-
firm the present results in animal models.
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RESUMEN 
Antecedentes del tema: La AR es una enfermedad autoinmune caracterizada por la inflamación 
sinovial y la formación de pannus, que provoca daños en el cartílago y en el hueso. Aunque la 
patogenia de la AR sigue sin conocerse en su totalidad, está ampliamente demostrado, que se 
produce un aumento de los niveles de citocinas proinflamatorias, que contribuyen a la 
cronicidad y al daño tisular en la AR. Este aumento se atribuye, al menos en parte, a una 
desregulación en las rutas de señalización celular protagonizadas por las MAPKs, JAK/STAT y el 
factor nuclear NF-κB. El modelo de artritis experimental inducida por colágeno tipo II en ratones, 
es un modelo ampliamente usado para determinar el potencial antiartrítico de nuevas 
moléculas. La terapia biológica, ha supuesto un gran avance en el tratamiento de la AR, sin 
embargo, este tipo de medicamentos sólo son efectivos en una parte de los pacientes y tienen 
otras limitaciones como su alto coste económico o el requerimiento de ser administrados por 
vía parenteral. Es por ello, por lo que en los últimos años se ha generado un auge en el uso de 
otras estrategias terapéuticas, entre las que destaca la terapia nutricional. El AOVE en los países 
Mediterráneos ha demostrado efectos beneficiosos en la prevención de ciertas enfermedades 
crónicas. Tradicionalmente, el efecto beneficioso del AOVE ha sido atribuido a su alto contenido 
en ácidos grasos monoinsaturados, como el ácido oleico; sin embargo, estudios recientes han 
puesto de manifiesto que los componentes minoritarios, el especial la fracción polifenólica, del 
AOVE juegan un papel fundamental. 
Objetivos: En base a los anteriores antecedentes, nos planteamos evaluar los efectos de la 
administración oral de un extracto polifenólico (PE) procedente de AOVE de la variedad picual, 
en un modelo de artritis experimental inducida por colágeno tipo II en ratones. 
 
Capítulo II 
70 
 
Material y Métodos: La artritis fue inducida en ratones DBA-1/J de 11 semanas de edad. El día 
29, después de la primera inmunización, los ratones ya presentaban signos de inflamación en 
sus extremidades; éste día fueron separados en 4 grupos: (1) Controles sanos (CS); (2) Controles 
artritis (CIA); (3) Ratones artríticos que recibían 100mg/Kg PE de forma oral (PE100); (4) Ratones 
artríticos que recibían 200 mg/Kg PE de forma oral (PE200). El grado de desarrollo de la 
enfermedad fue valorado de forma visual siguiendo una escala de 0-2, dónde 0=sin inflamación; 
1=inflamación leve; 1.5=inflamación marcada; 2=inflamación severa y según el estudio 
histológico de las articulaciones. Los niveles de citocinas proinflamatorias como TNF-α, IL-1β e 
IL-6, así como los niveles del ecosanoide PGE2, en el homogenado de pata fueron determinados 
mediante la técnica de ELISA. La expresión de COX-2 fue analizada por inmunohistoquímica y los 
cambios en la expresión proteica de m-PGES1 y el papel de las vías de señalización celular de 
MAPKs, JAK/STAT y NF-κB fueron estudiadas mediante western blot. 
Resultados: El tratamiento con PE fue capaz de reducir los signos y síntomas de la enfermedad, 
disminuyendo la inflamación articular, la migración celular, la degradación del cartílago y la 
erosión ósea. Tras el tratamiento con PE a ambas dosis, se redujeron significativamente los 
niveles de las citocinas proinflamatorias TNF-α, IL-1β e IL-6 y del ecosanoide PGE2 en el las patas 
de los animales artríticos, del mismo modo, los niveles de expresión de las proteínas 
proinflamatorias COX-2 y mPGES-1 también se encontraron disminuidas en las patas de los 
animales tratados con los polifenoles. El PE fue capaz de inhibir la fosforilación de la proteína 
STAT3, así como de las proteínas MAPKs JNK y p38. Finalmente tras la administración del 
extracto, los niveles de la proteína inhibitoria IκB-α se encontraron aumentados en comparación 
con los animales pertenecientes al grupo CIA, impidiendo la translocación al núcleo de la 
proteína p65 NF-κB. 
Conclusión: Estos resultados ponen de manifiesto, por primera vez, el efecto antiinflamatorio y 
protector de las articulaciones del extracto polifenólico procedente del AOVE, que puede estar 
relacionado con la inhibición de las principales vías de señalización celular implicadas en la 
inflamación, como son NF-κB, JAK/STAT o MAPKs, controlando la producción de mediadores 
proinflamatorios. Estos datos demuestran el interés de los compuestos naturales, como los 
polifenoles del AOVE, en el desarrollo de nuevos productos terapéuticos para el tratamiento de 
la AR. 
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Abstract
The consumption of extra virgin olive oil (EVOO) in Mediterranean countries has shown beneficial effects. A wide range of evidence indicates that phenolic
compounds present in EVOO are endowed with anti-inflammatory properties. In this work, we evaluated the effects of EVOO-polyphenol extract (PE) in a model of
rheumatoid arthritis, the collagen-induced arthritis model in mice. On day 0, DBA-1/J mice were immunized with bovine type II collagen. On day 21, mice received a
booster injection. PE (100and200mg/kg)wasorally administeredonce aday fromdays29 to 41 toarthriticmice.Wehavedemonstrated thatPEdecreases joint edema,
cell migration, cartilage degradation and bone erosion. PE significantly reduced the levels of proinflammatory cytokines and prostaglandin E2 in the joint as well as the
expression of cyclooxygenase-2 andmicrosomal prostaglandin E synthase-1. Our data indicate that PE inhibits c-Jun N-terminal kinase, p38 and signal transducer and
activator of transcription-3. In addition, PE decreases nuclear factor κB translocation leading to the down-regulation of the arthritic process. These results support the
interest of natural diet components in the development of therapeutic products for arthritic conditions.
© 2014 Elsevier Inc. All rights reserved.
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1. Introduction
Rheumatoid arthritis (RA) is an autoimmune disease character-
ized by synovial inflammation and pannus leading to cartilage and
bone damage. The earliest event is activation of the innate immune by
exogenous and autologous antigens and thus auto-antibodies and
later high levels of cytokines can be detected years before clinical
symptoms [1]. At a joint level, there are synovial hyperplasia and
massive infiltration of immune cells, including CD4+ T cells, B cells,
natural killer cells, macrophages, dendritic cells, neutrophils andmast
cells [2,3]. A wide range of evidence has demonstrated the
contribution of cytokines to the chronicity of inflammation and tissue
damage in RA. Therefore, the importance of proinflammatory cytokines
has been confirmed by the success of cytokine-directed therapies in RA
[4]. Proinflammatory cytokines such as interleukin (IL)-1β and tumor
necrosis factor α (TNFα) activate many signal transduction pathways
involved in inflammation. The mitogen-activated protein kinase
(MAPK) pathway includes extracellular signal-regulated kinases
(ERK1/2 or p42/p44), c-Jun N-terminal kinases (JNK)1/2/3 and p38,
which are activated in the synovium of patients with RA [5]. The janus
kinase-signal transducer and activator of transcription (JAK-STAT) is
another relevant inflammatory pathway activated in response to
cytokines. In particular, overexpression of STAT-3 has been reported
in synovial membranes from RA patients [6].
Proinflammatory cytokines activate different transcription factors to
induce the expression of inflammatory and catabolic mediators [7].
Nuclear factor κB (NF-κB) and activating protein-1 (AP-1) are activated
in RA synovium and play an important role in metalloproteinase
induction [8]. NF-κB regulates a wide range of genes that contribute to
inflammation, such as IL-1β, TNFα, IL-6, chemokines and microsomal
prostaglandin E synthase-1 (mPGES-1), an efficient downstream
enzyme functionally coupled with cyclooxygenase-2 (COX-2).
Biological therapies have improved the treatment of chronic
inflammatory diseases such as RA. Nevertheless, these drugs are
effective in a fraction of patients only and have other limitations
including a high cost, the requirement for parenteral administration
and important side effects. Therefore, new therapeutic strategies are
under investigation. Epidemiological studies about consumption of
functional foods, particularly extra virgin olive oil (EVOO) in
Mediterranean countries, have showed important beneficial effects.
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EVOO, obtained from the fruit of the olive tree solely by mechanical
or other physical means under conditions that do not lead to oil
alteration, has shown antioxidant, anti-inflammatory, immunomod-
ulatory, antiproliferative and anti-apoptotic effects [9–15]. Although
these health-protective effects have been traditionally ascribed to its
high monounsaturated fatty acid content [15,16] a wide range of
evidence indicates that many of the beneficial effects of EVOO intake
are due to its minor highly bioactive components. Among them,
phenolic compounds such as hydroxytyrosol, tyrosol and oleuropein
have shown anti-inflammatory and antioxidant effects [17]. Olive
oil polyphenols have also been associated with neuroprotective,
antiaging and antiatherogenic effects and the regulation of important
cellular signaling pathways. On the other hand, because of their
ability to modulate cell death, olive polyphenols have been proposed
as chemopreventive and therapeutic anti-cancer agents [18–21]. Our
research grouphas previously demonstrated that a dietmadewith EVOO
enrichedwith hydroxytyrosol, could improve inflammatory processes in
a chronic colitis model [22]. In addition, we evaluated the protective
effect of dietary EVOO-polyphenol extract (PE) supplementation in the
inflammatory response associated to a chronic colitis model [23].
Collagen-induced arthritis (CIA) in DBA/1mice is an animal model
of RA widely used to test potential therapeutic agents [24]. The
pathogenesis of CIA is dependent on the host's response to type II
collagen challenge and the subsequent generation of antibodies that
recognize collagen-rich joint tissue [25]. Joint inflammation in this
model is characterized by significant cellular exudate and infiltrate,
synovitis, and articular degradation. High levels of proinflammatory
cytokines are detected at the onset of the disease, leading to the
production of a wide range of mediators relevant in CIA pathogenesis
[26,27]. Taken into account the anti-inflammatory properties of olive
oil constituents, we hypothesized that PE may control the develop-
ment of inflammation and articular lesion. In fact, intraperitoneal
administration of oleuropein aglycone, amajor constituent of the leaves
and unprocessed olive drupes, has shown beneficial effects in CIA [28],
and a recent study has reported that EVOO diet in conjunction with
physical activity is able to preserve the articular cartilage in an
osteoarthritis model [29].
The present study was designed to evaluate the effects of the oral
administration of PE in the arthritis model of CIA in mice. In addition
to macroscopic and histological analyses, we have determined the
effects of PE on the production of inflammatory mediators. In order to
gain a better insight into its mechanisms of action, signaling pathways
were also explored.
2. Materials and methods
2.1. Extraction of PE
PEwas obtained by themethod described by Vazquez Roncero et al. [30] with some
modifications [31]. Fifty grams of EVOO (Oleoestepa, Seville, Spain) was extracted with
methanol/water (80:20, vol/vol, 125ml). The mixture was mixed with a vortex at 5000
g for 1 min and sonicated for 15 min. After decantation, the methanolic extract was
concentrated in vacuum under a stream of nitrogen at b35°C until it reached a syrup
consistency; finally, it was lyophilized and stored at −80°C.
2.2. Characterization of phenolic compounds in PE
PE (70–75 mg) extracted from EVOO (75 g) was dissolved in CDCl3 (750 μl)
or in DMSO-d6 (750 μl) and an precisely measured volume of the solution (550 μl)
was placed in a 5 mm NMR tube for the detection and quantification of phenolic
compounds. The phenolic mixture to be analyzed in DMSO-d6 was previously
dissolved in a MeOD-D2O 1:1 (1 ml) and concentrated to dryness at reduced pressure
in order to exchange hydroxyl protons with deuterium nuclei. The NMR solvents were
purchased from Sigma-Aldrich (St. Louis, MO, USA). NMR experiments were conducted
on a Bruker Avance III 700 spectrometer, operating at 700.25 M Hz. The probe
temperature was 24.8±1°C. All chemical shifts were given in ppm, and the J couplings
in Hz. The solvent itself was used as a chemical shift reference (7.26 ppm for CHCl3, and
2.50 for DMSO-d6). 1H NMR spectra were acquired with the following acquisition
parameters: acquisition time 2.3s, relaxation delay 5s, spectral width of 0–20 ppm,
data points 32k, number of scans 32, and line broadening of 0.3 Hz. Postacquisition
processing included zero-filling to 64k. The spectra were phase corrected automatically
using TOPSPIN and integration was performed manually.
We have determined the levels of oleocanthal and oleacein following a
modification of the method developed by Karkoula et al. [32] for direct measurement
of both dialdehydes in olive oil by quantitative high resolution 1H NMR in CDCl3. The
levels of other phenolic compounds have been determined by the procedure described
by Christophoridou and Dais [33].
2.3. Induction of CIA
Arthritis was induced in male DBA-1/J mice (Janvier, Le Genest St Isle, France) of 11
weeks of age. All studies were performed in accordance with European Union
regulations for the handling and use of laboratory animals. The protocols were
approved by the institutional Animal Care and Use Committee (University of Valencia,
Spain). Bovine type II collagen (CII; 2 mg/ml in dilute acetic acid; MD Biosciences,
Zürich, Switzerland) was emulsified in equal volumes of Freund's complete adjuvant
(2 mg/mlMycobacterium tuberculosis, strain H37Ra; Difco, Detroit, MI, USA). On day 0,
DBA-1/J mice were immunized at the base of the tail with 100 µg of bovine CII. On day
21, mice received an intraperitoneal booster injection of 100 µg of CII dissolved in
phosphate-buffered saline. Mice were considered to have arthritis when significant
changes in redness and/or swelling were noted in the digits or in other parts of the
paws. Joint inflammation was scored visually in each paw, using a scale of 0–2 where
0=uninflamed, 1=mild, 1.5=marked and 2=severe. Scoring was performed by two
independent observers without knowledge of the experimental groups. In addition,
photographs and X-ray (Carestream MS FX, Gainesville, FL, USA) images of hind paws
were obtained at the end of the experiment (day 42).
2.4. Treatment groups
On day 29, animals were randomized into control and treatment groups. The study
was performed in four groups of mice (n=10): naive group (NA), CIA group (CIA) and
two treatment groups: CIA mice with PE treatment (PE 100 and 200mg/kg, orally, once
a day from days 29 to 41). On day 42 after immunization mice were anesthetized, blood
samples were taken by intracardiac puncture and animals were killed by cervical
dislocation. Paws were amputated and processed for either histological analysis or
homogeneization and assessment of inflammatory mediators and mechanisms.
2.5. Histological and immunohistochemical analyses
Knee joints were fixed in 4% formalin. After decalcification in 10% EDTA, specimens
were processed for paraffin embedding. Tissue sections (7 μm) were stained with
hematoxylin and eosin to perform histological analyses. For immunohistochemistry,
the endogenous peroxidase activity was inhibited with hydrogen peroxide and then
the sections were incubated in normal horse serum (Vectastain Kit; Vector
Laboratories, Burlingame, CA, USA) for 20 min to reduce nonspecific staining and
successively incubated with rabbit anti-COX-2 (Cayman Chemical, Ann Arbor, MI, USA)
at dilution 1:250 overnight at 4°C. Later on, slides were treated with antirabbit IgG
antibody (Vectastain Kit, Vector Laboratories, Burlingame, CA, USA) for 30 min and
incubated with the streptavidin–peroxidase complex of the kit for 30 min, at room
temperature. After incubation with the peroxidase substrate 3,3′-diaminobenzidine
and washing with water, the sections were counterstained with hematoxylin. Negative
control sections were treated in the same way but in the absence of primary antibody.
Positive cells and total cells were counted in five random high-power fields by two
independent observers.
2.6. Enzyme-linked immunosorbent assay
Hind paws (knees) were homogenized in liquid N2 with 1 ml of A buffer pH 7.46
(10 mM HEPES, pH 8, 1 mM EDTA, 1 mM EGTA, 10 mM KCl, 1 mM dithiothreitol (DTT),
5 mM NaF, 1 mM Na3VO4, 1 μg/ml leupeptin, 0.1 μg/ml aprotinine, and 0.5 mM
phenylmethyl sulfonyl fluoride (PMSF)). The tissue homogenates were sonicated (10 s
three times at 20% with a 10-s incubation on ice between bursts) in an ultrasonic
processor (VC130PB, Sonics & Materials Inc., Newtown, CT, USA) and centrifuged at
600×g, 15 min at 4°C. Supernatants were removed and used for determination of
inflammatory mediators by enzyme-linked immunosorbent assay (ELISA): PGE2
(Cayman Chemical, Michigan, USA), TNFα and IL-1β (R&D Systems Inc., Minneapolis,
MN, USA), and IL-6 (Diaclone, Besançon Cedex, France).
2.7. Western blot
Hind paws were homogenized in liquid N2 with 1 ml of ice-cold phosphate
buffer (0.01 mM K2HPO4, KH2PO4 and 0.15 M NaCl) and centrifuged (800×g, 10
min at room temperature). Pellets were resuspended in hypotonic buffer [1.5
mMMgCl2, 10 mM KCl, 0.2 mM PMSF, 1 μg/ml leupeptin, 20 mM NaF, 0.5 mM DTT,
1 mM EDTA and 10 mM HEPES, pH 7.9], incubated for 10 min on ice and
centrifuged (14,000×g, 30 s at room temperature). Supernatants (cytoplasmic
proteins) and pellets (nuclear proteins) were collected. Pellets were resuspend-
ed in ice-cold low-salt buffer and nuclear proteins were released by adding a
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high-salt buffer (20%vol/vol glycerol, 1.5mMMgCl2, 0.2mMEDTA, 0.2mMPMSF, 0.5mM
DTT, 420 mM NaCl, 0.2 mM EDTA, 20 mM NaF, 1 μg/ml leupeptin and 20 mM HEPES, pH
7.9). Samples were incubated on ice for 30 min. Soluble nuclear proteins were recovered
by centrifugation (14,000×g, 10 min, 4°C) and proteins were stored at −80°C. Protein
concentration was determined by the Bradford's colorimetric method [34]. Nuclear
fractions were used to study p65 protein expression and cytoplasmic fractions were used
for the rest of determinations. Aliquots containing equal amount of protein (50mg) were
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (10% gel). The
proteins were then electrophoretically transferred onto a nitrocellulose membrane and
incubated with specific primary antibodies: rabbit polyclonal anti-mPGES-1 (1:200;
Cayman Chemical, USA) rabbit polyclonal anti-IκB-α (1:1000; Cell Signalling Technology,
USA), rabbit polyclonal p65 (1:200, Santa CruzBiotechnology, Inc.), rabbit polyclonal anti-
p-JNK and rabbit polyclonal anti-JNK (1:1000; Santa Cruz Biotechnology, Inc.), mouse
polyclonal anti-p-p38 and rabbit polyclonal anti-p38 (1:1000; Santa Cruz Biotechnology,
Inc.) and mouse polyclonal anti-p-STAT3 (1:200; Santa Cruz Biotechnology, Inc.),
overnight at 4°C. Membranes were washed three times for 15 min and incubated with
anti-rabbit (Pierce Biotechnology, IL, USA) or anti-mouse (Dako, Carpinteria, CA, USA)
horseradish peroxidase-labeled secondary antibody, for 1–2 h at room temperature. To
prove equal loading, the blots were analyzed for β-actin expression using an anti-β-actin
antibody (Sigma–Aldrich). Immunodetection was performed using enhanced chemilu-
minescence light-detecting kit (SuperSignal West Femto Chemiluminescent Substrate,
Pierce, IL, USA). Densitometric data were studied following normalization to the control
(housekeeping gene). The signals were analyzed and quantified by ImageJ software
(Bethesda, MD, USA).
2.8. Data analysis
All values in the figures and text are expressed as arithmetic means±standard
error (S.E.M.). Data were evaluated with Graph Pad Prism Version 5.04 software. The
statistical significance was evaluated by two-way (time course) or one-way (rest of
parameters) analysis of variance (ANOVA), followed by Bonferroni's test. P values b.05
were considered statistically significant.
3. Results
3.1. Chemical composition of PE
Table 1 shows the result of qualitative and quantitative analyses of
PE.Ninedifferent phenolic compoundshavebeen identified. Oleocanthal
and oleacein are the main components of PE.
3.2. Effect of PE on established CIA
The time-course of arthritic score (Fig. 1A) indicates that control
CIA mice showed a progressive development of clinical symptoms.
The severity of arthritis in the groups treated with PE (100 and
200 mg/kg) was lower than that of the arthritic control group with
significant results for the highest dose on days 39 and 41. Fig. 1B
shows representative photographs of hind paws from the different
groups. In addition, X-ray images (Fig. 1C) revealed the presence of
joint edema and focal bone erosions in hind paws of CIA mice,
whereas in animals treated with PE, the inflammation was lower.
Interestingly, in the PE200 group, the integrity of bone was similar to
that of naïve mice. Control CIA mice exhibited histological changes
indicative of severe arthritis, with extensive infiltration of inflamma-
tory cells into articular tissues, exudation into the synovial space,
synovial hyperplasia and cartilage erosion (Fig. 2). These histological
features were less apparent in mice treated with PE (200 mg/kg).
3.3. Effect of PE on joint inflammatory mediators
We also explored whether PE could modify the production of
proinflammatory cytokines and PGE2. At the end of the experimental
period (day 42), the levels of IL-1β, TNFα and IL-6were determined in
hind paw homogenates. As shown in Fig. 3, animals treated with PE
(100 or 200mg/kg) showed a significant reduction in joint levels of all
proinflammatory cytokines. In addition, a significant increase in PGE2
levels in the paws of arthritic control animals with respect to naïve
mice was found (Fig. 3). Treatment with PE reduced the levels of this
eicosanoid, which reached statistical significance at both doses.
3.4. Effect of PE on COX-2 and mPGES-1 expression
The effect of PE on COX-2 protein expression was determined by
immunohistochemistry of knee joint sections (Fig. 4A). We observed
a significant increase in the percentage of COX-2-positive cells in
cartilage of arthritic control group (CIA), with respect to naïve
animals. In the group treated with PE (200 mg/kg), the immunore-
activity for this protein was significantly reduced. COX-2 expression
was accompanied by a significant increase in mPGES-1 protein
expression, which was determined by Western blot, in the paws of
CIA control mice with respect to naïve animals (Fig. 4B). Treatment
with PE significantly decreased the expression of this protein.
3.5. Effect of PE on p38 and JNK phosphorylation
p38 and JNK play an important role in inflammation and tissue
damage in RA [5,35].We investigated the effect of PE on the activation
of JNK and p38 in the CIA model by western blot using phosphospecific
antibodies. The development of CIA induced strongMAPKphosphorylation
in joints (Fig. 5). However, PE at both doses significantly decreased the
phosphorylation of JNK and p38.
3.6. Effect of PE on p-STAT3 protein expression in paw homogenate
p-STAT3 protein expression was evaluated by Western blot
analysis of hind paw homogenates. Fig. 6 shows that arthritis strongly
induced STAT3 phosphorylation, as observed in CIA control mice with
respect to naïve animals. Treatment with PE at 200 mg/kg and, to a
lower extent, at 100 mg/kg, significantly reduced the expression of p-
STAT3 in arthritic mice.
3.7. Effects of PE on NF-κB signaling pathway
We investigated the effect of PE on IκB-α expression in
cytoplasmic extracts of mice joints. As shown in Fig. 7, the expression
of IκB-α was significantly reduced in arthritic control mice (CIA)
compared with naïve mice. The effect of arthritis on IκB-α was
blocked by PE treatment at the dose of 200 mg/kg. The reduction in
IκB-α expression observed in CIA mice is consistent with an increase
in IκB-α degradation thus allowing the translocation of NF-κB into the
nucleus to bind specific DNA sequences leading to the transcription of
proinflammatory genes. Therefore, CIA mice showed an increased
expression of p65 NF-κB in nuclear extracts of joints which was
significantly inhibited by PE at 200 mg/kg.
4. Discussion
In this study, we have demonstrated that oral administration of PE
is able to down-regulate the arthritic process in the CIA model of RA.
PE showed anti-inflammatory effects with reductions in joint edema
and migration of inflammatory cells. In addition, PE protected joints
against cartilage alterations and bone erosion. According to previous
Table 1
Chemical constituents of PE
Phenolic compound μmol/100 g ppm
Free hydroxytyrosol 2.25 3.47
Free tyrosol 5.21 7.20
Oleacein 9.62 30.82
Oleocanthal 10.43 31.74
Oleuropein aglycone monoaldehyde (5R, 8S, 9R) 1.49 5.63
Ligstroside aglycone monoaldehyde (5R, 8S, 9R) 3.88 14.06
Apigenin 0.56 1.52
Luteolin 1.26 3.61
Acetoxypinoresinol 1.92 8.00
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reports on the biological properties of olive oil constituents [17,18,28,9],
the anti-inflammatory effects of PE are likely dependent on themixture
of different phenolic compounds.
The progression of arthritis is associated with sustained produc-
tion of proinflammatory cytokines [4]. We have shown in the CIA
model that PE controls the local levels of these cytokines driving the
production of different inflammatory and catabolic mediators.
Proinflammatory cytokines induce further cytokines, chemokines,
eicosanoids and reactive oxygen species (ROS) amplifying the
inflammatory response [36]. Therefore, COX-2 and mPGES-1, en-
zymes responsible for the overproduction of PGE2 in inflammation,
are up-regulated [37] contributing to the progression of RA through
EP4 receptor activation [38]. We have shown that PE reduces PGE2
levels which would be dependent on the down-regulation of COX-2
and mPGES-1 expression in the joint. Cytokines also induce the
expression of matrix metalloproteinases at the pannus cartilage
junction leading to cartilage degradation [39,40]. In addition, TNFα
stimulates osteoclastogenesis [41], suppresses the recruitment of
osteoblasts and inhibits the expression of matrix genes [42], whereas
IL-6 increases osteoclast numbers in trabecular bone [43]. Therefore,
inhibition of proinflammatory cytokine production by PEwould result
in the reduction of the inflammatory response and tissue damage.
MAPKs regulate the synthesis of chemokines, cytokines, adhesion
molecules and PGs involved in inflammation. In addition, they
mediate the induction of matrix metalloproteinases responsible for
cartilage breakdown. JNK1/2 and p38 are also involved in osteoclast
differentiation and thus the activation of these enzymes may
contribute to bone destruction [35]. In particular, p38 plays a key
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role in RA [44]. JAKs bind to intracellular domains of IL-6 or interferon
receptors and catalyze ligand-induced phosphorylation of themselves
and of intracellular tyrosine residues. Phosphorylation of STATs
on tyrosine residues results in the formation of STAT dimers that
translocate into the nucleus to bind specific DNA sequences.
This pathway can be regulated by different protein kinases such as
MAPK that phosphorylate STATs on serine residues to potentiate
STAT-activating stimuli [45]. STAT3 may contribute to the chronicity
of inflammation in experimental arthritis [46]. Our data indicate that
PE administration is able to reduce the phosphorylation of JNK,
p38 and STAT3, suggesting that PE could control the activation of
these important signaling pathways during the arthritic process.
The NF-κB pathway is involved in the transcription of many
inflammatory genes [47]. Cellular stimulation by proinflammatory
cytokines induces the recruitment of costimulatory molecules, such
as TNF receptor-associated factor (TRAF) leading to the activation of
NF-κB-inducing kinase. This protein induces IκB kinase activation
resulting in the phosphorylation of IκB [6], which is followed by
ubiquitination and proteolytic degradation thus allowing the release
of NF-κB to enter the nucleus and regulate gene transcription [48].
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Our results indicate that PE enhances the levels of the inhibitory
protein IκB-α leading to the reduction of NF-κB nuclear translocation.
This mechanism may be responsible for the down-regulation of
proinflammatory cytokines in the joint during the CIA process in the
animals treated with PE. Proinflammatory cytokines and ROS could act
as mediators of NF-κB activation [49]. As demonstrated in previous
studies, PE inhibits the generation of ROS [50] besides its effect on
proinflammatory cytokines, suggesting that both mechanisms could be
involved in the control of NF-κB translocation.
In conclusion, or study has demonstrated the anti-inflammatory
and joint protective effects of PE from EVOO, which would be related
to the inhibition of relevant signaling pathways such as NF-κB, STAT-
3, JNK and p38 controlling the production of inflammatory mediators.
Our data also show the interest of natural diet components in the
development of therapeutic products for arthritic conditions.
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RESUMEN 
Antecedentes del tema: En la AR, a nivel de las articulaciones se produce hiperplasia sinovial y 
una infiltración masiva de células inmunes, incluyendo células T, células B, macrófagos, 
neutrófilos, células dendríticas, entre otras. Aunque la patogenia de la AR sigue sin conocerse 
en su totalidad, avances en la investigación de la enfermedad han demostrado que el aumento 
de los niveles de citocinas proinflamatorias como TNF-α, IL-1β, IL-6 e IFN-γ y el aumento de los 
niveles de metaloproteasas (MMP) en el sinovio de las articulaciones de los pacientes artríticos, 
juegan un papel fundamental en la erosión del cartílago articular y ósea. En la expresión génica 
de estos mediadores proinflamatorios, participan diversas vías de señalización celular entre las 
que cabe destacar las MAPKs, JAK/STAT o NF-κB, las cuales se encuentran activadas en el sinovio 
de pacientes con AR. La activación de estas vías de señalización, también están implicadas en la 
expresión de genes de proteínas proinflamatorias, como COX-2 o m-PGES-1, ambas relacionadas 
con el aumento de la expresión del ecosanoide proinflamatorio PGE2. Por otro lado, el factor 
nuclear Nrf2, es una pieza clave en la transcripción de distintas enzimas antioxidantes como la 
hemo oxigenasa 1 (HO-1), se ha demostrado que la activación de la expresión génica de esta 
proteína es capaz de modular la respuesta inflamatoria. A pesar de los avances en la terapia 
farmacológica para el tratamiento de la AR, supone ciertas limitaciones, como sus efectos 
adversos, es por lo que en los últimos años ha crecido el interés en la utilización de suplementos 
dietéticos y nutracéuticos, carentes de los efectos adversos que acompaña a la farmacoterapia 
clásica. Estudios epidemiológicos y experimentales han puesto de manifiesto el papel 
beneficioso que ejercen distintos polifenoles de la dieta en la AR. AOVE, es rico en una variedad 
de compuestos fenólicos, entre los que se encuentra el acetato de hidroxitirosol (Ac-HT), que ha 
demostrado tener efectos antioxidantes y antiinflamatorios. 
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Objetivos: En base a los anteriores antecedentes, nos planteamos evaluar la influencia de una 
dieta enriquecida con Ac-HT, en un modelo de artritis experimental inducida por colágeno tipo 
II en ratones. 
Material y Métodos: Ratones DBA-1/J recién destetados, fueron distribuidos en cuatro grupos 
experimentales: (1) Ratones sanos alimentados con dieta estándar (CS), (2) Ratones artríticos 
alimentados con dita estándar (CIA), (3) Ratones artríticos alimentados con dieta enriquecida 
con hidroxitirosol (HT) (CIA-HT), (4) Ratones artríticos alimentados con dieta enriquecida con Ac-
HT (CIA- Ac-HT). Después de seis semanas, la artritis fue inducida. El día 0, los ratones fueron 
inmunizados con una inyección en la base de la cola de 100 mg de colágeno II. El día 21, 
recibieron una inyección de refuerzo intraperitoneal, con la misma cantidad de colágeno. El 
grado de desarrollo de la enfermedad fue valorado de forma visual siguiendo una escala de 0-2, 
dónde 0=sin inflamación; 1=inflamación leve; 1.5=inflamación marcada; 2=inflamación severa y 
según el estudio histológico de las articulaciones. Los niveles en suero de IgG1, IgG2a, COMP y 
MMP-3 así como los niveles de citocinas proinflamatorias como TNF-α, IL-1β, IFN-γ, IL-6 e IL-17 
en el homogenado de pata fueron determinados mediante la técnica de ELISA. Los cambios en 
la expresión proteica de HO-1, Nrf2 y de las proteínas implicadas en las vías de señalización 
celular MAPKs, JAK/STAT y NF-κB fueron estudiadas mediante western blot. 
Resultados: la dieta enriquecida con Ac-HT, redujo de forma significativa el edema articular y la 
destrucción del cartílago, previniendo el desarrollo de la AR. Los niveles séricos de las IgG1 y 2 a 
tanto murinas como bobinas, así como los niveles de COMP y MMP-3, los encontramos 
disminuidos en aquellos animales alimentados con la dieta enriquecida con Ac-HT. La expresión 
de las citocinas proinflamatorias TNF-α, IL-1β, IFN-γ, IL-6 e IL-17 fue menor el tejido articular de 
los ratones artríticos que recibieron la dieta enriquecida con el acetato. El Ac-HT produjo una 
inhibición en la fosforilación de la proteína STAT-3, así como de las proteínas MAPKs e inhibió la 
translocación al núcleo de la proteína p 65 NF-κB, previniendo la degradación de la proteína 
inhibitoria IκB-α. Además, Ac-HT fue capaz de aumentar la expresión proteica de Nrf2 y HO-1. 
Conclusión: Estos resultados ponen de manifiesto, por primera vez, el efecto antiinflamatorio 
de una dieta enriquecida con Ac-HT en un modelo de artritis experimental en ratones, que 
estuvo acompañado por una reducción de los marcadores COMP y MMP-3 en suero. Los 
mecanismos implicados podrían estar relacionados con una regulación de la respuesta de las 
células B, una activación de la vía Nrf2/HO-1 y la inhibición de la activación de distintas vías de 
señalización, como son JAK/STAT, MAPKs y NF- κB, implicadas en la producción de mediadores 
inflamatorios como citocinas y PGE2. Concluyendo que un suplemento de AC-HT en la dieta, 
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podría servir de base para el desarrollo de una nueva estrategia nutricional para la prevención 
de la AR. 
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Scope: Hydroxytyrosol acetate (HTy-Ac), an extra virgin olive oil (EVOO) polyphenol, has re-
cently been reported to exhibit antioxidant and anti-inflammatory effects on LPS-stimulated
macrophagesand ulcerative colitis. This study was designed to evaluate dietary HTy-Ac supple-
mentation effects on collagen-induced arthritis (CIA) in mice.
Methods and results: DBA-1/J mice were fed fromweaning with 0.05%HTy-Ac. After 6 weeks,
arthritis was induced by type II collagen. Mice were sacrificed 42 days after first immunization.
Blood was recollected and paws were histological and biochemically processed. HTy-Ac diet
significantly prevent edarthritis development and decreased serum IgG1 and IgG2a, cartilage
olimeric matrix protein (COMP) and metalloproteinase-3 (MMP-3) levels, as well as, pro-
inflammatory cytokines levels (TNF-, IFN-, IL-1, IL-6 and IL-17A). The activation of Janus
kinase-signal transducer and activator of transcription (JAK/STAT), mitogen-activated protein
kinases (MAPKs) and nuclear transcription factor-kappa B (NF-B) pathways were drastically
ameliorated whereas nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1)
protein expressions were significantly up-regulated in those mice fed with HTy-Ac.
Conclusion: HTy-Ac improved the oxidative events and returned pro-inflammatory proteins
expression to basal levels probably through JAK/STAT, MAPKs and NF-B pathways. HTy-Ac
supplement might provide a basis for developing a new dietary strategy for the prevention of
rheumatoid arthritis.
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1 Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflammatory
disease characterized by inflammation of multiple joints and
destruction of cartilage and bone. The earliest event is the
development of systemic autoimmunity by exogenous and
autologous antigens and thus auto-antibodies and later high
levels of cytokines can be detected years before clinical symp-
tom [1, 2]. At a joint level, there are synovial hyperplasia and
massive infiltration of immune cells, including CD4+ T-cells,
B-cells, natural killer cells, macrophages, dendritic cells, neu-
trophils and mast cells. Although the cause of RA remains
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unclear, increasing evidences indicate that pro-inflammatory
cytokines such as tumor necrosis factor  (TNF), IL-1, IL-
6, IFN- and metalloproteinases (MMPs) produced from RA
synovium play an important role in the erosion of articular
cartilage and subchondral bones [3, 4].
The process of gene expression of these pro-inflammatory
mediators involves multiple signal transduction pathways in-
cluding mitogen-activated protein kinases (MAPKs) which
comprises extracellular signal-regulated kinases (ERK1/2 or
p42/p44), c-Jun N-terminal kinases (JNK)1/2/3 and p38, and
the nuclear transcription factor-kappa B (NF-B) which are
activated in the synovium of patients with RA [5, 6]. In
particular, NF-B plays an important role in MMPs induc-
tion and also regulates a wide range of genes that con-
tribute to inflammation, such IL-1, TNF, IL-6, chemokines
and microsomal prostaglandin E synthase-1 (mPGES-1),
an efficient downstream enzyme co-localized and function-
ally coupled with the inducible enzymes cyclooxygenase-
2 (COX-2). Both, COX-2 and mPGES-1, are up-regulated
and responsible for the overproduction of prostaglandin E2
(PGE2) which may affect joint integrity through EP4 receptor
activation [7].
The signal transducer and activator of transcription-
(STAT)-3 is another critical transcription factor inflamma-
tory pathway activated in response to cytokines involved in
the pathogenesis of RA by steering the abnormal activation,
automaticity and prolonged survival of synovial cells. Spe-
cially, overexpression of STAT-3 has been reported in syn-
ovial membranes from RA patients correlating with paired
serum IL-6 [8]. Likewise, nuclear factor E2-related factor
2 (Nrf2) is a key transcription factor orchestrator of the
induction of several antioxidant enzymes, such as heme
oxygenase (HO)-1. The activation of HO-1 in inflamma-
tory conditions could be part of an adaptive mechanism
to limit cytotoxicity. In fact, it has been reported that HO-
1 deficiency in mice results in a chronic inflammatory
state [9].
Despite significant advances in therapies for the treatment
of many autoimmune diseases such as RA, a persistent un-
met need still exists for more effective, durable and conve-
nient treatment options. In this sense, the interest by dietary
supplements and nutraceuticals without undesirable effects
that accompany the classical pharmacotherapy is growing.
Current epidemiological and experimental studies support a
beneficial role of dietary polyphenols in several inflammatory
diseases, including RA. In this regard, we have previously
demonstrated that oral administration of a phenolic extract
from extra virgin olive oil (EVOO) was able to down-regulate
the arthritic process in the collagen-induced arthritis (CIA)
model of RA [10].
EVOO is rich in a variety of phenolic compounds,
mainly constituted by secoiridoid derivatives of 2-(3,4-
dihydroxyphenyl)ethanol (hydroxytyrosol, HTy) and of 2-(4-
hydroxyphenyl)ethanol (tyrosol), and hydroxytyrosyl acetate
(HTy-Ac), alongwithminor amounts of freeHTy [11]. Todate,
HTy-Ac has shown protection effects against oxidative DNA
damage in blood cells [12], as well as against iron-induced ox-
idative stress in human cervical cells (HeLa) [13]. In addition,
a study from Gonza´lez-Correa et al. [14] showed a neuropro-
tective effect of HTy-Ac in a model of hypoxia–reoxygenation
in rat brain slices, both in vitro and after oral administra-
tion. A greater antiplatelet aggregating activity than HTy has
also been demonstrated [15]. More recently, we have showed
that HTy-Ac, exerted an anti-inflammatory effect on acute
ulcerative colitis. This effect involves a decrease in COX-2
and iNOS protein expression probably trough JNK MAPK
and NF-B signaling pathways [16]. In addition HTy-Ac was
able tomodulate inflammatory response inmurine peritoneal
macrophages [17].
Taken this background into account, the present study
was designed to evaluate the effects of HTy-Ac dietary sup-
plementation, in the arthritis model of CIA in mice. In addi-
tion to macroscopic and histological analyses, we have de-
termined the effects of HTy-Ac on the production of in-
flammatory mediators. In order to gain a better insight
into mechanisms of action, signaling pathways were also
explored.
2 Material and methods
To evaluate the beneficial effects of HTy-Ac on CIA model,
DBA 1J mice were used.
Mice were randomized in four experimental groups (10
animals per group): (i) naı¨ve group, (ii) Control group (CIA),
(iii) HTy diet group (CIA-HTy) and (iv) HTy-AC diet group
(CIA-HTy-Ac). After 6 weeks, arthritis was induced by type II
collagen. Mice were sacrificed 42 days after first immuniza-
tion. Blood was recollected and paws were histological and
biochemically processed.
ELISA, histopathological analysis and immunoblotting
were performed as indicated in Supporting Information Ma-
terial and Methods.
3 Results
3.1 Effects of dietary HTy-Ac on CIA-induced AR
model
The development of arthritis wasmonitored until day 42. The
time-course of arthritic score indicates that control CIA mice
developed a progressive development of arthritis observed
from day 34 (Fig. 1A). However, mice fed with HTy-Ac diet
showed a significant delayed onset (p<0.05 and p<0.01 ver-
sus CIA) and decreased the disease severity of CIA reducing
disease incidence, number of involved paws, footpad thick-
ness and clinical index from days 37 to 42. Surprisingly, HTy
dietary did not modify the development of arthritis. These
results suggested that dietary enriched with HTy-Ac not only
could retard the development but it alsomay have a therapeu-
tic effect on ongoing inflammatory arthritis. Representative
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Figure 1. Time course of the arthri-
tis macroscopic score (A), represen-
tative photographs (B) of hind paws
at the end of the experiment (day 42).
Naı¨ve (B, a), non-arthritic mice fed
with standard diet; CIA (B, b), con-
trol arthritic group feed with stan-
dard diet; HTy-CIA (B, c), arthriticmice
fed with HTy diet; HTy-Ac-CIA (B, d),
arthritic mice fed with HTy-Ac diet.
(C) Histological analysis of the frontal
sections of knee joints on day 42.
Sections were stained with hema-
toxylin and eosin. Original magnifica-
tion x200. Naı¨ve (C, a), non-arthritic
mice fed with standard diet; CIA (C,
b), control arthritic group feed with
standard diet; HTy-CIA (C, c), arthritic
mice fed with HTy diet; HTy-Ac-CIA
(C, d), arthritic mice fed with HTy-
Ac diet. The images are representa-
tive of at least six experiments per-
formed on different days. Data repre-
sent mean ± SEM. n = 10. *p<0.05,
**p<0.01 ***p<0.001 versus naı¨ve;
+p<0.05 and ++ p<0.01 versus CIA.
photographs of hind paws from the different experimental
animal groups are shown in Fig. 1B.
In addition, H&E staining revealed that histological fea-
tures of the joint from naı¨ve animals were typical of normal
structure with synovial membrane composed of synovial cells
and collagen and a clear synovial space (Fig. 1C, a). On the
contrary, joint from control CIA mice exhibited histologi-
cal changes indicative of severe arthritis, characterized by an
extensive infiltration of inflammatory cells into articular tis-
sues, exudation into the synovial space, synovial hyperplasia
and cartilage erosion (Fig. 1C, b). These histological features
were less evident in CIA-HTy-Ac group (Fig. 1C, d).
3.2 HTy-Ac diet reduced levels of CII-specific
antibodies
To determine the effect of HTy-Ac dietary on autoantibody
production, serum was collected at day 42 and anti-CII spe-
cific IgG antibodies were measured. As shown in Fig. 2A,
bovine IgG1 and IgG2a levels were significantly lower in di-
etary HTy-Ac feed group in comparison with CIA control (p<
0.01 versus CIA) and HTy fed group (p<0.01 and p<0.05
versus HTy group). Similarly, mouse IgG1 and IgG2a levels
were also significantly ameliorated in mice fed with HTy-Ac
diet (p<0.01 and p<0.05 versus CIA and p<0.05 versus HTy
group).
3.3 HTy-Ac diet decreased serum MMP-3 and COMP
levels in CIA-induced RA
In the present study we determined serum MMP-3 lev-
els, as synovial inflammatory biomarker, in CIA mice to
investigate the potential beneficial effects of our nutritional
therapeutic strategy. CirculatingMMP-3 levelsweremarkedly
increased (p<0.01 versus naı¨ve) in serum from arthritic CIA
control group (Fig. 2C). By contrast, a reduction in MMP-3
serum levels was observed in those arthritic animals feed-
ing with HTy-Ac (p<0.05 versus CIA). In addition, serum
levels of COMP were significantly elevated in CIA animals
when compared to naı¨ve controls (p<0.001 versus naı¨ve).
On the contrary, CIA-HTy-Ac animal group exhibited sig-
nificantly decreased COMP levels in comparison with CIA
group (p<0.001 versus CIA) reaching levels comparable to
those described in naı¨ve animals (Fig. 2C); whereas dietary
HTy treatment was ineffective.
3.4 Effects of dietary HTy-Ac on joint mediators
It has been reported that TNF-, IL-1, IL-6, IFN- and IL-17A
are critical cytokines involved in the pathogenesis of RA [1].
To explore whether cytokines joint levels were paralleled to
the disease severity of CIA, concentration of these cytokines
were examined in paw homogenates by ELISA. As shown
in Fig. 3, TNF-, IL-1, IL-6, IFN- and IL-17A levels were
significantly increased in paw homogenates from CIA ani-
mals when compared with naı¨ve mice (p<0.01 and p<0.01
versus naı¨ve) suggesting its relationship with the synovial
tissue inflammation. Conversely, our results indicate that an-
imals fed with HTy-Ac diet showed a significant reduction
in all those pro-inflammatory cytokines production in com-
parison with CIA group (TNF-: p<0.05, IL-1: p<0.001,IL-
6: p<0.01, IFN-: p<0.01 and IL-17A: p<0.001 versus
CIA).
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Figure 2. (A) Measurement of serum anti-bovine CII IgG1and IgG2a levels and (B) anti–mouse CII IgG1 and IgG2a levels. (C) Measurement
of serum MMP-3 and COMP levels. These were measured by ELISA kits. Data represent mean ± SEM, n = 10. **p<0.01 and ***p<0.001
versus naı¨ve; + p<0.05, ++p<0.01 and +++p<0.001 versus CIA; &p<0.05, && p<0.01 and &&& p<0.001 versus CIA-HTy.
3.5 Effect of dietary HTy-Ac on COX-2 and mPGES-1
expression
COX-2 and mPGES1 expressions were determined by west-
ern blot in paw homogenate (Fig. 4A). Arthritic control
animal group showed an overexpression of both these
pro-inflammatory enzymes (COX-2: p<0.01 and mPGES1:
p<0.001 versus naı¨ve) whereas HTy-Ac diet was able to re-
duce the protein expression levels of both them (p<0.01 ver-
sus CIA) (Fig. 4B). By contrast, dietary HTy treatment failed
to reduce significantly the protein expression levels of both
COX-2 and mPGES1 in CIA mice. On the other hand, levels
of PGE2 weremeasured on the paw homogenate, HTy-Acwas
capable to reduce the levels of these eicosanoid (Fig. 4B).
3.6 Effect of dietary HTy-Ac on p-STAT-3 protein
expression
STAT-3 has been described as a critical transcription fac-
tor involved in the pathogenesis of RA by steering the ab-
normal activation, automaticity and prolonged survival of
synovial cells. It has been also described that IL-6 active
the JAK/STAT pathway and mainly culminates in the ac-
tivation of the STAT-3 transcription factor [18]. We evalu-
ated p-STAT-3 protein expression by western blot from hind
paw homogenates. Statistical analysis revealed a significant
p-STAT-3 overexpression inCIA groupwhen compared to the
naı¨ve control groups (p<0.001 versus naı¨ve) whereas nutri-
tional therapy with HTy-Ac significantly suppressed STAT3
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Figure 3. Measurement of TNF-
, IL-1, IFN-, IL-6 and IL-17A
levels in hind paw homogena-
tes. These were determined by
ELISA kits. Data represent
mean ± SEM, n = 10. **p<0.01
and ***p<0.001 versus
naı¨ve; +p<0.05, ++p<0.01
and +++p<0.001 versus
CIA; &p<0.05, &&p<0.01 and
&&&p<0.001 versus CIA-HTy.
phosphorylation in arthritic CIA mice (p<0.01 versus CIA),
this suppression was also significant in comparison with
HTy-CIA group (p<0.01 versus CIA-HTy) (Fig. 5A). These
results are in accordance with those obtained in the measure-
ment of pro-inflammatory cytokines levels suggesting that
dietary HTy-Ac may repress STAT-3 activation reducing IL-6
levels in CIA mice.
3.7 Dietary HTy-Ac induces Nrf2/HO-1 antioxidant
pathway activation
The expression of the proteins HO-1 and Nrf2 were also eval-
uated in paw homogenates by western blotting. Our data
show that HO-1 was significantly downregulated in CIAmice
during the maintenance of chronic inflammation (p<0.001
versus naı¨ve); however, dietary HTy-Ac treatment induced a
HO-1 overexpression in comparison with CIA arthritic con-
trol group (p<0.05 versus CIA) (Fig. 5B). Nrf2 activation has
been reported to play an important role in HO-1 expression.
According to our results, Nrf2 expression was similarly re-
duced in those arthritic animals fed with standard diet (SD;
p<0.001 versus naı¨ve) whereas a significant increase in Nrf2
protein levels was observed in CIA-HTy-Ac animals (p<0.05
versus CIA and p<0.05 versus CIA-HTy) (5B).
3.8 Effect of dietary HTy-Ac on MAPKs signaling
pathway
MAPKs play a key role inducing the pro-inflammatory gene
expression which initiates inflammatory responses. We in-
vestigated the effect of dietary HTy-Ac on MAPKs (JNK and
p38) signaling pathway activation in CIAmice. In the present
study, phosphorylation of JNK, p38 and ERK (1/2) proteins
increased significantly in cytosolic extracts from CIA mice
paw homogenates. Nonetheless, the proteins expression of
all phosphorylated MAPKs proteins, p-JNK, p-p38 and p-ERK
(1/2) was significantly ameliorated after dietary HTy-Ac treat-
ment (p<0.05 and p<0.01 versus CIA) (Fig. 6A). Again, the
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Figure 4. (A) Expression of
COX-2 and mPGES-1 in hind
paws. COX-2 and mPGES-1
were determined by western
blot, quantified by densitometry
and normalized with respect
to -actin. (B) Measurement
of PGE2 levels in hind paw
homogenates. These were
determined by ELISA kits. Data
represent mean ± SEM, n =
4. **p<0.01 and ***p<0.001
versus naı¨ve; ++p<0.01 and
+++p<0.001 versus CIA;
&&p<0.01 versus CIA-HTy.
HTy diet showed its ineffectiveness along the experimental
period.
3.9 Effects of dietary HTy-Ac on NF-B signaling
pathway
We also investigated the effects of HTy-Ac on IkB- degra-
dation in cytoplasmic extracts from mice joints. As shown
in Fig. 6B, IB- expression was significantly reduced in
CIA-induced arthritis mice when compared with naı¨ve mice
(p<0.001 versus naı¨ve). The IB- expression observed in
CIA mice was consistent with an increase in IB- degra-
dation thus allowing NF-B translocation into the nucleus
to bind specific DNA sequences leading to pro-inflammatory
genes transcription. According to the results obtained, the
effect observed in arthritic control group on IB- protein
degradation was prevented by dietary HTy-Ac treatment. On
the contrary, the nuclear p65 protein levels were signifi-
cantly increased inCIAgroup (p<0.001 versus naı¨ve) whereas
Figure 5. (A) Changes in p-STAT3 protein expression in hind paws homogenate. The expression of p-STAT3was quantified by densitometry
and normalized with respect to -actin. (B) HTy-Ac dietary upregulated HO-1 and Nrf2 protein expression in hind paws homogenate. The
expression was quantified by densitometry and normalized with respect to -actin. Data represent mean ± SEM, n = 4. ***p<0.001 versus
naı¨ve; +p<0.05 and ++p<0.01 versus CIA; &p<0.05 and &&p<0.01 versus CIA-HTy.
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Figure 6. (A) Effect of dietary HTy-Ac on JNK, p38 and ERK (1/2) MAPKs phosphorylation in hind paws homogenate. The expression of
phosphorylated proteins was expressed related to the expression of the corresponding total protein. (B) Expression of IB- in cytoplasmic
fraction and p65 NF-B in nuclear fraction of homogenates from hind paws. The expression was quantified by densitometry and normalized
with respect to -actin. Data represent mean ± SEM, n = 4. *p<0.05 and ***p<0.001 versus naı¨ve; +p<0.05, ++p<0.01 versus CIA; &p<0.05
and &&p<0.01 versus CIA-HTy.
dietaryHTy-Ac treatment prevented the CIA-induced nuclear
translocation level of p65 in paw homogenate in comparison
with those arthritic animals fed with SD (p<0.01 versus CIA)
(Fig. 6B) avoiding the NF-kB-mediated transcriptional activa-
tion. HTy diet failed tomodify IB- degradation and nuclear
p65 translocation in CIA mice.
4 Discussion
Our findings, have shown, for the first time, that dietary HTy-
Ac enrichment was able to prevent and down-regulate the
arthritic process in the CIA model of RA. This model is com-
monly used to investigate relevant pathogenic mechanisms
of RA as well as new antiarthritic treatments [19]. HTy-Ac
was described for the first time in olive oil by Brenes et al.
[20] and is found in most Spanish virgin olive oils. Moreover,
recently, it was reported by Mateos et al. [21] that HTy-Ac is
more soluble in the lipophilic phases than HTy, due to the
presence of the ester group, which was demonstrated in a
Caco-2 cell model. Thus, this increased lipophilicity suggests
that HTy-Ac is better absorbed across intestinal epithelial
cell monolayers than free HTy [22]. CIA induction resulted
in the development of a pronounced synovitis associated
with cartilage degradation and bone erosion [23]. However,
dietary HTy-Ac supplementation could improve the arthri-
tis score which was correlated with a minor migration of
inflammatory cells into articular tissues in addition to a
marked reduction of joint edema, synovial hyperplasia and
cartilage erosion in comparison with those animals fed with
SD and HTy enriched diets.
A role of humoral immunity in the pathogenesis of au-
toimmune arthritis is suggested by evidence derived from
animal models as well as patients with RA. Antibody/antigen
complexes are abundantly found in the joints of RA patients
and are believed to play a role in triggering the joint inflamma-
tion [24]. CIA pathogenesis is characterized by the generation
of anti-CII anti-bodies. All isotypes (IgG1, IgG2a and IgG2b)
of anti-CII antibodies were arthritogenic, with the IgG1 and
IgG2b isotypes as the dominating arthritogenic antibodies
[25]. In the present study, dietary HTy-Ac supplementation
significantly decreased serum levels of IgG1-and IgG2a-anti-
CII antibodies in CIA mice. These results suggest a potential
role for HTy-Ac in regulating B cell responses, which may be
in part, responsible for its anti-arthritic effects.
The development and progression of RA is closely related
to an imbalance of cytokine network. In RA synovium, ele-
vated levels of pro-inflammatory cytokines such as TNF-, IL-
1, IL-6, IL-17 and INF- are produced by macrophages and
synovial fibroblasts. These pro-inflammatory cytokines both
directly and indirectly exert their effects through the produc-
tion of additional pro-inflammatory cytokines, chemokines
and MMPs at the pannus cartilage junction leading to car-
tilage degradation [26–28]. In addition, TNF- stimulates
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osteoclastogenesis [29], suppresses the recruitment of os-
teoblasts and inhibit the expression of matrix genes [30],
whereas IL-6 increases osteoclast numbers in trabecular bone
[31]. Besides, IL-17 is a T cell-derived cytokine able to induce
the release of IL-8 and IL-6, and plays a considerable role in
the additive/synergistic effects induced by TNF- and IL-1
[32].
The present study showed that arthritic mice fed with
HTy-Ac enriched diet had decreased IL-1, IL-6, IFN-, IL-17
and TNF- levels in paw homogenate in comparison with
CIA mice fed with SD and HTy enriched diet. These results
indicate that dietary HTy-Ac exerts anti-inflammatory activi-
ties by the blockage of IL-1, IL-6, IFN-, IL-17 and TNF-
production.
COMP, a prominent non-collagenous component of car-
tilage, accounts for approximately 1% of the wet weight of ar-
ticular tissue and shows great potential as a biological marker
of cartilage metabolism in arthritis [33]. Increased fragments
of COMP have been reported in patients with osteoarthritis,
RA and joint injury, thus and the monitoring of COMP levels
in synovial fluid or serum has been suggested to be a helpful
method for assessing the presence and progression of arthri-
tis. In fact, serum COMP is reduced in RA patients in remis-
sion [33]. In addition, COMP is a putative substrate forMMPs.
In particular, MMP-3, is a proteinase secreted by synovial fi-
broblasts and chondrocytes. Its synthesis and activation is
induced by various factors, including pro-inflammatory cy-
tokines and Toll-like receptor ligand. Its activity is associated
with higher joint damage in RA [34] and CIA [4] and results in
degradation of aggrecan core protein, cartilage link protein,
fibronectin and collagen types IV, VII, IX and XI. Likewise,
serum MMP-3 level is suggested as a predictor for joint de-
struction in early RA or established RA and should be used in
association with usual inflammatory markers to follow ther-
apy efficiency [35]. Our data are in agreement with above
studies and showed that high serum COMP and MMP-3 lev-
els were associated with disease activity and joint progression
in CIA mice, by contrast the production of both cartilage and
synovial biomarkers were significantly inhibited by the HTy-
Ac enriched diet in CIA mice.
COX-2 and mPGES-1, enzymes responsible for the over-
production of PGE2 in inflammation, are up-regulated [36]
contributing to the progression of RA through EP4 recep-
tor activation [7]. We have shown that dietary HTy-Ac sup-
plementation reduced PGE2 levels which could be possibly
due to decreased expression of both COX-2 and mPGES-1
in the joint. Therefore, regulation of these pro-inflammatory
biomarkers by HTy-Ac could represent a potential molecular
target susceptible to HTy-Ac modulation, which has not been
demonstrated previously.
Signal transduction pathways closely involved in inflam-
mation include the MAPKs, JAK-STAT and NF-B pathways
[37,38]. In fact, NF-B nuclear transcription factor plays a piv-
otal role in the development and activation of Th-1 responses
[39] and is responsible in addition to MAPKs for COX-2 up-
regulation [40]. We investigated whether the activation of
NF-B signaling pathway was inhibited by HTy-Ac diet. Our
data are in agreement with Sanchez-Fidalgo et al. that showed
that HTy-Ac increased the inhibitory protein IkB- and re-
duced p65 translocation, indicating that dietary HTy-Ac in-
hibited the NF-B activation by blocking IB- degradation
in dextran sulfate sodium -induced colitis in mice [16].
MAPK family members, including p38 kinases, ERKs 1
and 2 and JNKs, are involved in many important cell pro-
cesses, mainly the regulation of the synthesis of chemokines,
cytokines, adhesionmolecules and PGs involved in RA [6,41].
Besides JNK MAPK modulates MMPs production by syn-
ovial fibroblasts and drives osteoclast differentiation in RA
[42]. In particular, p38 MAPK regulates MMP-3 induction
in fibroblasts [43] and osteoclast differentiation [44]. More-
over, MAPKs phosphorylate the JAK-STAT important in pro-
inflammatory cytokine-mediated signaling pathways such as
Th17 cell differentiation, leading to STAT-3 activation by
phosphorylation on tyrosine residues resulting in the for-
mation of STAT dimers that translocate into the nucleus to
bind specific DNA sequences [45]. In this line, STAT-3 over-
expression has been also detected in synovial membranes
from RA patients and it has been reported to contribute to
the chronicity of CIA induced arthritis model [4, 46]. Our
findings are in concordance with above reports and showed
that p38 and JNK MAPKs phosphorylation were increased
in CIA control mice. Similarly, STAT-3 overexpression was
also evidenced in RA synovium of control CIA mice and was
positively related to the severity of synovitis, whereas dietary
HTy-Ac supplementation reduced significantly both MAPKs
and STAT-3 activation at transcriptional level. Collectively,
our data suggest that dietary HTy-Ac may repress IL-17 pro-
duction interfering negatively with JNK, p-38, p-ERKMAPKs
and STAT-3 signaling pathways.
Nrf2, is a redox-sensitive transcription factor and binds
to antioxidant response elements (ARE) located in the pro-
moter regions ofmany detoxifying/antioxidant genes, includ-
ing HO-1 [47]. In inflammatory conditions, HO-1 expression
protein could be part of an adaptive mechanism to limit cy-
totoxicity via several mechanisms including scavenging of
reactive oxygen or nitrogen species, regulation of cell pro-
liferation and prevention of apoptosis. Likewise, it has been
reported that HO-1 deficiency in mice results in a chronic
inflammatory state [9]. Thus, Nrf2 regulates redox status and
plays key roles in cellular defense by enhancing the removal
of reactive oxygen species [48]. Furthermore, it has been doc-
umented that deficiency of Nrf2 accelerates the effector phase
of arthritis and aggravates joint disease [49]. In the present
study, in concordance with Karatas et al. [50], expressions of
Nrf2 and HO-1 were decreased in the arthritis group, by con-
trast dietaryHTy-Ac could restoreNrf2 andHO-1 expressions
conferring a role of Nrf2/HO-1 signaling in the beneficial ef-
fects of HTy-Ac in this murine model of RA.
Collectively, our study has demonstrated for the first time
the anti-inflammatory effects of dietary HTy-Ac in the CIA
model, which were accompanied by an important reduction
of the serum synovial and cartilage biomarkers COMP and
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MMP-3. The mechanisms underlying these protective effects
could be related to the regulation of B cell responses, activa-
tion of the Nrf2/HO-1 signaling and the inhibition of relevant
signaling pathways such as JAK-STAT, MAPKs and NF-B
thus controlling the production of inflammatory mediators
such as Th1 cytokines and PGE2. We concluded that HTy-
Ac supplement might provide a basis for developing a new
dietary strategy for the prevention of RA.
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The focus of the chapter I has been to demonstrate the potential protective role of a 
diet elaborated with EVOO in the prevention and development of inflammatory arthritis and 
joint damage in a murine CIA-induced experimental arthritis model. This model is commonly 
used to investigate mechanisms relevant to RA as well as new antiarthritic treatments 
(Ferrandiz, Maicas et al. 2008). CIA induction resulted in the development of a pronounced 
synovitis associated with an autoimmune response against cartilage and production of matrix 
degrading enzymes accompanying cartilage degradation and bone erosions (Schurgers, Billiau 
et al. 2011). The results of the present work clearly indicate, for the first time, that EVOO, as the 
lipid component of the diet, effectively exhibited preventive and therapeutic effects in the 
development of inflammatory arthritis and joint damage in CIA arthritic mice in comparison with 
those CIA mice fed with SO (Chapter I. Figure 1 A and B). This effect was well correlated to an 
improved arthritis score, a minor inflammatory cells infiltration into articular tissues, reduced 
exudation into the synovial space, synovial hyperplasia and cartilage erosion (Chapter I. Figure 
2).  
The pathogenesis of RA is closely related to an imbalance of cytokine network 
contributing to the development and progression of both CIA and RA (Komatsu and Takayanagi 
2012). Actually, overexpression of pro-inflammatory cytokines, such as IL-1β, TNF-α and IL-17 
may activate osteoclasts and macrophages and also recruit leukocytes in inflamed joints. The 
infiltrated leukocytes produce cytokines, chemokines and tissue destructive enzymes leading to 
chronic inflammation, cartilage damage and bone erosion. Besides, IL-17 is able to induce the 
release of IL-8, IL-6 and plays a remarkable role in the additive/synergistic effects induced by 
TNF-α and IL-1β (Jeong, Kim et al. 2004). Importantly, targeting IL-17 has demonstrated 
therapeutic effects in animal models of inflammatory and autoimmune diseases, including RA 
(Miossec and Kolls 2012). Cytokines also up-regulate MMPs expression by chondrocytes and 
synoviocytes at the pannus cartilage junction leading to cartilage degradation (Fossiez, Djossou 
et al. 1996, Azizi, Jadidi-Niaragh et al. 2013, Noack and Miossec 2014). Therefore, we examined 
TNF-α, IL-1ß and IL-17 levels in paw homogenates from CIA animals in comparison with naïve 
control group. Our results indicate that animals fed with EVOO diet showed a significant 
reduction in all pro inflammatory cytokines levels. Consequently, EVOO intake would contribute 
to reduce the inflammatory response and joint damage by suppressing the production of the 
key Th17 polarisation cytokines, TNF- α, and IL-1β, in CIA arthritic mice (Chapter I. Figure 4). 
COMP, is a matrix protein with a great potential as a biological marker of cartilage metabolism 
in arthritis (Saxne and Heinegard 1992). Increased fragments of COMP have been reported in 
patients with osteoarthritis, RA and joint injury; thus, the monitoring of COMP levels in synovial 
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fluid or serum has been suggested to be a helpful method for assessing the presence and 
progression of the inflammatory disease. In this sense, serum COMP levels are reduced in RA 
patients in remission (Saxne and Heinegard 1992, Lai, Yu et al. 2012). In addition, COMP is a 
putative substrate for MMPs. Particularly, MMP-3, is a proteinase secreted by synovial 
fibroblasts and chondrocytes. Its activity results in degradation of aggrecan core protein, 
cartilage link protein, fibronectin, and collagen types IV, VII, IX, and XI. MMP-3 is present in RA 
synovial fluid and overexpressed in rheumatoid synovium and then, associated with higher joint 
damage in RA (Ally, Hodkinson et al. 2013). Likewise, serum MMP-3 level is suggested as a 
predictor for joint destruction in early RA or established RA and should be used in association 
with usual inflammatory markers to follow therapy efficiency (Denarie, Constant et al. 2014). 
Our data are in agreement with above studies and showed that high serum COMP and MMP-3 
levels were associated with disease activity and joint progression in CIA mice, by contrast the 
production of both cartilage and synovial biomarkers were significantly inhibited by dietary 
EVOO treatment in CIA mice (Chapter I. Figure 3). 
Abnormal signalling pathways play an important role in the inflammatory process and 
can lead to dysregulation of the inflammatory response being crucial in RA pathogenesis. Signal 
transduction pathways closely involved in inflammation included the MAPKs, JAK-STAT and NF-
κB pathways (Morel and Berenbaum 2004). NF-κB is a crucial transcriptional activator for the 
expression of multiple proinflammatory genes in the microenvironment of the arthritic joints, 
including TNF-α, IL-1β, IL-6 and IL-17, that exert their influences on both osteoclasts and 
osteoblasts differentiation and thereby contributing to progressive joint destruction in RA 
patients and CIA mice (Okamoto, Yoshio et al. 2010, Molinero, Cubre et al. 2012) as mentioned 
above. In fact, several anti-rheumatic drugs, currently in clinical use, inhibit NF-κB activation 
(Hwang, Noh et al. 2013). Interestingly, intra-articular or systemic blockade of NF-κB signalling 
is an effective target in the treatment of arthritis in animal models of RA (Min, Yan et al. 2015). 
Taken together, these studies confirm the importance of NF-κB activation in the development 
of RA. Consequently, NF-kB pathway suppression could be a novel strategy for delaying the 
progress of RA. Our results suggested that dietary EVOO treatment suppressed NF-κB activation 
(Chapter I. Figure 8), down-regulating pro-inflammatory cytokines and MMP-3 expression thus 
minimizing joint destruction in CIA-induced arthritic mice. MAPK family members, including p38 
kinases, ERKs 1 and 2, and JNKs, play critical roles in many important cell processes, including 
cell division, differentiation, inflammation, and apoptosis. They are especially drawing attention 
in RA because of the involvement in regulating both cytokine production and cytokine action 
(Criado, Risco et al. 2014, Li, Li et al. 2014). In fact, JNK MAPK regulates MMPs production by 
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synovial fibroblasts and drives osteoclast differentiation in RA (Han, Boyle et al. 2001) and p38 
MAPK regulates MMP-3 induction in fibroblasts (Suzuki, Tetsuka et al. 2000) and osteoclast 
differentiation (Matsumoto, Sudo et al. 2000). Moreover, MAPKs phosphorylate the janus kinase 
signal transducer and activator of transcription (JAK-STAT) important in proinflammatory 
cytokine-mediated signalling pathway leading to STAT-3 activation (Aaronson and Horvath 
2002). STAT-3 has been described as a critical transcription factor involved in Th17 cell 
differentiation (Park, Lim et al. 2013). In this line, STAT-3 overexpression has been also detected 
in synovial membranes from RA patients and it has been reported to contribute to the chronicity 
of inflammation in a murine zymosan-induced arthritis model (de Hooge, van de Loo et al. 2004). 
Recently, STA-21, a promising STAT-3 inhibitor has shown antiarthritic effects in interleukin-1 
receptor antagonist-knockout (IL-1Ra-KO) mice, an animal model of RA (Park, Kwok et al. 2014). 
Our study showed that p38 and JNK MAPKs phosphorylations were increased in SO-CIA mice. 
Similarly, STAT-3 overexpression was also evidenced in RA synovium of SO-CIA mice and was 
positively related to the severity of synovitis. Whereas EVOO diet intake reduced significantly 
both MAPKs and STAT-3 activation at transcriptional level (Chapter I. Figures 5 and 7). 
 Altogether, our results suggest that dietary EVOO may repress IL-17 production interfering 
negatively with JNK and p-38 MAPKs and STAT-3 signalling pathways. HO-1 activity catabolises 
heme to carbon monoxide, iron and biliverdin, the latter being reduced to bilirubin by biliverdin 
reductase. Nrf2 plays a central role for expression of HO-1. In basal conditions, Nrf2 is 
sequestered in the cytoplasm by Kelch like ECH-associated protein1 (Keap1) and degraded by 
the ubiquitin dependent 26S proteasome system. Under activation, Nrf2 released from Keap1 
inhibition, translocate to the nucleus, heterodimerizes with Maf, and binds antioxidant response 
elements (AREs) located in the promoter regions of many detoxifying/antioxidant genes, 
including HO-1 (Bang, Kim et al. 2012). In inflammatory and immune conditions the expression 
of this protein could be part of an adaptative mechanism to limit cytotoxicity via several 
mechanisms including scavenging of reactive oxygen or nitrogen species, regulation of cell 
proliferation and prevention of apoptosis (Ferrandiz, Maicas et al. 2008). Likewise, it has been 
reported that HO-1 deficiency in mice results in a chronic inflammatory state (Minamino, 
Christou et al. 2001). Our data showed that HO-1 could represent a potential molecular target 
susceptible to EVOO modulation, which has not been demonstrated previously, since dietary 
EVOO treatment strongly augmented Nrf2 and HO-1 expression conferring a role of HO-1 in the 
beneficial effects of EVOO in this murine model of chronic inflammation (Chapter I. Figure 6). 
Since our results show that EVOO diet was more effective in reducing arthritis severity 
in comparison with SO diet, we could suggest that the responsibility for such beneficial 
 Resultados/Discusión general 
 
102 
 
properties could to be assigned to both an adequate fatty acid profile of EVOO and the presence 
of a high proportion of phenolic compounds. In this sense, a recent report showed that 
oleuropein aglycone, a polyphenol found in olive oil, exerted an anti-inflammatory effect and 
ameliorated the joint damage associated with CIA (Impellizzeri, Esposito et al. 2011). In addition, 
these improved effects observed could be due to a possible synergistic effect among EVOO 
constituents, since it is not clear whether all the possible beneficial mechanisms act 
independently of each other or whether they have a synergistic or competitive action (Lopez-
Miranda, Perez-Jimenez et al. 2010, de la Lastra Romero 2011). 
In the chapter II, we elucidated the effects of oral PE from EVOO treatment in murine 
CIA and study, the biochemical routes and signalling pathway involved. According to our results, 
we have demonstrated that oral administration of PE is able to down-regulate the arthritic 
process in the CIA model of RA (Chapter II. Figure 1 A and B). PE showed anti-inflammatory 
effects with reductions in joint oedema and migration of inflammatory cells. In addition, PE 
protected joints against cartilage alterations and bone erosion (Chapter II. Figure2). The 
progression of arthritis is associated with sustained production of proinflammatory cytokines 
(Goronzy and Weyand 2009). We have shown in the CIA model that PE controls the local levels 
of these cytokines driving the production of different inflammatory and catabolic mediators 
(Chapter II. Figure 3). These findings are in agreement with ours previous results evaluated in 
CIA mice fed with dietary EVOO.  
Particularly, proinflammatory cytokines induce further cytokines, chemokines, 
eicosanoids and reactive oxygen species amplifying the inflammatory response (Abramson and 
Amin 2002). Therefore, COX-2 and mPGES-1, enzymes responsible for the overproduction of 
PGE2 in inflammation, are up-regulated (Lazarus, Kubata et al. 2002) contributing to the 
progression of RA through EP4 receptor activation (McCoy, Wicks et al. 2002). We have shown 
that PE reduces PGE2 levels (Chapter II. Figure 3), which would be dependent on the down-
regulation of COX-2 and mPGES-1 expression in the joint (Chapter II. Figure 4 A and B). Cytokines 
also induce the expression of matrix metalloproteinases at the pannus cartilage junction leading 
to cartilage degradation (Okada, Nagase et al. 1987, Ribbens, Martin y Porras et al. 2002). In 
addition, TNFα stimulates osteoclastogenesis (Cenci, Weitzmann et al. 2000), suppresses the 
recruitment of osteoblasts and inhibits the expression of matrix genes (Nanes 2003) whereas IL-
6 increases osteoclast numbers in trabecular bone (Jilka, Hangoc et al. 1992). Therefore, 
inhibition of proinflammatory cytokine production by PE would result in the reduction of the 
inflammatory response and tissue damage. MAPK regulate the synthesis of chemokines, 
cytokines, adhesion molecules and PGs involved in inflammation. In addition, they mediate the 
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induction of matrix metalloproteinases responsible for cartilage breakdown. JNK1/2 and p38 are 
also involved in osteoclast differentiation and thus the activation of these enzymes may 
contribute to bone destruction (Thalhamer, McGrath et al. 2008). In particular, p38 plays a key 
role in RA (Hammaker and Firestein 2010). JAKs bind to intracellular domains of IL-6 or interferon 
receptors and catalyze ligand-induced phosphorylation of themselves and of intracellular 
tyrosine residues. Phosphorylation of STATs on tyrosine residues results in the formation of STAT 
dimers that translocate into the nucleus to bind specific DNA sequences. This pathway can be 
regulated by different protein kinases such as MAPK that phosphorylate STATs on serine 
residues to potentiate STAT-activating stimuli (Aaronson and Horvath 2002). STAT3 may 
contribute to the chronicity of inflammation in experimental arthritis (de Hooge, van de Loo et 
al. 2004). Our data indicate that PE administration is able to reduce the phosphorylation of JNK, 
p38 and STAT3, suggesting that PE could control the activation of these important signalling 
pathways during the arthritic process (Chapter II. Figures 5 and 6). 
The NF-κB pathway is involved in the transcription of many inflammatory genes 
(Foxwell, Browne et al. 1998). Cellular stimulation by proinflammatory cytokines induces the 
recruitment of costimulatory molecules, such as TNF receptor-associated factor (TRAF) leading 
to the activation of NF-κB-inducing kinase. This protein induces IκB kinase activation resulting in 
the phosphorylation of IκB (Morel and Berenbaum 2004), which is followed by ubiquitination 
and proteolytic degradation thus allowing the release of NF-κB to enter the nucleus and regulate 
gene transcription (Karin and Ben-Neriah 2000). Our results indicate that PE enhances the levels 
of the inhibitory protein IκB-α leading to the reduction of NF-κB nuclear translocation (Chapter 
II. Figure 7). This mechanism may be responsible for the down-regulation of proinflammatory 
cytokines in the joint during the CIA process in the animals treated with PE.  
Finally, in chapter III, we tried to deep insight into the effects of phenolic isolated 
compounds from minor PF from EVOO (HTy and HTy-Ac) in CIA model of RA, showing that dietary 
HTy-Ac enrichment was able to prevent and down-regulate the arthritic process. HTy-Ac was 
described for the first time in olive oil by Brenes et al. (Brenes, Garcia et al. 1999) and is found 
in most Spanish virgin olive oils. Moreover, recently, it was reported by Mateos et al. (Mateos, 
Trujillo et al. 2008) that HTy-Ac is more soluble in the lipophilic phases than HTy, due to the 
presence of the ester group, which was demonstrated in a Caco-2 cell model. Thus, this 
increased lipophilicity means that HTy-Ac is better absorbed across intestinal epithelial cell 
monolayers than free HTy (Rubio, Macia et al. 2012). CIA induction resulted in the development 
of a pronounced synovitis associated with cartilage degradation and bone erosion (Schurgers, 
Billiau et al. 2011). 
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Parallel to our results mentioned above in CIA animals treated with PE (Chapter II) or fed 
with EVOO diet (Chapter I), dietary HTy-Ac supplementation improved the arthritis score, which 
was correlated with a minor migration of inflammatory cells into articular tissues in addition to 
a marked reduction of joint oedema, synovial hyperplasia and cartilage erosion in comparison 
with those animals fed with SD and HTy-enriched diets (Chapter III. Figure 1 A, B and C).  
A role of humoral immunity in the pathogenesis of autoimmune arthritis is suggested by 
evidence derived from animal models as well as patients with RA. Antibody/antigen complexes 
are abundantly found in the joints of RA patients and are believed to play a role in triggering the 
joint inflammation (Mullazehi, Mathsson et al. 2007). CIA pathogenesis is characterized by the 
generation of anti-CII anti-bodies. All isotypes (IgG1, IgG2a and IgG2b) of anti-CII antibodies were 
arthritogenic, with the IgG1 and IgG2b isotypes as the dominating arthritogenic antibodies 
(Nandakumar, Andren et al. 2003). In the present study, dietary HTy-Ac supplementation 
significantly decreased serum levels of IgG1-and IgG2a-anti-CII antibodies in CIA mice (Chapter 
III. Figure 2 A and B). These results suggest a potential role for HTy-Ac in regulating B cell 
responses, which may be in part, responsible for its anti-arthritic effects.  
As mentioned above, the development and progression of RA is closely related to an 
imbalance of cytokine network. In fact, in RA synovium, elevated levels of pro-inflammatory 
cytokines such as TNF-α, IL-1β, IL-6, IL-17 and INF-γ are produced by macrophages and synovial 
fibroblasts. These pro-inflammatory cytokines both directly and indirectly exert their effects 
through the production of additional pro-inflammatory cytokines, chemokines and MMPs at the 
pannus cartilage junction leading to cartilage degradation (Komatsu and Takayanagi 2012, Azizi, 
Jadidi-Niaragh et al. 2013, Noack and Miossec 2014). In the present chapter, we showed that 
arthritic mice fed with HTy-Ac enriched diet had decreased IL-1β, IL-6, IFN-γ, IL-17 and TNF-α 
levels in paw homogenate in comparison with CIA mice fed with SD and HTy-enriched diet 
(Chapter III. Figure 3). These results indicate that dietary HTy-Ac exerts anti-inflammatory 
activities by the blockage of IL-1β, IL-6, IFN-γ, IL-17 and TNF-α production. 
Serum MMP-3 level is suggested as a predictor for joint destruction in early RA or established 
RA and should be used in association with usual inflammatory markers to follow therapy 
efficiency (Denarie, Constant et al. 2014). Our data are in agreement with numerous studies 
(Saxne and Heinegard 1992, Ally, Hodkinson et al. 2013) showing that high serum COMP and 
MMP-3 levels were associated with disease activity and joint progression in CIA mice, whereas, 
the production of both cartilage and synovial biomarkers were significantly inhibited by the HTy-
Ac enriched diet in CIA mice (Chapter III. Figure 2 C). 
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It is well-known that both COX-2 and mPGES-1 are up-regulated in RA joint patients (Lazarus, 
Kubata et al. 2002) contributing to the progression of the disease through EP4 receptor 
activation (McCoy, Wicks et al. 2002). In this sense, we have shown that dietary HTy-Ac 
supplementation reduced PGE2 levels, which could be possibly due to decreased expression of 
both COX-2 and mPGES-1 in the joint (Chapter III. Figure 4). Therefore, regulation of these pro-
inflammatory biomarkers by HTy-Ac could represent a potential molecular target susceptible to 
HTy-Ac modulation, which has not been demonstrated previously.  
Signal transduction pathways closely involved in inflammation include the MAPKs, JAK-
STAT and NF-κB pathways (Morel and Berenbaum 2004, Feldmann and Maini 2008). We 
investigated whether the activation of NF-κB signalling pathway was inhibited by HTy-Ac diet. 
Our data are in agreement with Sanchez-Fidalgo et al. that showed that HTy-Ac increased the 
inhibitory protein IkB-α and reduced p65 translocation (Chapter III. Figure 6 B), indicating that 
dietary HTy-Ac inhibited the NF-κB activation by blocking IκB-α degradation in dextran sulfate 
sodium-induced colitis in mice (Sanchez-Fidalgo, Villegas et al. 2015). 
Our findings are in concordance with above reports (de Hooge, van de Loo et al. 2004, 
Rosillo, Sanchez-Hidalgo et al. 2015)  and showed that p38 and JNK MAPKs phosphorylation were 
increased in CIA control mice. Similarly, STAT-3 overexpression was also evidenced in RA 
synovium of control CIA mice and was positively related to the severity of synovitis, whereas 
dietary HTy-Ac supplementation reduced significantly both MAPKs and STAT-3 activation at 
transcriptional level (Chapter III. Figures 5 A and 6 A). Collectively, our data suggest that dietary 
HTy-Ac may repress IL-17 production interfering negatively with JNK, p-38, p-ERK MAPKs and 
STAT-3 signalling pathways. 
In inflammatory conditions, it has been documented that deficiency of Nrf2 accelerates 
the effector phase of arthritis and aggravates joint disease (Maicas, Ferrandiz et al. 2011). In the 
present study, in concordance with Karatas et al. (Karatas, Koca et al. 2015), expressions of Nrf2 
and HO-1 were decreased in the arthritis group, by contrast dietary HTy-Ac could restore Nrf2 
and HO-1 expressions conferring a role of Nrf2/HO-1 signalling in the beneficial effects of HTy-
Ac in this murine model of RA (Chapter III. Figure 5 B). 
Altogether, our results suggest that EVOO exerts preventive effects in the development 
of experimental RA, playing its PE and isolated HTy-Ac compound a key role in these healthy 
benefits. Thus, EVOO may be considered as supportive nutritional therapy for RA patients as 
well as its PE and/or HTy-Ac supplement might provide an attractive nutraceutical complement 
in management of RA, mainly when the effects of inexpensive, side effect free therapies based 
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on dietary EVOO might suppose an improvement in public health on the prevention of high 
prevalence chronic pathologies. 
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Introduction 
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by 
inflammation of the synovial membrane and progressive destruction of the articular cartilage 
and bone. (Salgado and Maneiro 2014).  
RA patients exhibit an inflammatory chronic condition, which usually affects 
symmetrically arthrodial and small joints of hands and feet 
Global prevalence of RA has been estimated to be around 0.5-1.0% of adults in 
developed countries with a large variation across regions and approximately three-times more 
common in the female gender. The disease may begin at any age, but around 80% of all patients 
initiate the disease between the ages of 35 and 50 years (Rudan et al. 2015).  
Although the specific triggers and exact mechanisms of tissue damage in RA is still 
unknown, an increase in inflammatory mediators as well as a dysregulation of the immune 
system with uncontrolled T cell activity, play a remarkable role in its pathogenesis. 
Pharmacological treatment in AR including nonsteroidal anti-inflammatory drugs (NSAIDs), 
glucocorticoids, disease-modifying antirheumatic drugs (DMARDs) and biological agents have 
improved the signs and symptoms of RA, but these drugs are only effective in a fraction of 
patients and have other limitations including a high cost, the requirement for parenteral 
administration and important side effects.  Therefore, new therapeutic strategies are under 
investigation including nutritional therapy. The beneficial effects of the Mediterranean diet have 
been proven not only in cardiovascular diseases but also in diabetes, obesity, arthritis and cancer 
(Cardeno, Sanchez-Hidalgo, and Alarcon-de-la-Lastra 2013).  Evidence points out that 
Mediterranean diet decreases both pain and disease activity leading to better outcomes, and 
decreasing the doses of anti-inflammatory drugs, which exhibit important secondary effects 
(Smedslund et al. 2010). 
 Olive Oil is the characteristic culinary fat of the Mediterranean area being described as 
a key bio-active food (Puertollano et al. 2010). Extra virgin olive oil (EVOO) is obtained from the 
fruit of the olive tree (Olea europea L.) solely by mechanical or other physical means under 
conditions that do not alter its natural composition. 
Traditionally the beneficial effects of EVOO have been ascribed to its monounsaturated 
fatty acid (MUFA) (Bermudez et al. 2011). However, a wide range of evidence indicates that 
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many of the beneficial effects of EVOO intake are due to its minor highly bioactive components 
(about 1–2 % of oil weight) (Alarcon de la Lastra et al. 2001)  
Among them, phenolic compounds such as hydroxytyrosol, tyrosol and oleuropein have 
shown anti-inflammatory and antioxidant effects (Omar et al. 2010). Current experimental 
studies support a beneficial role of polyphenols from EVOO in several inflammatory diseases, 
including RA (Martinez-Dominguez, de la Puerta, and Ruiz-Gutierrez 2001; Impellizzeri et al. 
2011; Gong et al. 2009). Although EVOO has demonstrated anti-inflammatory effects, it has not 
reported so much evidence of its possible immunomodulatory effects. 
Therefore, the objectives of this thesis were: 
1. To determinate the possible protective effect of dietary extra virgin olive oil (EVOO) 
in collagen-induced arthritis (CIA) in DBA 1/J mice, an experimental model of RA and 
explore the biochemical routes and possibly intracellular signalling pathways. 
 
2. To evaluate the oral polyphenolic extract from EVOO treatment in murine collagen-
induced arthritis and study the biochemical routes and signalling pathway involved. 
 
3. To investigate the effects of hydroxytyrosol (HTy) or hydroxytyrosol acetate (HTy-
Ac), polyphenolics compounds from EVOO enriched-diets in experimental arthritis 
model in mice and elucidate the molecular mechanisms and signalling pathways 
involved. 
 
Results and Discussion 
 
1. Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix 
degradation in murine collagen‑induced arthritis. (Rosillo et al. Eur J Nutr. 2015 In 
press) 
Three-week-old male DBA-1/J mice were randomized into four experimental groups: (1) 
Sham sunflower diet (SO-Sham) group received a diet elaborated with a marketable sunflower 
oil; (2) CIA sunflower diet (SO-CIA) group received a diet elaborated with a marketable sunflower 
oil; (3) Sham EVOO diet (EVOO-Sham) group were fed with a diet made with a marketable EVOO 
picual variety and (4) CIA EVOO diet (EVOO-CIA) group were fed with a diet made with a 
marketable EVOO picual variety. After 6 weeks, arthritis was induced by type II collagen. 
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Experiments followed a protocol approved by the Animal Ethics Committee of the University of 
Seville, and all experiments were in accordance with the recommendations of the European 
Union regarding animal experimentation (Directive of the European Counsel 2010/630/EU) 
Our results revealed, that EVOO, as the lipid component of the diet, effectively exhibited 
preventive and therapeutic effects in the development of inflammatory arthritis and joint 
damage in CIA arthritic mice in comparison with those CIA mice fed with SO. This effect was 
correlated to an improved arthritis score, a minor inflammatory cells infiltration into articular 
tissues, reduced exudation into the synovial space, synovial hyperplasia and cartilage erosion. 
Overexpression of pro-inflammatory cytokines, such as IL-1β, TNF-α and IL-17 may activate 
osteoclasts and macrophages and recruit leukocytes in inflamed joints. Besides, it is well-known 
that IL-17 is able to induce the release of IL-8 and IL-6, and plays a remarkable role in the 
additive/synergistic effects induced by TNF-α and IL-1β (Jeong et al. 2004). Our results indicate 
that animals fed with EVOO diet showed a significant reduction in IL-1β, TNF-α and IL-17 pro-
inflammatory cytokines levels in paw homogenates.  
Cartilage oligomeric matrix protein (COMP) is a matrix protein with a great potential as 
a biological marker of cartilage metabolism in arthritis (Saxne and Heinegard 1992). In addition, 
COMP is a putative substrate for metalloproteinases (MMPs). Particularly, MMP-3 is a 
proteinase secreted by synovial fibroblasts and chondrocytes and its activity results in 
degradation of aggrecan core protein, cartilage link protein, fibronectin and collagen. Our data 
showed that the production of both cartilage (COMP) and synovial (MMP-3) biomarkers was 
significantly inhibited by dietary EVOO treatment in CIA mice. 
Abnormal signalling pathways play an important role in the inflammatory process and 
can lead to a dysregulation of the inflammatory response being crucial in RA pathogenesis. 
Nuclear factor κB (NF-κB) is a crucial transcriptional activator for the expression of multiple pro-
inflammatory genes involved in the microenvironment of the arthritic joints, playing an 
important role in the development of RA. (Morel and Berenbaum 2004; Okamoto et al. 2010). 
Our results suggested that dietary EVOO treatment suppressed NF-κB activation in CIA-induced 
arthritic mice. Similarly, the mitogen-activated protein kinase (MAPK) family also plays critical 
roles in RA pathogenesis (Han et al. 2001; Suzuki et al. 2000) regulating  cytokine production, 
and  activating the janus kinase-signal transducer and activator of transcription (JAK-STAT) 
signalling pathway through STAT-3 phosphorylation (Aaronson and Horvath 2002). Our results 
demonstrated that EVOO diet intake reduced significantly both MAPKs and STAT-3 activation. 
On the other hand, nuclear factor E2-related factor 2 (Nrf2) plays a central role for expression 
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of heme oxigenase 1 (HO-1), antioxidant enzyme. Our data showed that HO-1 could represent a 
potential molecular target susceptible to EVOO modulation, since dietary EVOO treatment 
strongly augmented Nrf2 and HO-1 protein expression conferring a role of HO-1 in the beneficial 
effects of EVOO in this murine model of chronic inflammation. 
Altogether, our results confirm, for the first time, that EVOO intake dramatically 
attenuated the progression and severity of arthritis in CIA DBA/1 J mice through Nrf2/HO-1 
upregulation and NF-κB, MAPKs and JAK-STAT signalling pathway inhibition, decreasing the 
inflammatory cascade induced by CIA. 
 
2. Anti-inflammatory and joint protective effects of extra-virgin olive-oil polyphenol 
extract in experimental arthritis. (Rosillo et al. Pharmacol Res. 2012;66(3):235-42.) 
 
CIA was induced in nine-weeks-old male DBA-1/J mice. On day 29, animals were 
randomized in four groups of mice: naïve group (NA), CIA group (CIA) and two treatment groups: 
CIA mice with polyphenolic extract (PE) treatment (PE 100 and 200 mg/kg, orally, once a day 
from days 29 to 41). 
In this study, we have demonstrated that oral administration of PE was able to down-
regulate the arthritic process in the CIA model of RA. PE showed anti-inflammatory effects with 
reductions in joint edema and migration of inflammatory cells. In addition, PE protected joints 
against cartilage alterations and bone erosion. The progression of arthritis is associated with 
sustained production of pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6 (Goronzy and 
Weyand 2009). Our data shown that PE treatment controls the local levels of these cytokines, 
driving the production of different inflammatory and catabolic mediators in CIA model.  
In this sense, COX-2 and microsomal prostaglandin E synthase-1 (mPGES-1), enzymes 
responsible for the overproduction of PGE2 in inflammation, are dramatically up-regulated 
(Lazarus et al. 2002) contributing to the progression of RA through EP4 receptor activation 
(McCoy, Wicks, and Audoly 2002). Our data suggest that PE reduces PGE2 levels, which would be 
dependent on the down-regulation of COX-2 and mPGES-1 protein expression in the joint. 
In addition, PE treatment inhibits the phosphorilation of JNK and p38 MAPK and 
transcription factor STAT-3. Similarly, PE addition decreases NF-κB nuclear translocation leading 
to the down-regulation of the arthritic process. 
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In summary, our study has demonstrated, for the first time, the anti-inflammatory and 
joint protective effects of PE from EVOO in a CIA-induced experimental model, which would be 
related to the inhibition of relevant signalling pathways such as NF-κB, JAK/STAT and MAPKs 
controlling the production of inflammatory mediators. 
 
3. Preventive effects of dietary hydroxytyrosol acetate, an extra virgin olive oil 
polyphenol in murine collagen-induced arthritis. (Rosillo et al. Mol Nutr Food Res. 2015. 
In press) 
Three-weeks-old male DBA-1/J mice, were randomized into four experimental groups 
during all experimental period: (i) naïve group received a standard diet (SD), (ii) CIA group 
received a SD, (iii) CIA-HTy group received a 0.05% HTy diet and (iv) CIA-HTy-Ac group received 
a 0.05% HTy-Ac diet. After 6 weeks, arthritis was induced by type II collagen. 
HTy-Ac was described for the first time in olive oil by Brenes et al. (Brenes et al. 1999) 
and is found in most Spanish virgin olive oils. Moreover, recently, it was reported that HTy-Ac is 
more soluble in the lipophilic phases than HTy, due to the presence of the ester group. Thus, 
this increased lipophilicity suggests that HTy-Ac is better absorbed across intestinal epithelial 
cell monolayers than free HTy (Rubio et al. 2012). 
Our findings have revealed that dietary HTy-Ac supplementation could improve the 
arthritis score which was correlated with a minor migration of inflammatory cells into articular 
tissues in addition to a marked reduction of joint edema, synovial hyperplasia and cartilage 
erosion in comparison with those animals fed with standard diet (SD) and hydroxytyrosol (HTy) 
enriched diets. 
CIA pathogenesis is characterized by the generation of anti-CII anti-bodies (Nandakumar 
et al. 2003). All isotypes (IgG1, IgG2a and IgG2b) of anti-CII antibodies were arthritogenic, with 
the IgG1 and IgG2b isotypes as the dominating arthritogenic antibodies (Nandakumar et al. 
2003). Our results demonstrated that dietary HTy-Ac supplementation significantly decreased 
serum levels of IgG1-and IgG2a-anti-CII antibodies in CIA mice. These results suggest a potential 
role for HTy-Ac in regulating B cell responses, which may be in part, responsible for its anti-
arthritic effects. 
Our results shown that arthritic mice fed with HTy-Ac enriched diet had decreased 
serum COMP and MMP-3 levels, as well as, pro-inflammatory cytokines such as IL-1β, IL-6, IFN-
γ, IL-17 and TNF-α levels in paw homogenate in comparison with CIA mice fed with SD and HTy 
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enriched diet. Moreover, the activation of JAK/STAT, MAPKs and NF-κB pathways were 
drastically ameliorated whereas Nrf2 and HO-1 protein expressions were significantly up-
regulated in those mice fed with HTy-Ac. 
As a conclusion, our study reveals, for the first time, the anti-inflammatory effects of 
dietary HTy-Ac in the CIA model. The mechanisms underlying these protective effects could be 
related to the regulation of B cell responses, activation of the Nrf2/HO-1 signalling pathway and 
the inhibition of relevant signalling pathways such as JAK-STAT, MAPKs and NF-κB controlling 
the production of inflammatory mediators. 
Conclusion 
Altogether, our results suggest that EVOO exerts preventive effects in the development 
of experimental RA, playing its multiple minor components a key role in these healthy benefits. 
Thus, EVOO may be considered as supportive nutritional therapy for RA patients as well as its 
poliphenolic fraction might provide an attractive nutraceutical complement in management of 
RA, mainly when the effects of inexpensive, side effect-free therapies based on dietary EVOO 
might suppose an improvement in public health on the prevention of chronic pathologies with 
high prevalence in the population. 
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